ATS posts C$5M Q2 loss, drops FY2027 growth goal
Customer order timing and tariff uncertainty accompanied management's revised fiscal 2027 outlook and $640 million to $680 million third-quarter revenue range.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
ATS Corporation (ATS) reported fiscal 2027 second-quarter revenue of $665.8 million in Canadian dollars, down 8.6% year over year, and a $5.0 million net loss versus $33.6 million net income. Adjusted earnings from operations were $57.4 million versus $79.1 million; adjusted EBITDA was $80.7 million versus $103.7 million. Order Bookings rose 12.7% to $827 million, while Order Backlog was $2,009 million, down 2.9% year over year.
Management no longer expects its fiscal 2027 goals for modest revenue growth and 50 to 75 basis points of margin expansion. Third-quarter revenue is expected to be $640 million to $680 million. It attributed non-life-sciences booking delays, particularly in packaging equipment, to customer order timing and tariff uncertainty. The Fixed Cost Transformation Program is designed to deliver $65 million to $75 million in annualized savings; announced actions are expected to reduce the workforce, including subcontractors, by approximately 300 to 400.
Net debt to pro forma adjusted EBITDA was 3.1 times at September 27, 2026, above the 2.0-to-3.0-times target range; management cited repurchases of 2,244,461 shares for $61.3 million as a factor. After quarter-end, ATS completed sales of two U.S. facilities for $71.2 million consideration, with an estimated gain of approximately $12.2 million.
2 points · 0 major0 major · 3 points
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointEnergy revenue increased 45.1% year over year to $74.0 million.
- Moderate pointFacility sales: $71.2 million consideration; approximately $12.2 million estimated gain. 3.8% of market cap
Negative
- Moderate pointRevenue fell 8.6% to $665.8 million.
- Moderate pointNet loss was $5.0 million versus prior-year net income of $33.6 million.
- Moderate pointAdjusted EBITDA declined 22.2% to $80.7 million.
Filing Explained
ATS's normal-course issuer bid allows purchases for cancellation of up to 8,225,621 shares through December 21, 2026, with 5,981,160 still available at September 27; that remaining amount is authorization, not a reported commitment to buy.
Key Figures
Revenue (Canadian dollars): $665.8 million
Net income (loss): Loss of $5.0 million
Adjusted earnings from operations: $57.4 million
+5 more
8 metrics
Revenue (Canadian dollars)
$665.8 million
Second quarter fiscal 2027; down 8.6% year over year.
Net income (loss)
Loss of $5.0 million
Three months ended September 27, 2026; prior-year net income was $33.6 million.
Adjusted earnings from operations
$57.4 million
Second quarter fiscal 2027, compared with $79.1 million a year earlier.
Adjusted EBITDA
$80.7 million
Second quarter fiscal 2027; down 22.2% from $103.7 million.
Order Bookings
$827 million
Second quarter fiscal 2027; up 12.7% from $734 million.
Order Backlog
$2,009 million
As of September 27, 2026; down 2.9% year over year.
Third-quarter revenue outlook
$640 million to $680 million
Expected for the third quarter of fiscal 2027.
Annualized cost savings
$65 million to $75 million
Designed outcome of the Fixed Cost Transformation Program.
Key Terms
Adjusted EBITDA, Order Bookings, Order Backlog, book-to-bill ratio, +1 more
5 terms
Adjusted EBITDA financial
"Adjusted EBITDA was $80.7 million"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
Order Bookings financial
"Order Bookings in the second quarter were $827 million"
Order bookings are the value of customer orders a company has received during a period, similar to a restaurant taking reservations for future meals. They show demand before sales are recorded and help investors gauge future revenue and production needs; rising bookings can signal growing sales momentum, while falling bookings may warn of weakening demand. Because bookings may be subject to cancellations or timing differences, they are an indicator rather than guaranteed revenue.
Order Backlog financial
"Order Backlog of $2,009 million at period-end"
Order backlog is the total value or number of customer orders a company has received but not yet fulfilled or delivered. It acts like a queue at a busy restaurant: a healthy backlog signals steady future sales and revenue visibility, while a growing backlog can also warn of production bottlenecks, delayed cash collection, or rising costs — all important when assessing a company’s near-term performance and operational risks.
book-to-bill ratio financial
"book-to-bill ratio being approximately 1.05:1"
The book-to-bill ratio compares the value of new orders a company receives to the value of products it ships out or bills for over a certain period. If the ratio is above 1, it means the company is getting more orders than it is completing, which can indicate growth. If it's below 1, it suggests demand is slowing down.
normal course issuer bid financial
"purchased 2,244,461 common shares under the NCIB program"
A Normal Course Issuer Bid is when a company buys back its own shares from the stock market over time. This usually shows that the company believes its stock is undervalued and wants to support its price, which can be important for investors to watch.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were ATS's revenue and net income in Q2 fiscal 2027?
ATS reported revenue of $665.8 million and a net loss of $5.0 million for the quarter ended September 27, 2026. Revenue was down 8.6% from the prior-year quarter, when ATS reported $728.5 million in revenue and $33.6 million in net income.
What is ATS's third-quarter fiscal 2027 revenue outlook?
Management expects revenue of $640 million to $680 million for the third quarter of fiscal 2027. Its estimates assess project schedules across customer contracts in Order Backlog, faster-turn product and services revenue, third-party equipment delivery timing, and operational capacity.
What savings and workforce changes does ATS expect from its Fixed Cost Transformation Program?
The program is designed to deliver $65 million to $75 million of annualized cost savings. Announced actions are expected to reduce the workforce, including subcontractors, by approximately 300 to 400. Implementation is expected to continue over the next 15 months, with benefits accruing as actions are completed within the original 18-month timeframe.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2026
Commission File Number: 001-41713
ATS CORPORATION
(Translation of registrant’s name into English)
730 Fountain Street North
Building 3
Cambridge, Ontario N3H 4R7
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐ Form 40-F ☒
INCORPORATION BY REFERENCE Exhibits 99.1 and 99.2 of this form 6-K are incorporated by reference as additional exhibits to the registrant's Registration Statements on Form F-10 (File No. 333-278270) and Form S-8 (File No. 333-273050). | ||
99.1 | Management's Discussion and Analysis of the registrant for the quarter ended September 27, 2026 | ||||
99.2 | Financial Statements of the registrant for the quarter ended September 27, 2026 | ||||
99.3 | Certification of Interim Filings - Chief Executive Officer | ||||
99.4 | Certification of Interim Filings - Chief Financial Officer | ||||
99.5 | Press Release dated November 4, 2026 | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ATS CORPORATION (Registrant) | ||||||||||||||||||||
Date: November 4, 2026 | By: | /s/ Gordon Raman | ||||||||||||||||||
Name: Gordon Raman | ||||||||||||||||||||
Title: Chief Legal Officer | ||||||||||||||||||||
Exhibit 99.1 | ||
ATS CORPORATION
Management's Discussion and Analysis
For the Quarter Ended September 27, 2026
TSX: ATS
NYSE: ATS
NYSE: ATS
Management's Discussion and Analysis
For the Quarter Ended September 27, 2026
This Management's Discussion and Analysis ("MD&A") for the three and six months ended September 27, 2026 ("second quarter of fiscal 2027") is as of November 4, 2026 and provides information on the operating activities, performance and financial position of ATS Corporation ("ATS" or the "Company"). It should be read in conjunction with the unaudited interim condensed consolidated financial statements of the Company for the second quarter of fiscal 2027, which have been prepared in accordance with International Accounting Standard ("IAS") 34 – Interim Financial Reporting, and are reported in Canadian dollars. All references to "$" or "dollars" in this MD&A are to Canadian dollars unless otherwise indicated. The Company assumes that the reader of this MD&A has access to, and has read, the audited consolidated financial statements of the Company prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board and the MD&A of the Company for the year ended March 31, 2026 ("fiscal 2026 MD&A"), and accordingly, the purpose of this document is to provide a second quarter of fiscal 2027 update to the information contained in the fiscal 2026 MD&A. Additional information is contained in the Company's filings with Canadian and U.S. securities regulators, including its annual information form for fiscal 2026 ("AIF"), found on the Company's profile on System for Electronic Data Analysis and Retrieval+ ("SEDAR+") at www.sedarplus.com, on the Company's profile on the U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis and Retrieval System ("EDGAR") website at www.sec.gov, and on the Company's website at www.atsautomation.com.
IMPORTANT NOTES
Forward-Looking Statements
This document contains forward-looking information within the meaning of applicable securities laws. Please see "Forward-Looking Statements" for further information on page 32.
Non-IFRS and Other Financial Measures
Throughout this document, management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures within the meaning of applicable securities laws to evaluate the performance of the Company. See "Non-IFRS and Other Financial Measures" on page 36 for an explanation of such measures and "Reconciliation of Non-IFRS Measures to IFRS Measures" beginning on page 24 for a reconciliation of non-IFRS measures.
COMPANY PROFILE
ATS is an industry leader in planning, designing, building, commissioning and servicing automated manufacturing and assembly systems - including automation products and test solutions - for a broadly diversified base of customers. ATS' reputation, knowledge, global presence and standard automation technology platforms differentiate the Company and provide competitive advantages in the worldwide manufacturing automation market for life sciences, industrial & consumer, food & beverage, and energy. Founded in 1978, ATS employs over 7,000 people at more than 65 manufacturing facilities and over 85 offices in North America, Europe, Asia and Oceania. The Company's website can be found at www.atsautomation.com. The Company's common shares are traded on the Toronto Stock Exchange ("TSX") and the New York Stock Exchange ("NYSE") under the symbol ATS.
1
STRATEGY
To create sustainable shareholder value, the Company employs a three-part value creation strategy: Build, Grow and Expand.
Build: To build on the Company's foundation and drive performance improvements, management is focused on the advancement of the ATS Business Model ("ABM"), the pursuit and measurement of value drivers and key performance indicators, a rigorous strategic planning process, succession planning, talent management, employee engagement, and instilling autonomy with accountability.
Grow: To drive organic growth, ATS has developed and implemented growth tools under the ABM, which provide innovation and value to customers and work to grow reoccurring revenues.
Expand: To expand the Company's reach, management is focused on the development of new markets and business platforms, expanding service offerings, investment in innovation and product development, along with strategic and disciplined acquisitions that strengthen ATS.
The Company pursues all of its initiatives by using a strategic capital framework aimed at driving the creation of long-term sustainable shareholder value.
ATS Business Model
The ABM is a business management system that ATS developed with the continuing goal of enabling the Company to pursue its strategies, outpace the growth of its chosen markets, and drive year-over-year continuous improvement. The ABM emphasizes:
•People: developing, engaging and empowering ATS' people to build the best team;
•Process: aligning ATS' people to implement and continuously improve robust and disciplined business processes throughout the organization; and
•Performance: consistently measuring results in order to yield world-class performance for ATS' customers and shareholders.
The ABM is ATS' playbook, serving as the framework to achieve business goals and objectives through disciplined, continuous improvement. The ABM is employed by ATS divisions globally and is supported with extensive training in the use of key problem-solving tools, and applied through various projects to drive continuous improvement. When ATS makes acquisitions, the ABM is quickly introduced to new companies as a means of supporting cultural and business integration.
2
FINANCIAL HIGHLIGHTS
(In millions of dollars, except per share and margin data)
Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Variance | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | Variance | |||||||||||||||||||||||||||
| Revenues | $ | 665.8 | $ | 728.5 | (8.6)% | $ | 1,359.5 | $ | 1,465.2 | (7.2)% | ||||||||||||||||||||||
Adjusted revenues1 | $ | 665.8 | $ | 728.5 | (8.6)% | $ | 1,364.1 | $ | 1,465.2 | (6.9)% | ||||||||||||||||||||||
Net income (loss) | $ | (5.0) | $ | 33.6 | (114.9)% | $ | (5.3) | $ | 57.9 | (109.2)% | ||||||||||||||||||||||
Adjusted earnings from operations1 | $ | 57.4 | $ | 79.1 | (27.4)% | $ | 125.5 | $ | 157.7 | (20.4)% | ||||||||||||||||||||||
Adjusted earnings from operations margin2 | 8.6% | 10.9% | (224)bps | 9.2% | 10.8% | (156)bps | ||||||||||||||||||||||||||
Adjusted EBITDA1 | $ | 80.7 | $ | 103.7 | (22.2)% | $ | 173.4 | $ | 205.3 | (15.5)% | ||||||||||||||||||||||
Adjusted EBITDA margin2 | 12.1% | 14.2% | (211)bps | 12.7% | 14.0% | (130)bps | ||||||||||||||||||||||||||
Basic earnings (loss) per share | $ | (0.05) | $ | 0.34 | (114.7)% | $ | (0.05) | $ | 0.59 | (108.5)% | ||||||||||||||||||||||
Adjusted basic earnings per share1 | $ | 0.27 | $ | 0.45 | (40.0)% | $ | 0.62 | $ | 0.85 | (27.1)% | ||||||||||||||||||||||
Order Bookings3 | $ | 827 | $ | 734 | 12.7% | $ | 1,482 | $ | 1,427 | 3.9% | ||||||||||||||||||||||
| As At | September 27 2026 | September 28 2025 | Variance | ||||||||||||||
Order Backlog3 | $ | 2,009 | $ | 2,070 | (2.9)% | ||||||||||||
1Non-IFRS financial measure — See "Non-IFRS and Other Financial Measures."
2Non-IFRS ratio — See "Non-IFRS and Other Financial Measures."
3Supplementary financial measure — See "Non-IFRS and Other Financial Measures."
EXECUTIVE UPDATE
Updated fiscal 2027 performance expectations
Management continues to see healthy activity in the Company's pipelines across its chosen end markets, supported by its differentiated technologies, deep domain expertise, and strong customer relationships. In the second quarter of fiscal 2027, Order Bookings were $827 million, including the highest life sciences quarterly total since the second quarter of fiscal 2025, and the Company's second-highest quarter of life sciences Order Bookings on record. Strength in radiopharmaceuticals and medical devices markets drove Order Bookings, resulting in ATS' book-to-bill ratio being approximately 1.05:1 on a trailing-twelve-month basis. Management also continues to see increasing revenue contribution from services and remains well positioned to participate in the long-term growth of the nuclear and radiopharmaceutical markets, although customer awards in these markets can vary in timing and size.
During the second quarter of fiscal 2027, the Company experienced temporary delays in Order Bookings within its non-life sciences businesses, primarily related to packaging automation equipment. These delays reflected a timing shift in customer orders, which was further exacerbated by tariffs imposed under Section 338 of the Tariff Act of 1930 ("Section 338 tariffs") that came into effect in late August 2026 following the breakdown of trade talks between Canada and the U.S. and affected packaging equipment manufactured in Canada and sold into the U.S. As a result of these delays and the execution time for the Company's Order Backlog to convert to revenues, Management does not expect to achieve
3
its previous goals for modest revenue growth and for margin expansion of 50 to 75 basis points in fiscal 2027. Third quarter fiscal 2027 revenues are expected to be $640 million to $680 million. Management's revenue estimates are calculated each quarter based on the assessment of project schedules across all customer contracts in Order Backlog, expectations for faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity.
At the end of October the U.S. announced modifications to Section 338 tariffs, which eliminate the impact on a majority of the covered products. This modification is expected to be beneficial to ATS and its affected customers as they digest the various changes over time and advance their capital expenditure plans. The near-term impact has been driven primarily by customer deferral of capital decisions, including as a result of tariff uncertainty, rather than by the Company's ability to serve those customers, or the strength of the Company's pipelines. The Company's global manufacturing footprint provides the flexibility to shift production of tariff-impacted volume to U.S. facilities if needed and the Company has been evaluating such adjustments in consultation with affected customers.
Fixed Cost Transformation Program and margin expansion update
In the second quarter of fiscal 2027, the Company advanced the implementation of its previously announced Fixed Cost Transformation Program, a multi-phase initiative to simplify its operating structure, optimize its global footprint and reduce fixed costs. When completed, the program is designed to deliver $65 million to $75 million of annualized cost savings, equivalent to approximately 250 basis points of adjusted earnings from operations margin. This represents approximately half of the 500 basis points of adjusted earnings from operations margin expansion required to move from ATS' fiscal 2026 base of approximately 10% to the Company's long-term target of 15%. The Company has made initial progress in line with its expectations; however, lower revenues and mix are temporarily offsetting the benefits of the program in the near term. To date, the Fixed Cost Transformation Program has resulted in several announced facility closures, including in Europe, which will result in the reduction of approximately 10% in the Company's overall square footage. As a result of the announced actions from Fixed Cost Transformation and other restructuring activities, the Company expects to reduce its workforce, including subcontractors, by approximately 300 to 400, with additional adjustments expected as further steps in the program are taken.
Of the $21.3 million of restructuring costs recorded in the second quarter of fiscal 2027, approximately half was related to the Fixed Cost Transformation Program. Management continues to expect that payback on restructuring will be less than one year, with some variability depending on jurisdiction.
Given the nature of the facility and reorganization activities involved, implementation is expected to continue over the next 15 months, with benefits accruing progressively as program actions are completed within the original 18-month timeframe.
Management continues to believe that executing on the Company's long-term growth opportunities and operational-improvement initiatives, together with portfolio optimization and cost-reduction activities, including the Fixed Cost Transformation Program, support the Company's achievement of its long-term adjusted earnings from operations margin target of 15%.
Second quarter performance summary
•Second quarter revenues were $665.8 million and decreased by 8.6% year-over-year, due to a more normalized level of GLP-1-related activities compared to the prior year and lower activity in other non-life sciences businesses, partially offset by growth in energy and revenues from services.
4
•Order Bookings in the second quarter were $827 million, compared to $734 million in the second quarter last year, an increase of 12.7%. The increase primarily reflected the inclusion of large enterprise orders in the current fiscal year, partially offset by lower nuclear refurbishment order activity compared to the prior-year period, primarily based on customer ordering cycles in this space, as expected. The funnel in the Company's chosen markets remains healthy, despite variability in timing and magnitude of Order Bookings.
•Order Backlog of $2,009 million at period-end was 2.9% lower than the second quarter last year. Order Backlog remains distributed across strategic global markets and regulated industries and provides good revenue visibility. The Company is committed to outpacing the growth of its chosen end markets over the long-term.
•Non-cash working capital as a percentage of adjusted revenues1 was 13.4%, The Company had a net debt to pro forma adjusted EBITDA ratio1 at September 27, 2026 of 3.1 times, slightly above the targeted range of 2.0 to 3.0 times. This reflects the Company's lower trailing twelve-month adjusted EBITDA, as well as Management's intentional capital deployment decision to repurchase 2,244,461 common shares under its normal course issuer bid ("NCIB") for $61.3 million. Excluding the impact from the share repurchases, net debt to pro forma adjusted EBITDA ratio1 was 3.0 times. Such share repurchases are one aspect of ATS' capital allocation program, which includes tools to evaluate organic investments, acquisitions and portfolio optimization. As the Company continues to execute its capital allocation program, its net debt to pro forma adjusted EBITDA ratio1 may exceed the target range at times. The Company will pursue such capital allocation opportunities only where they meet Management's disciplined criteria for shareholder value creation and where there is a clear path to returning to the target leverage range within a specified timeframe. The Company's acquisition funnel remains active across a number of its end markets. Based on the execution of the Company's capital allocation program, absent any material acquisitions, Management expects to operate moderately above the range throughout the remainder of fiscal 2027, given Management's fiscal 2027 outlook.
•Adjusted earnings from operations for the quarter were $57.4 million (8.6% adjusted earnings from operations margin), compared to $79.1 million (10.9% adjusted earnings from operations margin) a year ago, primarily due to lower volumes and mix.
ORDER BOOKINGS BY QUARTER
Second quarter of fiscal 2027 Order Bookings were $827 million, a 12.7% year-over-year increase, primarily reflecting a 12.4% increase in organic Order Bookings. By market, Order Bookings in life sciences increased compared to the prior-year period, reflecting continued customer capital investment across a broad range of applications, including large enterprise orders. Order Bookings within life sciences remain well diversified, including orders for radiopharmaceutical applications and for a range of pharmaceutical and medical device automation solutions. Order Bookings decreased in industrial & consumer compared to the prior period a year ago, primarily due to the timing of customer projects and the Company's ongoing portfolio repositioning towards opportunities that support improved profitability and capital efficiency. Order Bookings in food & beverage increased compared to the prior-year period due to the timing of customer orders. Order Bookings in energy decreased compared to the prior-year period primarily due to the timing of customer projects, specifically for nuclear refurbishment projects, and due to strong nuclear refurbishment-related activity in the prior-year period that benefited from several large project awards. Given the nature of the nuclear market, Order Bookings can fluctuate based on the timing of customer investment decisions and project awards. Organic Order Bookings and Organic Order Bookings growth are supplementary financial measures — see "Non-IFRS and Other Financial Measures."
1 Non-cash working capital as a percentage of adjusted revenues, and net debt to pro forma adjusted EBITDA are non-IFRS ratios — see "Non-IFRS and Other Financial Measures."
5
ORDER BACKLOG CONTINUITY
(In millions of dollars)
Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
Opening Order Backlog | $ | 1,889 | $ | 2,068 | $ | 1,958 | $ | 2,139 | |||||||||||||||
Adjusted Revenues | (666) | (728) | (1,364) | (1,465) | |||||||||||||||||||
Order Bookings | 827 | 734 | 1,482 | 1,427 | |||||||||||||||||||
Order Backlog Adjustments1 | (41) | (4) | (67) | (31) | |||||||||||||||||||
Total | $ | 2,009 | $ | 2,070 | $ | 2,009 | $ | 2,070 | |||||||||||||||
1Order Backlog adjustments include foreign exchange adjustments, and normal course scope changes and cancellations.
OUTLOOK
Order Backlog by Market
(In millions of dollars)
| As at | September 27, 2026 | September 28, 2025 | |||||||||
Life Sciences | $ | 1,238 | $ | 1,144 | |||||||
Industrial & Consumer | 312 | 431 | |||||||||
Food & Beverage | 223 | 218 | |||||||||
Energy | 236 | 277 | |||||||||
Total | $ | 2,009 | $ | 2,070 | |||||||
At September 27, 2026, Order Backlog was $2,009 million, 2.9% lower than at September 28, 2025.
The life sciences funnel remains strong and diversified, with opportunities across strategic submarkets such as pharmaceuticals, radiopharmaceuticals and medical devices, partially offsetting lower levels of GLP‑1-related activity compared to recent periods. Management continues to identify opportunities with both new and existing customers across diagnostic and therapeutic radiopharmaceuticals, isotope production, wearable devices, automated pharmacy solutions, contact lenses and pre-filled syringes, as well as integrated life sciences solutions that leverage capabilities from across the Company. Management continues to see strong customer interest in specialized radiopharmaceutical production, containment and automation solutions, supported primarily by increasing adoption of therapeutic applications and ongoing investment in isotope production. As programs advance from clinical development towards commercialization, management continues to observe broader market activity aimed at securing capacity, enhancing supply-chain resilience and supporting reliable, compliant operations in highly regulated environments. ATS' differentiated capabilities in radiopharmaceutical containment systems, integrated automation and lifecycle support position the Company to participate in multiple phases of customer investment across the radiopharmaceutical value chain. ATS continues to strengthen its coordinated go-to-market approach, with initiatives focused on broader market coverage, improved customer engagement and development of a pipeline of opportunities.
Funnel activity in industrial & consumer is stable. While discretionary consumer spending may influence the timing of certain customer investments, the Company continues to broaden its opportunity pipeline across specialized industrial applications. These opportunities allow ATS to deploy its differentiated automation, testing and high-speed assembly capabilities into higher-value areas such as data center infrastructure, warehouse packaging automation and other mission-critical production environments.
6
Funnel activity in food & beverage remains strong despite lower order activity in certain markets, particularly global tomato processing, following elevated investment levels in recent years. ATS continues to see opportunities across its core and adjacent end markets and is expanding its opportunity set beyond tomato processing into fresh fruit processing, secondary processing and packaging applications. Customer demand is increasingly focused on solutions that improve productivity and reduce operating costs, rather than investments primarily intended to add capacity. In addition, customers' equipment replacement requirements may support investment activity even during periods of softer underlying demand. Through its market position and capabilities, management believes it is well positioned to participate as customer investment activity improves over time.
Funnel activity in energy remains strong, supported by industry investment in energy security, infrastructure modernization and new power generation capacity to support data center needs. Within nuclear, demand related to CANDU reactor refurbishment and life-extension programs continues to support capital project opportunities in the near term and lifecycle service opportunities over the longer term. ATS is also engaged in front-end engineering, design and prototype-equipment development for small modular reactors and conventional new builds. As customer programs advance, ATS can support automation for modular fabrication and assembly, fuel fabrication and related manufacturing processes, as well as fuel handling and other specialized testing systems designed for reliable and repeatable operation in high-risk environments. Opportunities in fuel fabrication are also emerging as customers seek to strengthen domestic supply chains and invest in the facilities and equipment required to support future reactor deployment. Based on management's assessment of where ATS' capabilities can be deployed, the Company's addressable opportunity on a reactor program may represent a low-single-digit percentage of total customer capital expenditure, depending on the application.
After-sales revenues and reoccurring revenues, which ATS defines as revenues from ancillary products and services associated with equipment sales, and revenues from customers who purchase non-customized ATS products at regular intervals, are expected to provide some balance to customers' capital expenditure cycles. Management expects reoccurring revenues to be in the range of 25%-35% on a trailing-twelve-month basis and remains focused on expanding this proportion of the business over time. After-sales service revenues are accretive to the Company's overall margin, and growth in this proportion is expected to support the Company's margin expansion targets.
Across its end markets, ATS' competitive position is reinforced by a broad base of differentiated technologies, products and engineering know-how developed across the portfolio. These capabilities include precision and high-speed assembly systems for medical-device applications, modular sterile-filling platforms that integrate containment, inspection and magnetic conveyance, and adaptable automation platforms that can be deployed across emerging industrial applications. The Company is also advancing practical artificial intelligence and data-enabled automation applications combining machine vision, data, analytics and machine learning with automated equipment and lifecycle service offerings. Current applications include advanced inspection and sorting, digital tools for regulated workflows, and solutions intended to improve equipment performance, maintenance and operator effectiveness. These capabilities are at varying stages of development and are expected to support higher-value automation solutions and lifecycle service opportunities across complex and regulated applications.
Customers seeking to de-risk or enhance supply chain resiliency, address skilled worker shortages or combat higher labour costs present ongoing and future opportunities for ATS. Management believes that the underlying trends driving customer demand for ATS solutions, including growing labour constraints, production onshoring or reshoring and the need for scalable, high-quality, energy-efficient production, remain favourable. In addition, funnel growth in markets where sustainability requirements
7
are a focus for customers — including nuclear and grid battery storage, as well as consumer goods packaging — provides ATS with opportunities to use its capabilities to respond to customer needs, such as global and regional requirements to reduce carbon emissions.
See "Executive Update" for management's discussion on timing dynamics associated with Order Bookings, organic revenue growth in fiscal 2027 and earnings from operations margin. The Company continues to have high conviction in the breadth and ongoing diversification of its opportunity pipeline, including continued momentum in radiopharmaceutical and nuclear markets and growth in service-related revenues. Over the long term, ATS' objective remains to grow revenue at a rate that exceeds the underlying growth of its chosen end markets, supported by its technology differentiation, global scale and disciplined execution of the ABM.
Order Backlog of $2,009 million is expected to help mitigate some of the impact of quarterly variability in Order Bookings on revenues in the short term. The Company's Order Backlog includes several large enterprise programs that have longer periods of performance and therefore longer revenue recognition cycles, particularly in life sciences.
The Company's initiatives to improve adjusted earnings from operations margin include restructuring and reorganization programs (see "Executive Update" and "Reorganization and Transformation Activity").
A portion of the savings generated through the Company's restructuring and reorganization programs is being reinvested in higher-growth areas, including the Company's radiopharmaceutical and related businesses, where management sees significant long-term opportunity. These investments are intended to strengthen ATS' competitive position in markets supported by long-term secular growth drivers while maintaining a disciplined approach to cost and capital allocation. As noted above, the Company's long-term adjusted earnings from operations margin target of 15% remains unchanged.
Management's approach to long-term value creation is centered on disciplined execution of the Company's Growth Algorithm, which is designed to drive sustainable growth in per-share cash generation. The Growth Algorithm combines organic growth, disciplined acquisitions, margin expansion and improved working-capital efficiency, while supporting continued investment in differentiated technologies, lifecycle services and strategic acquisitions. Together, these priorities are intended to enhance the quality, resilience and growth of the Company's earnings and cash flow profile. Management also considers return on invested capital and cash return on investment as part of its capital allocation framework. This framework is intended to balance growth, profitability and capital efficiency across organic investments, acquisitions and operational improvement initiatives, with the objective of maximizing long-term shareholder value.
Supplier lead times are generally acceptable across key categories; however, inflationary and other cost increases, including those related to tariffs (see "Tariffs"), as well as price and lead-time volatility, may continue to disrupt the timing and progress of the Company's margin expansion efforts and may affect revenue recognition. Over time, achieving management's margin target assumes that the Company will successfully implement its margin expansion initiatives, and that such initiatives will result in improvements to its adjusted earnings from operations margin that offset these shorter-term pressures (see "Forward-Looking Statements" for a description of the risks underlying the achievement of the margin target in future periods).
8
The timing and geographies of customer capital expenditure decisions on larger opportunities, including as a result of their evaluations of tariffs, can cause variability in Order Bookings from quarter to quarter (see "Tariffs"). Revenues in a given period are dependent on a combination of the volume of outstanding projects the Company is contracted to perform, the size and duration of those projects, and the timing of project activities including design, assembly, testing, and installation. Given the specialized nature of the Company's offerings, the size and scope of projects vary based on customer needs. The Company seeks to achieve revenue growth organically and by identifying strategic acquisition opportunities that provide access to attractive end markets and new products and technologies and deliver hurdle-rate returns.
As management increases its focus on cash returns, improving non-cash working capital velocity and asset utilization more broadly are clear priorities within the Company's operating models. These priorities are intended to support stronger cash generation and improved returns on invested capital. The Company's long-term goal is to maintain its investment in non-cash working capital as a percentage of annualized revenues below 15%, although fluctuations are expected on a quarter-over-quarter basis. The Company expects that continued cash flows from operations, together with cash and cash equivalents on hand and credit available under operating and long-term credit facilities, will be sufficient to fund its requirements for investments in non-cash working capital and capital assets, and to fund strategic investment plans including some potential acquisitions. Acquisitions could result in additional debt or equity financing requirements for the Company. Non-cash working capital as a percentage of adjusted revenues is a non-IFRS ratio — see "Non-IFRS and Other Financial Measures."
The Company continues to make progress with its plans to integrate acquired companies, and expects to realize cost and revenue synergies consistent with announced integration plans.
Reorganization and Transformation Activity
Total restructuring expenses
Total restructuring expenses in the second quarter of fiscal 2027 were $21.3 million, with approximately half related to the Fixed Cost Transformation Program.
Fixed Cost Transformation Program
In the second quarter of fiscal 2027, the Company recorded restructuring expenses primarily related to its European Footprint Consolidation and the activities described above. See "Executive Update" for second quarter of fiscal 2027 updates relating to this initiative.
Transportation reorganization and other restructuring activities
The Company completed the restructuring activities announced in the fourth quarter of fiscal 2026 in the second quarter of fiscal 2027.
At quarter end, two U.S. facilities and one German facility were held for sale, with one U.S. facility expected to be structured as a sale and leaseback following quarter end. Subsequent to quarter end, the Company completed the sale of the two U.S. facilities for consideration of $71.2 million, resulting in an estimated gain on disposal of approximately $12.2 million. The Company entered into an agreement to lease back one of the facilities to support the growth of the nuclear business in the U.S. The transaction will be recognized in the third quarter of fiscal 2027. Proceeds from the sale of these facilities are expected to fund restructuring activities and other costs of exiting businesses.
9
Tariffs
The majority of the Company's shipments from Canada into the U.S. fall within the current terms of the U.S.-Mexico-Canada trade agreement ("USMCA"). In 2026, the U.S. declined to agree to extend the USMCA in its current form, triggering annual joint reviews that will continue until the parties either agree to an extension or the agreement expires on July 1, 2036. Although the USMCA remains in full force and effect, the annual review process, and the ability of any party to withdraw from the agreement on six months' written notice, creates potential long-term uncertainty regarding North American free trade compounded by additional tariffs imposed by the U.S. on certain goods from various jurisdictions globally, including Canada and Europe; and further tariffs and trade agreements continue to be discussed. The uncertainty of Section 338 tariffs has had a more material impact during the quarter than previously anticipated, primarily affecting packaging equipment and customer decision making based on expected tariff impacts. Subsequent changes to tariff policy may reduce the impact of these tariffs on the Company going forward, although the effect of such changes may not translate immediately into Order Bookings and revenues. The Company does not currently expect tariffs imposed under Section 301 of the Trade Act of 1974 ("Section 301 tariffs") to have a material impact and continues to assess the application of these tariffs. Management continues to actively monitor the situation as it evolves and is taking steps to mitigate risks where possible while continuing to offer support to customers based on their needs, which may include onshoring or reshoring production. Supply chain impacts resulting from shifting trade dynamics have been largely mitigated through alternative sourcing, along with pricing strategies. While the Company could see impacts over time arising from unmitigated costs related to the tariffs themselves, potential supplier price increases, and the timing and geographic shifts in customers' capital deployment, ATS' global footprint and decentralized operating model, supported by the ABM, provide some flexibility to address potential disruptions over the long term. On a trailing-twelve-month basis, the Company's equipment and product adjusted revenues from its Canadian and European operations being sold into the U.S. remained consistent with the range previously disclosed of just over 20% of the Company's adjusted revenues.
DETAILED ANALYSIS
CONSOLIDATED RESULTS
(In millions of dollars, except per share data)
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
Revenues | $ | 665.8 | $ | 728.5 | $ | 1,359.5 | $ | 1,465.2 | |||||||||||||||
Cost of revenues | 476.3 | 510.6 | 980.1 | 1,027.5 | |||||||||||||||||||
| Selling, general and administrative | 144.6 | 149.4 | 298.6 | 300.5 | |||||||||||||||||||
| Restructuring costs | 21.3 | — | 27.0 | 2.5 | |||||||||||||||||||
| Stock-based compensation (recovery) | 0.4 | (6.7) | 6.4 | 1.7 | |||||||||||||||||||
| Earnings from operations | $ | 23.2 | $ | 75.2 | $ | 47.4 | $ | 133.0 | |||||||||||||||
| Net finance costs | $ | 22.2 | $ | 24.4 | $ | 42.9 | $ | 50.0 | |||||||||||||||
| Income tax expense | 6.0 | 17.2 | 9.8 | 25.1 | |||||||||||||||||||
| Net income (loss) | $ | (5.0) | $ | 33.6 | $ | (5.3) | $ | 57.9 | |||||||||||||||
| Basic earnings (loss) per share | $ | (0.05) | $ | 0.34 | $ | (0.05) | $ | 0.59 | |||||||||||||||
10
Non-IFRS Financial Measures1 | Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | |||||||||||||||||||
Adjusted revenues2 | $ | 665.8 | $ | 728.5 | $ | 1,364.1 | $ | 1,465.2 | |||||||||||||||
Adjusted earnings from operations | $ | 57.4 | $ | 79.1 | $ | 125.5 | $ | 157.7 | |||||||||||||||
| EBITDA | $ | 60.5 | $ | 114.6 | $ | 124.9 | $ | 209.8 | |||||||||||||||
| Adjusted EBITDA | $ | 80.7 | $ | 103.7 | $ | 173.4 | $ | 205.3 | |||||||||||||||
Adjusted basic earnings per share | $ | 0.27 | $ | 0.45 | $ | 0.62 | $ | 0.85 | |||||||||||||||
1Non-IFRS financial measures — see "Non-IFRS and Other Financial Measures."
2The transportation reorganization in the first quarter included a decrease to revenue which was recorded to reflect the completion of legacy customer programs.
Consolidated Adjusted Revenues
(In millions of dollars)
| Adjusted revenues by type | Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | |||||||||||||||||||
Revenues from construction contracts | $ | 324.4 | $ | 401.6 | $ | 688.2 | $ | 823.1 | |||||||||||||||
Services rendered | 179.1 | 168.8 | 361.9 | 332.9 | |||||||||||||||||||
| Sale of goods | 162.3 | 158.1 | 314.0 | 309.2 | |||||||||||||||||||
Total adjusted revenues1 | $ | 665.8 | $ | 728.5 | $ | 1,364.1 | $ | 1,465.2 | |||||||||||||||
| Adjusted revenues by market | Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | |||||||||||||||||||
Life Sciences | $ | 355.8 | $ | 374.5 | $ | 701.6 | $ | 753.2 | |||||||||||||||
Industrial & Consumer | 136.4 | 178.2 | 312.0 | 362.4 | |||||||||||||||||||
Food & Beverage | 99.6 | 124.8 | 216.6 | 263.2 | |||||||||||||||||||
Energy | 74.0 | 51.0 | 133.9 | 86.4 | |||||||||||||||||||
Total adjusted revenues1 | $ | 665.8 | $ | 728.5 | $ | 1,364.1 | $ | 1,465.2 | |||||||||||||||
1Unless otherwise noted, all below commentary is on adjusted revenues.
Second quarter fiscal 2027 revenues were 8.6% or $62.7 million lower than in the corresponding period a year ago, primarily reflecting a year-over-year decrease in organic revenue (excluding contributions from acquired companies and foreign exchange translation) of $66.1 million or 9.1%, partially offset by the positive impact of foreign exchange translation. Revenues generated from construction contracts decreased 19.2% or $77.2 million from the prior period primarily due to lower Order Backlog entering the period. Revenues from services increased 6.1% or $10.3 million, primarily due to organic revenue growth on higher Order Backlog entering the period and the positive impact of foreign exchange translation. Revenues from the sale of goods increased 2.7% or $4.2 million, which included a positive impact from foreign exchange translation. Organic revenue is a non-IFRS financial measure - see "Non IFRS and Other Financial Measures."
By market, revenues generated in life sciences decreased $18.7 million or 5.0% year-over-year. This was primarily due to timing of both customer capital allocation as well as project execution. Revenues in industrial & consumer decreased $41.8 million or 23.5% compared to the prior year as a result of lower activity in certain legacy industrial applications, as the Company continues to reposition its capabilities towards other strategic areas. Revenues generated in food & beverage decreased $25.2 million or 20.2% from the corresponding period last year due to lower Order Backlog entering the period, in
11
addition to timing of project execution. Revenues in energy increased $23.0 million or 45.1% year-over-year primarily related to execution of nuclear projects.
Revenues for the six months ended September 27, 2026 were 7.2% or $105.7 million lower than in the prior year. On an adjusted basis, revenues were 6.9% or $101.1 million lower than the prior year, primarily reflecting a decrease in organic revenue (excluding contributions from acquired companies and foreign exchange translation) of $113.5 million or 7.7%, partially offset by a 0.8% positive impact of foreign exchange translation. Revenues generated from construction contracts decreased 16.4% or $134.9 million primarily due to lower Order Backlog entering the year. Revenues from services increased 8.7% or $29.0 million primarily due to organic revenue growth on higher Order Backlog entering the period and the positive impact of foreign exchange translation. Revenues from the sale of goods increased 1.6% or $4.8 million, which included a positive impact from foreign exchange translation.
By market, revenues in the first six months of fiscal 2027 from life sciences decreased $51.6 million or 6.9% over the prior period primarily due to timing of both customer capital allocation and project execution. Revenues in industrial & consumer decreased $50.4 million or 13.9%, primarily as a result of lower activity in certain legacy industrial applications. Revenues generated in food & beverage decreased $46.6 million or 17.7% from the prior period due to lower Order Backlog entering the period in addition to timing of project execution. Revenues in energy increased $47.5 million or 55.0% over the prior period due to organic revenue growth on higher Order Backlog entering the fiscal year, including execution of nuclear projects.
Cost of revenues. At $476.3 million, second quarter of fiscal 2027 cost of revenues decreased by $34.3 million, or 6.7%, compared to the corresponding period a year ago, primarily due to lower revenues. Second quarter fiscal 2027 gross margin was 28.5% (or 28.6% on adjusted revenues and excluding cost of revenues from other reorganization-related costs of $0.9 million), compared to 29.9% in the corresponding period a year ago. The year-over-year decrease in gross margin on adjusted revenues excluding adjusting items was 131 basis points, primarily due to the impact of lower revenue volumes.
Year-to-date gross margin was 27.9% (or 29.3% on adjusted revenues and excluding cost of revenues of $2.3 million from the transportation reorganization, cost of revenues from the services reorganization of $4.2 million, impairment costs relating to the software-focused businesses reorganization of $7.1 million, and cost of revenues from other reorganization-related costs of $2.4 million), compared to 29.9% in the corresponding period a year ago. The year-to-date gross margin on adjusted revenues excluding adjusting items decreased primarily due to the impact on margin of lower revenues, partially offset by program mix including the impact of increased higher-margin after-sales service revenues.
Selling, general and administrative expenses. SG&A expenses for the second quarter of fiscal 2027 were $144.6 million and included $14.0 million of costs related to the amortization of identifiable intangible assets on business acquisitions, $0.1 million of incremental costs related to the Company's acquisition activity, $1.4 million of CEO inducement costs, and $0.3 million related to other reorganization-related costs. Excluding these items, SG&A expenses were $128.8 million in the second quarter of fiscal 2027. Comparably, SG&A expenses for the second quarter of fiscal 2026 were $134.5 million, which excluded $14.8 million of costs related to the amortization of identifiable intangible assets on business acquisitions, and $0.1 million of incremental costs related to the Company's acquisition activity. Lower SG&A expenses in the second quarter of fiscal 2027 primarily reflected the impact of lower employee costs. The CEO inducement costs are recognized over the term of the award, which will be paid April 1, 2027.
12
For the six months ended September 27, 2026, SG&A expenses were $298.6 million, which included $28.2 million of costs related to the amortization of identifiable intangible assets on business acquisitions, $0.2 million of incremental costs related to the Company's acquisition activity, $0.5 million from the SG&A impact of the services reorganization, $0.7 million from the SG&A impact of the transportation reorganization, $0.9 million related to other reorganization-related costs, and $2.8 million of CEO inducement costs. Excluding these costs, SG&A expenses were $265.3 million. Comparably, SG&A expenses for the six months ended September 28, 2025 were $270.9 million, which excluded $29.2 million of expenses related to the amortization of identifiable intangible assets on business acquisitions, and $0.4 million of incremental costs related to the Company's acquisition activity. Excluding these costs, lower SG&A expenses for the six months ended September 27, 2026 primarily reflected lower employee costs, partially offset by foreign exchange translation.
Restructuring costs. Restructuring costs for the three and six months ended September 27, 2026 were $21.3 million and $27.0 million, respectively, compared to nil and $2.5 million in the corresponding periods a year ago. For further information on the restructuring costs, refer to "Reorganization and Transformation Activity" on page 9.
Stock-based compensation. Stock-based compensation expense was $0.4 million in the second quarter of fiscal 2027 and included a $3.8 million recovery of revaluation expenses from deferred share units ("DSUs") and restricted share units ("RSUs"), resulting from the change in the market price of the Company's common shares between periods ("stock-based compensation revaluation expenses"). Comparably, stock-based compensation expense was a recovery of $6.7 million in the corresponding period a year ago, which included a $3.7 million recovery of stock-based compensation revaluation expenses, in addition to a $7.3 million reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
For the six months ended September 27, 2026, stock-based compensation expense was $6.4 million, which included a $2.8 million recovery of stock-based compensation revaluation expenses. This is compared to a stock-based compensation expense of $1.7 million a year earlier, which included a $0.1 million recovery of stock-based compensation revaluation expenses, in addition to a $7.3 million reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
13
Earnings and adjusted earnings from operations
(in millions of dollars)
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
Earnings from operations | $ | 23.2 | $ | 75.2 | $ | 47.4 | $ | 133.0 | |||||||||||||||
| Amortization of acquisition-related intangible assets | 14.0 | 14.8 | 28.2 | 29.2 | |||||||||||||||||||
| Acquisition-related transaction costs | 0.1 | 0.1 | 0.2 | 0.4 | |||||||||||||||||||
Restructuring charges2 | 21.3 | — | 27.0 | 2.5 | |||||||||||||||||||
Stock-based compensation forfeiture3 | — | (7.3) | — | (7.3) | |||||||||||||||||||
Transportation reorganization4 | — | — | 7.6 | — | |||||||||||||||||||
Services reorganization5 | — | — | 4.7 | — | |||||||||||||||||||
| CEO inducement | 1.4 | — | 2.8 | — | |||||||||||||||||||
Software-focused businesses reorganization | — | — | 7.1 | — | |||||||||||||||||||
Other reorganization-related costs6 | 1.2 | — | 3.3 | — | |||||||||||||||||||
| Mark to market portion of stock-based compensation | (3.8) | (3.7) | (2.8) | (0.1) | |||||||||||||||||||
Adjusted earnings from operations1 | $ | 57.4 | $ | 79.1 | $ | 125.5 | $ | 157.7 | |||||||||||||||
1Non-IFRS financial measure — see "Non-IFRS and Other Financial Measures."
2Approximately half of the restructuring costs recognized in the second quarter of fiscal 2027 related to the Fixed Cost Transformation Program.
3Reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
4Included in the year-to-date transportation reorganization costs was a decrease of $4.6 million of revenue, a $2.3 million increase in cost of revenues and a $0.7 million increase in SG&A expense.
5Included in the year-to-date services reorganization is a $3.5 million increase to cost of revenues, $0.7 million of amortization charges recorded to cost of revenues, and $0.5 million increase to SG&A expense.
6Included in the year-to-date other reorganization-related costs is a $2.4 million increase to cost of revenues, a $0.3 million increase to SG&A expense, and $0.6 million of amortization recorded to SG&A expense.
Second quarter fiscal 2027 earnings from operations were $23.2 million (3.5% operating margin) compared to $75.2 million (10.3% operating margin) in the second quarter a year ago. Operating margin is a supplementary financial measure — see "Non-IFRS and Other Financial Measures." Second quarter fiscal 2027 earnings from operations included $14.0 million related to amortization of acquisition-related intangible assets, $0.1 million of incremental costs for the Company's acquisition activity, $21.3 million of restructuring charges, $1.4 million related to CEO inducement costs, $1.2 million of other reorganization-related costs, and a $3.8 million recovery of stock-based compensation revaluation expenses. Second quarter fiscal 2026 earnings from operations included $14.8 million of amortization of acquisition-related intangible assets, $0.1 million of incremental costs for acquisition activity, $7.3 million of stock-based compensation recovery due to forfeiture of unvested awards, and a $3.7 million recovery of stock-based compensation revaluation expense.
Excluding these items in both quarters, adjusted earnings from operations were $57.4 million (8.6% adjusted earnings from operations margin), compared to $79.1 million (10.9% adjusted earnings from operations margin) a year ago. The second quarter of fiscal 2027 adjusted earnings from operations primarily reflected lower revenues.
For the six months ended September 27, 2026, earnings from operations were $47.4 million (3.5% operating margin), compared to $133.0 million (9.1% operating margin) a year ago. Earnings from operations included $28.2 million related to amortization of acquisition-related intangible assets, $0.2 million of incremental costs related to the Company's acquisition activity, $27.0 million of restructuring charges, $7.6 million related to the impact of the transportation reorganization, $4.7 million related to the impact of the services reorganization, $2.8 million related to CEO inducement costs, $7.1 million
14
related to the software-focused businesses reorganization, $3.3 million of other reorganization-related costs, and a $2.8 million recovery of stock-based compensation revaluation expenses of cash-settled awards recorded to stock-based compensation. For the six months ended September 28, 2025, earnings from operations included $29.2 million related to amortization of acquisition-related intangible assets, $0.4 million of incremental costs related to the Company's acquisition activity, $2.5 million of restructuring charges, $7.3 million of stock-based compensation recovery due to forfeiture of unvested awards, and a $0.1 million recovery of stock-based compensation revaluation expenses.
Excluding these items in both years, adjusted earnings from operations were $125.5 million (9.2% margin), compared to $157.7 million (10.8% margin) in the corresponding period a year ago. Decreased adjusted earnings from operations primarily reflected lower revenues and mix. Adjusted earnings from operations is a non-IFRS financial measure — see "Non-IFRS and Other Financial Measures" and "Reconciliation of Non-IFRS Measures to IFRS Measures."
Net finance costs. Net finance costs were $22.2 million in the second quarter of fiscal 2027, compared to $24.4 million a year ago. For the six months ended September 27, 2026, finance costs were $42.9 million compared to $50.0 million a year ago. For the six months ended September 27, 2026, the decrease primarily reflected reduced average borrowings versus the prior-year period.
Income tax expense. For the three and six months ended September 27, 2026, the Company's effective income tax rates of 604.0% and 217.2%, respectively, differed from the combined Canadian basic federal and provincial income tax rate of 26.5% primarily due to losses in certain entities where an income tax benefit has not been recognized in relation to reorganization activities.
After adjusting for the impact of current year non-IFRS adjustments, in addition to the tax impact for losses where an income tax benefit has not been recognized, the adjusted effective tax rates for the three and six months ended September 27, 2026 were 26.1% and 26.9%, respectively, compared to 20.3% and 22.5%, respectively, for the periods ending September 28, 2025. Adjusted effective tax rate is a non-IFRS ratio — see "Non-IFRS and Other Financial Measures" and "Reconciliation of Non-IFRS Measures to IFRS Measures."
Net income (loss). Net loss for the second quarter of fiscal 2027 was $5.0 million ((5) cents per share basic), compared to net income of $33.6 million (34 cents per share basic and diluted) for the second quarter of fiscal 2026. The decrease primarily reflected lower revenues. Adjusted basic earnings per share were 27 cents compared to 45 cents in the second quarter of fiscal 2026.
For the six months ended September 27, 2026, net loss was $5.3 million ((5) cents per share basic and diluted), a decrease of $63.2 million (and $0.64 per share basic) compared to a year ago. This was primarily the result of lower revenues. Adjusted basic earnings per share were $0.62 for the six months ended September 27, 2026 compared to $0.85 in the corresponding period a year ago. Adjusted basic earnings per share is a non-IFRS financial measure — see "Non-IFRS and Other Financial Measures" and "Reconciliation of Non-IFRS Measures to IFRS Measures."
15
Other Non-IFRS Measures of Performance
(In millions of dollars)
Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
Earnings from operations | $ | 23.2 | $ | 75.2 | $ | 47.4 | $ | 133.0 | |||||||||||||||
Depreciation and amortization | 37.3 | 39.4 | 77.5 | 76.8 | |||||||||||||||||||
EBITDA1 | $ | 60.5 | $ | 114.6 | $ | 124.9 | $ | 209.8 | |||||||||||||||
Restructuring charges2 | 21.3 | — | 27.0 | 2.5 | |||||||||||||||||||
Acquisition-related transaction costs | 0.1 | 0.1 | 0.2 | 0.4 | |||||||||||||||||||
Stock-based compensation forfeiture3 | — | (7.3) | — | (7.3) | |||||||||||||||||||
Transportation reorganization | — | — | 7.6 | — | |||||||||||||||||||
Services reorganization4 | — | — | 4.0 | — | |||||||||||||||||||
CEO inducement | 1.4 | — | 2.8 | — | |||||||||||||||||||
Software-focused businesses reorganization | — | — | 7.1 | — | |||||||||||||||||||
Other reorganization-related costs5 | 1.2 | — | 2.6 | — | |||||||||||||||||||
Mark to market portion of stock-based compensation | (3.8) | (3.7) | (2.8) | (0.1) | |||||||||||||||||||
Adjusted EBITDA1 | $ | 80.7 | $ | 103.7 | $ | 173.4 | $ | 205.3 | |||||||||||||||
1Non-IFRS financial measure — See "Non-IFRS and Other Financial Measures."
2Approximately half of the restructuring costs recognized in the second quarter of fiscal 2027 related to the Fixed Cost Transformation Program.
3Reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
4Year-to-date services reorganization costs incurred in the quarter include $0.7 million of amortization costs arising from a change in useful lives of certain assets. These amounts are excluded from the reconciling adjustment as they are already excluded in the calculation of EBITDA.
5Year-to-date other reorganization-related costs incurred in the quarter include $0.6 million of amortization costs arising from a change in useful lives of certain assets. These amounts are excluded from the reconciling adjustment as they are already excluded in the calculation of EBITDA.
Depreciation and amortization expense was $37.3 million in the second quarter of fiscal 2027, compared to $39.4 million a year ago.
EBITDA was $60.5 million (9.1% EBITDA margin) in the second quarter of fiscal 2027 compared to $114.6 million (15.7% EBITDA margin) in the second quarter of fiscal 2026. EBITDA for the second quarter of fiscal 2027 included $21.3 million of restructuring charges, $0.1 million of incremental costs related to acquisition activity, $1.4 million related to CEO inducement costs, $1.2 million of other reorganization-related costs, and a $3.8 million recovery of stock-based compensation revaluation expense. EBITDA for the corresponding period in the prior year included $0.1 million of incremental costs related to acquisition activity, $7.3 million of stock-based compensation recovery due to forfeiture of unvested awards, and $3.7 million recovery of stock-based compensation revaluation expenses. Excluding these amounts, adjusted EBITDA was $80.7 million (12.1% adjusted EBITDA margin), compared to $103.7 million (14.2% adjusted EBITDA margin) for the corresponding period in the prior year. Lower adjusted EBITDA primarily reflected lower revenues. EBITDA and adjusted EBITDA are non-IFRS financial measures and EBITDA margin and adjusted EBITDA margin are non-IFRS ratios — see "Non-IFRS and Other Financial Measures."
Depreciation and amortization expense was $77.5 million for the first six months of fiscal 2027, compared to $76.8 million a year ago.
EBITDA was $124.9 million (9.2% EBITDA margin) in the first six months of fiscal 2027 compared to $209.8 million (14.3% EBITDA margin) a year ago. EBITDA for the first six months of fiscal 2027 included $27.0 million of restructuring charges, $0.2 million of incremental costs related to the Company's acquisition activity, $7.6 million related to the impact of the transportation reorganization,
16
$4.0 million related to the impact of the services reorganization, $2.8 million related to CEO inducement costs, $7.1 million related to the software-focused businesses reorganization, $2.6 million of other reorganization-related costs, and a $2.8 million recovery of stock-based compensation revaluation expenses of cash-settled awards. EBITDA a year ago included $2.5 million of restructuring charges, $0.4 million of incremental costs related to the Company's acquisition activity, $7.3 million of stock-based compensation recovery due to forfeiture of unvested awards, and a $0.1 million recovery of stock-based compensation revaluation expenses. Excluding these amounts in both periods, adjusted EBITDA was $173.4 million (12.7% adjusted EBITDA margin), compared to $205.3 million (14.0% adjusted EBITDA margin) a year ago. Lower adjusted EBITDA primarily reflected lower revenues. EBITDA and adjusted EBITDA are non-IFRS financial measures, and EBITDA margin and adjusted EBITDA margin are non-IFRS ratios — see "Non-IFRS and Other Financial Measures" and "Reconciliation of Non-IFRS Measures to IFRS Measures."
SHARE DATA
During the first six months of fiscal 2027, 22,921 stock options were exercised. At November 4, 2026, the total number of common shares outstanding was 95,885,092. There were also 1,144,314 stock options outstanding to acquire common shares of the Company and 1,103,797 RSUs outstanding that may be settled in ATS common shares where deemed advisable by the Company, as an alternative to cash payments. A portion of the RSUs are subject to the performance vesting conditions of the Company's RSU plan.
In fiscal 2023, a trust was created for the purpose of purchasing common shares of the Company on the stock market. The common shares are being held in trust and may be used to settle some or all of the RSU grants when such RSU grants are fully vested. During the three and six months ended September 27, 2026, 66,339 shares were purchased for $2.6 million and placed in the trust. The trust is included in the Company's interim condensed consolidated financial statements with the value of the acquired common shares presented as a reduction of share capital.
NORMAL COURSE ISSUER BID
On December 18, 2025, the Company announced that the TSX had accepted a notice filed by the Company of its intention to make an NCIB. Under the NCIB, ATS may purchase for cancellation up to a maximum of 8,225,621 common shares during the 12-month period ending December 21, 2026.
During the three and six months ended September 27, 2026, the Company purchased 2,244,461 common shares under the NCIB program for $61.3 million. At September 27, 2026, a total of 5,981,160 common shares remained available for repurchase under the current NCIB.
Some purchases under the NCIB may be made pursuant to an automatic share purchase plan between ATS and its broker. This plan enables the purchase of common shares when ATS would not ordinarily be active in the market due to internal trading blackout periods, insider trading rules, or otherwise. ATS security holders may obtain a copy of the notice, without charge, upon request from the Secretary of the Company. The NCIB program is viewed by the Company as one component of an overall capital structure strategy and complementary to its acquisition growth plans.
17
INVESTMENTS, LIQUIDITY, CASH FLOW AND FINANCIAL RESOURCES
Liquidity, Cash Flow and Financial Resources
(In millions of dollars, except ratios)
| As at | September 27, 2026 | March 31, 2026 | |||||||||
| Cash and cash equivalents | $ | 231.0 | $ | 285.0 | |||||||
Debt-to-equity ratio1 | 0.92:1 | 0.89:1 | |||||||||
1Debt is calculated as bank indebtedness, long-term debt and lease liabilities. Equity is calculated as total equity less accumulated other comprehensive income.
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | |||||||||||||||||||||||||||||
| Cash, beginning of period | $ | 198.9 | $ | 188.6 | $ | 285.0 | $ | 225.9 | ||||||||||||||||||||||||
Total cash provided by (used in): | ||||||||||||||||||||||||||||||||
| Operating activities | 80.7 | 28.5 | 70.3 | 184.3 | ||||||||||||||||||||||||||||
| Investing activities | (18.0) | (18.4) | (32.6) | (34.6) | ||||||||||||||||||||||||||||
| Financing activities | (31.2) | (2.7) | (95.2) | (179.6) | ||||||||||||||||||||||||||||
| Net foreign exchange difference | 0.6 | 1.3 | 2.3 | 1.3 | ||||||||||||||||||||||||||||
| Initial adoption of amendments to IFRS 9 | — | — | 1.2 | — | ||||||||||||||||||||||||||||
| Cash, end of period | $ | 231.0 | $ | 197.3 | $ | 231.0 | $ | 197.3 | ||||||||||||||||||||||||
In the second quarter of fiscal 2027, cash flows provided by operating activities were $80.7 million compared to $28.5 million provided by operating activities in the corresponding period a year ago. The increase in cash flow from operations was primarily attributed to the timing of investments in non-cash working capital.
In the six months ended September 27, 2026, cash flows provided by operating activities were $70.3 million compared to $184.3 million provided by operating activities a year ago. The year-over-year change is primarily attributed to the first quarter of fiscal 2026 collection of the settlement amount with an electric vehicle ("EV") customer in addition to timing of investments in non-cash working capital.
In the second quarter of fiscal 2027, the Company's investment in non-cash working capital decreased $46.7 million compared to June 28, 2026. On a year-to-date basis, investment in non-cash working capital decreased $1.1 million; accounts receivable decreased by 0.5%, or $2.5 million, while net contracts in progress decreased 10.5%, or $13.6 million, compared to March 31, 2026, primarily due to the timing of billings relative to certain customer contracts. The Company actively manages its accounts receivable, contract asset and contract liability balances through billing terms on long-term contracts and collection efforts. Inventories increased 2.2%, or $6.4 million compared to March 31, 2026. Deposits and prepaid assets increased 0.5% or $0.5 million compared to March 31, 2026. Accounts payable and accrued liabilities decreased 2.2% or $13.6 million compared to March 31, 2026 due to timing of supplier billings and payments. Provisions increased 20.9% or $6.7 million compared to March 31, 2026 primarily due to restructuring costs recognized in connection with previously announced restructuring activities and the Fixed Cost Transformation Program.
The free cash flow of the Company for the six months ended September 27, 2026 was an inflow of $36.5 million, compared to an inflow of $149.6 million a year ago, primarily due to the prior year including collection on the negotiated settlement with an EV customer in the first quarter of fiscal 2026, partially offset by decreased investment in non-cash working capital. The Company has a multi-year
18
free cash flow target of 100% of net income. Free cash flow is a non-IFRS financial measure — see "Non-IFRS and Other Financial Measures" and "Reconciliation of Non-IFRS Measures to IFRS Measures."
Non-cash working capital as a percentage of adjusted revenues was 13.4% at September 27, 2026 compared to 12.1% at March 31, 2026. Non-cash working capital as a percentage of adjusted revenues is a non-IFRS ratio — see "Non-IFRS and Other Financial Measures."
Cash investments in property, plant and equipment totalled $16.2 million in the first six months of fiscal 2027, primarily related to construction of new facilities, in addition to purchases of production equipment and computer hardware. Intangible asset expenditures were $17.6 million in the first six months of fiscal 2027, primarily related to various internal development projects and computer software. Capital expenditures for fiscal 2027 for tangible assets and intangible assets are expected to be between $60 million and $80 million, just below the Company's previously disclosed range. The Company adds capacity to support growth while continuing to invest in innovation. This investment is based on the needs of the business and timing of projects, and management continues to build flexibility into plans for the balance of the year.
At September 27, 2026, the Company had $966.7 million of unutilized multipurpose credit, including letters of credit, available under existing credit facilities and an additional $277.2 million available under letter of credit facilities.
On December 4, 2025, the Company amended its senior secured credit facility (the "Credit Facility"), extending the maturity date to December 4, 2029. The Credit Facility consists of (i) a $900.0 million secured committed revolving line of credit and (ii) a fully drawn $150.0 million secured term credit facility. The Company incurred transaction costs of $2.6 million which were deferred and are being amortized over the term of the Credit Facility. The Credit Facility is secured by the Company's assets, including a pledge of shares of certain of the Company's subsidiaries. Certain of the Company's subsidiaries also provide guarantees under the Credit Facility. At September 27, 2026, the Company had utilized $190.0 million under the Credit Facility, of which $190.0 million was classified as long-term debt (March 31, 2026 - $200.0 million) and $nil by way of letters of credit (March 31, 2026 - $nil).
The Credit Facility is available in Canadian dollars by way of prime rate advances, Term CORRA advances and/or Daily Compounded CORRA advances, in U.S. dollars by way of base rate advances and/or Term SOFR advances, in Euros by way of EURIBOR advances, in British pounds sterling by way of Daily Simple SONIA advances, and by way of letters of credit for certain purposes. The interest rates applicable to the Credit Facility are determined based on a net debt-to-EBITDA ratio as defined in the Credit Facility. For prime rate advances and base rate advances, the interest rate is equal to the agent's prime rate or the agent's U.S. dollar base rate in Canada, respectively, plus a margin ranging from 0.45% to 2.00%. For Term CORRA advances, Daily Compounded CORRA advances, Term SOFR advances, EURIBOR advances and Daily Simple SONIA advances, the interest rate is equal to the Term CORRA rate, the Daily Compounded CORRA rate, the Term SOFR rate, the EURIBOR rate or the Daily Simple SONIA rate, respectively, plus a margin that varies from 1.45% to 3.00%. The Company pays a fee for usage of financial letters of credit that ranges from 1.45% to 3.00%, and a fee for usage of non-financial letters of credit that ranges from 0.97% to 2.00%. The Company pays a standby fee on the unadvanced portions of the amounts available for advance or drawdown under the Credit Facility at rates ranging from 0.29% to 0.60%. The Company's Credit Facility is subject to changes in market interest rates. Changes in economic conditions outside of the Company's control could result in higher interest rates, thereby increasing its interest expense. The Company uses a variable for fixed interest rate swap to hedge a portion of its Credit Facility (see "Risk Management").
19
The Credit Facility is subject to financial covenants including a net debt-to-EBITDA test and an interest coverage test. Under the terms of the Credit Facility, the Company is restricted from encumbering any assets with certain permitted exceptions. At September 27, 2026, all of the covenants were met.
The Company has additional credit facilities available of $111.6 million (40.0 million EUR, U.S. $24.0 million, 110.0 million THB, 2.5 million GBP, 5.0 million CNY, $1.0 million AUD and $1.8 million CAD). The total amount outstanding on these facilities as at September 27, 2026 was $4.2 million, of which $2.4 million was classified as bank indebtedness (March 31, 2026 - $6.7 million), $1.8 million was classified as long-term debt (March 31, 2026 - $1.9 million) and $nil by way of letters of credit (March 31, 2026 - $nil). The interest rates applicable to the credit facilities range from 3.05% to 7.00% per annum, in local currency. A portion of the long-term debt is secured by certain assets of the Company.
The Company's U.S. $350.0 million aggregate principal amount of senior notes (the "U.S. Senior Notes") were issued at par, bear interest at a rate of 4.125% per annum and mature on December 15, 2028. After December 15, 2023, the Company may redeem the U.S. Senior Notes, in whole at any time or in part from time to time, at specified redemption prices and subject to certain conditions required by the U.S. Senior Notes. If the Company experiences a change of control, the Company may be required to repurchase the U.S. Senior Notes, in whole or in part, at a purchase price equal to 101% of the aggregate principal amount of the U.S. Senior Notes, plus accrued and unpaid interest, if any, to, but not including, the redemption date. The U.S. Senior Notes contain customary covenants that restrict, subject to certain exceptions and thresholds, some of the activities of the Company and its subsidiaries, including the Company's ability to dispose of assets, incur additional debt, pay dividends, create liens, make investments, and engage in specified transactions with affiliates. At September 27, 2026, all of the covenants were met. Subject to certain exceptions, the U.S. Senior Notes are guaranteed by each of the subsidiaries of the Company that is a borrower or has guaranteed obligations under the Credit Facility. Transaction fees of $8.1 million were deferred and are being amortized over the term of the U.S. Senior Notes. The Company uses a cross-currency interest rate swap instrument to hedge a portion of its U.S. Senior Notes (see "Risk Management").
On August 21, 2024, the Company completed a private placement of $400.0 million aggregate principal amount of CAD Senior Notes. The CAD Senior Notes were issued at par, bear interest at a rate of 6.50% per annum and mature on August 21, 2032. On December 19, 2024, the Company completed a private placement of an additional $200.0 million of CAD Senior Notes, bringing the total amount of CAD Senior Notes issued to $600.0 million. The additional CAD Senior Notes were issued at a premium of $1.3 million which is classified as long-term debt. The Company may redeem the CAD Senior Notes, at any time after August 21, 2027, in whole or in part, at specified redemption prices and subject to certain conditions required by the CAD Senior Notes. If the Company experiences a change of control, the Company may be required to repurchase the CAD Senior Notes, in whole or in part, at a purchase price equal to 101% of the aggregate principal amount of the CAD Senior Notes, plus accrued and unpaid interest, if any, to, but not including, the redemption date. The CAD Senior Notes contain customary covenants that restrict, subject to certain exceptions and thresholds, some of the activities of the Company and its subsidiaries, including the Company's ability to dispose of assets, incur additional debt, pay dividends, create liens, make investments, and engage in specified transactions with affiliates. Transaction fees of $9.6 million were deferred and are being amortized over the term of the CAD Senior Notes. At September 27, 2026, all of the covenants were met. Subject to certain exceptions, the CAD Senior Notes are guaranteed by each of the subsidiaries of the Company that is a borrower or has guaranteed obligations under the Credit Facility.
20
Contractual Obligations
(In millions of dollars)
The Company's contractual obligations are as follows as at September 27, 2026:
| Payments Due by Period | |||||||||||||||||||||||||||||||||||||||||
| Total | <1 Year | 1-2 Years | 2-3 Years | 3-4 Years | 4-5 Years | >5 Years | |||||||||||||||||||||||||||||||||||
| Bank indebtedness | $ | 2.4 | $ | 2.4 | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||||||||||
Long-term debt obligations1 | 1,571.3 | 59.6 | 59.8 | 544.5 | 229.3 | 39.3 | 638.8 | ||||||||||||||||||||||||||||||||||
Lease liability obligations1 | 165.4 | 41.1 | 34.9 | 28.1 | 24.7 | 17.6 | 19.0 | ||||||||||||||||||||||||||||||||||
| Purchase obligations | 283.7 | 264.9 | 16.1 | 2.4 | 0.2 | 0.1 | — | ||||||||||||||||||||||||||||||||||
| Accounts payable and accrued liabilities | 608.8 | 608.8 | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Total | $ | 2,631.6 | $ | 976.8 | $ | 110.8 | $ | 575.0 | $ | 254.2 | $ | 57.0 | $ | 657.8 | |||||||||||||||||||||||||||
1Long-term debt obligations and lease liability obligations include principal and interest.
The Company's off-balance sheet arrangements consist of purchase obligations, primarily commitments for material purchases, which have been entered into in the normal course of business.
In accordance with industry practice, the Company is liable to customers for obligations relating to contract completion and timely delivery. In the normal conduct of its operations, the Company may provide letters of credit as security for advances received from customers pending delivery and contract performance. In addition, the Company provides letters of credit for post-retirement obligations and may provide letters of credit as security on equipment under lease and on order. As at September 27, 2026, the total value of outstanding letters of credit was approximately $274.4 million (March 31, 2026 - $283.9 million).
In the normal course of operations, the Company is party to a number of lawsuits, claims and contingencies. Although it is possible that liabilities may be incurred in instances for which no accruals have been made, the Company does not believe that the ultimate outcome of these matters will have a material impact on its interim condensed consolidated financial statements.
The Company is exposed to credit risk on derivative financial instruments arising from the potential for counterparties to default on their contractual obligations to the Company. The Company minimizes this risk by limiting counterparties to major financial institutions and monitoring their creditworthiness. The Company's credit exposure to forward foreign exchange contracts is the current replacement value of contracts that are in a gain position. The Company is also exposed to credit risk from its customers. Substantially all of the Company's trade accounts receivable are due from customers in a variety of industries and, as such, are subject to normal credit risks from their respective industries. The Company regularly monitors customers for changes in credit risk. The Company does not believe that any single market or geographic region represents significant credit risk. Credit risk concentration, with respect to trade receivables, is mitigated as the Company primarily serves large, multinational customers and obtains receivables insurance in certain instances.
FINANCIAL INSTRUMENTS
The Company has various financial instruments including cash and cash equivalents, trade accounts receivable, bank indebtedness, trade accounts payable and accrued liabilities and long-term debt which are used in the normal course of business to maintain operations. The Company uses derivative financial instruments to help manage and mitigate various risks that the business faces.
21
RISK MANAGEMENT
An interest rate risk exists with financial instruments held by the Company, which is the risk that the fair value of future cash flows of a financial instrument will fluctuate as a result of changes in market interest rates. The Company manages interest rate risk on a portfolio basis and seeks financing terms in individual arrangements that are most advantageous, taking into account all relevant factors.
The Company uses a variable for fixed interest rate swap as a derivative financial instrument to hedge a portion of its interest rate risk. Effective November 21, 2023, the Company entered into a variable for fixed interest rate swap instrument to swap the variable interest rate on the $300.0 million outstanding on the Company's Credit Facility at that date, to a fixed 4.044% interest rate for the period November 4, 2024 to November 4, 2026. On March 16, 2026, the Company discontinued hedge accounting on the $150.0 million revolver portion of the Credit Facility due to a repayment of the hedged item. The $150.0 million term loan remains in the pre-existing hedging relationship.
On March 16, 2026, the Company entered into a forward starting variable for fixed interest rate swap instrument to swap the variable interest rate on the $150.0 million outstanding on the term loan to a fixed 3.264%. The terms of the hedging relationship will be effective November 4, 2026 and will end on November 4, 2028, aligned with the terms of the Company's Credit Facility.
A credit risk exists with financial instruments held by the Company, which is the risk of financial loss if a counterparty to a financial instrument fails to meet its contractual obligations. The Company attempts to mitigate this risk by following policies and procedures surrounding accepting work with new customers, and performing work for a large variety of multinational customers in diversified industries.
There is a liquidity risk, which is the risk that the Company may encounter difficulties in meeting obligations associated with some financial instruments. This is managed by ensuring, to the extent possible, that the Company will have sufficient liquidity to meet its liabilities when they become due.
FOREIGN EXCHANGE RISK
The Company is exposed to foreign exchange risk as a result of transactions in currencies other than its functional currency of the Canadian dollar, through borrowings in currencies other than its functional currency and through its investments in its foreign-based subsidiaries.
The Company's Canadian operations generate significant revenues in major foreign currencies, primarily U.S. dollars, which exceed the natural hedge provided by purchases of goods and services in those currencies. In order to manage a portion of this foreign currency exposure, the Company has entered into forward foreign exchange contracts. The timing and amount of these forward foreign exchange contract requirements are estimated based on existing customer contracts on hand or anticipated, current conditions in the Company's markets and the Company's past experience. Certain of the Company's foreign subsidiaries will also enter forward foreign exchange contracts to hedge identified balance sheet, revenue and purchase exposures. The Company's forward foreign exchange contract hedging program is intended to mitigate movements in currency rates primarily over a one- to twenty-four-month period.
The Company uses cross-currency interest rate swaps as derivative financial instruments to hedge a portion of its foreign exchange risk related to its U.S. Senior Notes as well as its Euro-denominated net investment.
22
On December 5, 2024, the Company entered into a cross-currency interest rate swap instrument to swap U.S. $175.0 million into Canadian dollars to hedge a portion of its foreign exchange risk related to its U.S. Senior Notes. The Company will receive interest of 4.125% U.S. per annum and pay interest of 3.128% Canadian. The terms of the hedging instrument will end on December 15, 2027.
On December 5, 2024, the Company entered into a cross-currency interest rate swap instrument to swap 165.3 million Euros into Canadian dollars to hedge its Euro-denominated net investment. The Company will receive interest of 3.128% Canadian per annum and pay interest of 2.645% Euros. The terms of the hedging relationship will end on December 15, 2027.
In addition, from time to time, the Company may hedge the foreign exchange risk arising from foreign currency debt, intercompany loans, net investments in foreign-based subsidiaries and committed acquisitions through the use of forward foreign exchange contracts or other non-derivative financial instruments. The Company uses hedging as a risk management tool, not to speculate.
Period Average Exchange Rates in Canadian Dollars
| Period End Actual Exchange Rates | Three Months Ended Avg Exchange Rates | Six Months Ended Avg Exchange Rates | |||||||||||||||||||||||||||
| September 27, 2026 | September 28, 2025 | % change | September 27, 2026 | September 28, 2025 | % change | September 27, 2026 | September 28, 2025 | % change | |||||||||||||||||||||
| U.S. dollar | 1.414 | 1.394 | 1.4% | 1.398 | 1.377 | 1.5% | 1.391 | 1.381 | 0.7 | % | |||||||||||||||||||
| Euro | 1.612 | 1.631 | (1.2)% | 1.610 | 1.610 | —% | 1.610 | 1.589 | 1.3 | % | |||||||||||||||||||
CONSOLIDATED QUARTERLY RESULTS
(In millions of dollars, except per share amounts)
Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | ||||||||||||||||||||||||||||||||||||||||
| Revenues | $ | 665.8 | $ | 693.7 | $ | 747.1 | $ | 760.7 | $ | 728.5 | $ | 736.7 | $ | 574.2 | $ | 652.0 | |||||||||||||||||||||||||||||||
Adjusted revenues1 | $ | 665.8 | $ | 698.3 | $ | 744.3 | $ | 760.7 | $ | 728.5 | $ | 736.7 | $ | 721.1 | $ | 652.0 | |||||||||||||||||||||||||||||||
Earnings (loss) from operations | $ | 23.2 | $ | 24.2 | $ | 8.1 | $ | 57.7 | $ | 75.2 | $ | 57.8 | $ | (113.6) | $ | 33.1 | |||||||||||||||||||||||||||||||
Adjusted earnings from operations1 | $ | 57.4 | $ | 68.1 | $ | 76.8 | $ | 79.9 | $ | 79.1 | $ | 78.6 | $ | 74.3 | $ | 65.7 | |||||||||||||||||||||||||||||||
Net income (loss) | $ | (5.0) | $ | (0.3) | $ | (16.2) | $ | 30.0 | $ | 33.6 | $ | 24.3 | $ | (68.9) | $ | 6.5 | |||||||||||||||||||||||||||||||
| Basic earnings (loss) per share | $ | (0.05) | $ | — | $ | (0.16) | $ | 0.31 | $ | 0.34 | $ | 0.25 | $ | (0.70) | $ | 0.07 | |||||||||||||||||||||||||||||||
| Diluted earnings (loss) per share | $ | (0.05) | $ | — | $ | (0.16) | $ | 0.30 | $ | 0.34 | $ | 0.25 | $ | (0.70) | $ | 0.06 | |||||||||||||||||||||||||||||||
Adjusted basic earnings per share1 | $ | 0.27 | $ | 0.35 | $ | 0.36 | $ | 0.48 | $ | 0.45 | $ | 0.41 | $ | 0.41 | $ | 0.32 | |||||||||||||||||||||||||||||||
Order Bookings2 | $ | 827 | $ | 656 | $ | 704 | $ | 821 | $ | 734 | $ | 693 | $ | 863 | $ | 883 | |||||||||||||||||||||||||||||||
Order Backlog3 | $ | 2,009 | $ | 1,889 | $ | 1,958 | $ | 2,053 | $ | 2,070 | $ | 2,068 | $ | 2,139 | $ | 2,060 | |||||||||||||||||||||||||||||||
1Non-IFRS financial measure — See "Non-IFRS and Other Financial Measures" and "Reconciliation of Non-IFRS Measures to IFRS Measures."
2Supplementary financial measure —See "Non-IFRS and Other Financial Measures" and "Order Bookings by Quarter."
3Supplementary financial measure — See "Non-IFRS and Other Financial Measures" and "Order Backlog Continuity."
Interim financial results are not necessarily indicative of annual or longer-term results because capital equipment markets served by the Company tend to be cyclical in nature. Operating performance quarter to quarter is also affected by the timing of revenue recognition on large programs in Order Backlog, which is impacted by such factors as customer delivery schedules, the timing of receipt of third-party components, and by the timing of acquisitions. General economic trends, product life cycles
23
and product changes may impact revenues and operating performance. ATS typically experiences some seasonality with its Order Bookings, revenues and earnings from operations due to employee vacations, seasonality of growing seasons within the food industry and summer plant shutdowns by its customers.
RELATED PARTY TRANSACTIONS
There were no significant related party transactions in the first six months of fiscal 2027.
Reconciliation of Non-IFRS Measures to IFRS Measures
(In millions of dollars, except per share data)
The following table reconciles adjusted revenues to the most directly comparable IFRS measure (revenues):
Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
Revenues | $ | 665.8 | $ | 728.5 | $ | 1,359.5 | $ | 1,465.2 | |||||||||||||||
Transportation reorganization1 | — | — | 4.6 | — | |||||||||||||||||||
Adjusted revenues | $ | 665.8 | $ | 728.5 | $ | 1,364.1 | $ | 1,465.2 | |||||||||||||||
1The transportation reorganization included a decrease to revenue and was recorded to reflect the impact of completing legacy customer programs — see "Reorganization and Transformation Activity."
24
The following table reconciles adjusted EBITDA and EBITDA to the most directly comparable IFRS measure (net income (loss)):
Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
Adjusted EBITDA | $ | 80.7 | $ | 103.7 | $ | 173.4 | $ | 205.3 | |||||||||||||||
Less: Restructuring charges1 | 21.3 | — | 27.0 | 2.5 | |||||||||||||||||||
Less: Acquisition-related transaction costs | 0.1 | 0.1 | 0.2 | 0.4 | |||||||||||||||||||
Less: Stock-based compensation forfeiture2 | – | (7.3) | — | (7.3) | |||||||||||||||||||
Less: Transportation reorganization | – | — | 7.6 | — | |||||||||||||||||||
Less: Services reorganization3 | – | — | 4.0 | — | |||||||||||||||||||
Less: CEO inducement | 1.4 | — | 2.8 | — | |||||||||||||||||||
Less: Software-focused businesses reorganization | – | — | 7.1 | — | |||||||||||||||||||
Less: Other reorganization-related costs4 | 1.2 | — | 2.6 | — | |||||||||||||||||||
Less: Mark to market portion of stock-based compensation | (3.8) | (3.7) | (2.8) | (0.1) | |||||||||||||||||||
EBITDA | $ | 60.5 | $ | 114.6 | $ | 124.9 | $ | 209.8 | |||||||||||||||
Less: Depreciation and amortization expense | 37.3 | 39.4 | 77.5 | 76.8 | |||||||||||||||||||
Earnings from operations | $ | 23.2 | $ | 75.2 | $ | 47.4 | $ | 133.0 | |||||||||||||||
Less: Net finance costs | 22.2 | 24.4 | 42.9 | 50.0 | |||||||||||||||||||
Less: Income tax expense | 6.0 | 17.2 | 9.8 | 25.1 | |||||||||||||||||||
Net income (loss) | $ | (5.0) | $ | 33.6 | $ | (5.3) | $ | 57.9 | |||||||||||||||
1Approximately half of the restructuring costs recognized in the second quarter of fiscal 2027 related to the Fixed Cost Transformation Program.
2Reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
3Year-to-date services reorganization costs incurred in the quarter include $0.7 million of amortization costs arising from a change in useful lives of certain assets. These amounts are excluded from the reconciling adjustment as they are already excluded in the calculation of EBITDA.
4Other reorganization-related costs incurred in the quarter include $0.6 million of amortization costs arising from a change in useful lives of certain assets. These amounts are excluded from the reconciling adjustment as they are already excluded in the calculation of EBITDA.
25
The following table reconciles adjusted earnings from operations, adjusted net income, and adjusted basic earnings per share to the most directly comparable IFRS measures (net income (loss) and basic earnings (loss) per share):
Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings from operations | Finance costs | Income tax recovery | Net income (loss) | Basic EPS | Earnings from operations | Finance costs | Income tax expense (recovery) | Net income | Basic EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported (IFRS) | $ | 23.2 | $ | (22.2) | $ | (6.0) | $ | (5.0) | $ | (0.05) | $ | 75.2 | $ | (24.4) | $ | (17.2) | $ | 33.6 | $ | 0.34 | |||||||||||||||||||||||||||||||||||||||
| Amortization of acquisition- related intangibles | 14.0 | — | — | 14.0 | 0.14 | 14.8 | — | — | 14.8 | 0.15 | |||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring charges1 | 21.3 | — | — | 21.3 | 0.22 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Acquisition-related transaction costs | 0.1 | — | — | 0.1 | — | 0.1 | — | — | 0.1 | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation forfeiture2 | — | — | — | — | — | (7.3) | — | — | (7.3) | (0.07) | |||||||||||||||||||||||||||||||||||||||||||||||||
| CEO inducement | 1.4 | — | — | 1.4 | 0.02 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Other reorganization-related costs | 1.2 | — | — | 1.2 | 0.01 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Mark to market portion of stock-based compensation | (3.8) | — | — | (3.8) | (0.04) | (3.7) | — | — | (3.7) | (0.04) | |||||||||||||||||||||||||||||||||||||||||||||||||
Adjustment to income tax expense3 | — | — | (3.2) | (3.2) | (0.03) | — | — | 6.1 | 6.1 | 0.07 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted (non-IFRS) | $ | 57.4 | $ | 26.0 | $ | 0.27 | $ | 79.1 | $ | 43.6 | $ | 0.45 | |||||||||||||||||||||||||||||||||||||||||||||||
1Approximately half of the restructuring costs recognized in the second quarter of fiscal 2027 related to the Fixed Cost Transformation Program.
2Reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
3For a breakdown of items included in adjustments to income tax expense (recovery) see reconciliation of adjusted effective income tax rate table.
26
Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings from operations | Finance costs | Income tax recovery | Net income (loss) | Basic EPS | Earnings from operations | Finance costs | Income tax expense (recovery) | Net income | Basic EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported (IFRS) | $ | 47.4 | $ | (42.9) | $ | (9.8) | $ | (5.3) | $ | (0.05) | $ | 133.0 | $ | (50.0) | $ | (25.1) | $ | 57.9 | $ | 0.59 | |||||||||||||||||||||||||||||||||||||||
| Amortization of acquisition- related intangibles | 28.2 | — | — | 28.2 | 0.29 | 29.2 | — | — | 29.2 | 0.30 | |||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring charges1 | 27.0 | — | — | 27.0 | 0.28 | 2.5 | — | — | 2.5 | 0.03 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Acquisition-related transaction costs | 0.2 | — | — | 0.2 | — | 0.4 | — | — | 0.4 | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation forfeiture2 | — | — | — | — | — | (7.3) | — | — | (7.3) | (0.08) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Transportation reorganization | 7.6 | — | — | 7.6 | 0.08 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Services reorganization | 4.7 | — | — | 4.7 | 0.05 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| CEO inducement | 2.8 | — | — | 2.8 | 0.03 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Software-focused businesses reorganization | 7.1 | — | — | 7.1 | 0.07 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Other reorganization-related costs | 3.3 | — | — | 3.3 | 0.03 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Mark to market portion of stock-based compensation | (2.8) | — | — | (2.8) | (0.03) | (0.1) | — | — | (0.1) | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Adjustment to income tax expense (recovery)3 | — | (12.4) | (12.4) | (0.13) | — | — | 0.9 | 0.9 | 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted (non-IFRS) | $ | 125.5 | $ | 60.4 | $ | 0.62 | $ | 157.7 | $ | 83.5 | $ | 0.85 | |||||||||||||||||||||||||||||||||||||||||||||||
1Approximately half of the restructuring costs recognized in the second quarter of fiscal 2027 related to the Fixed Cost Transformation Program.
2Reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
3For a breakdown of items included in adjustments to income tax expense (recovery) see reconciliation of adjusted effective income tax rate table.
The following table reconciles organic revenue to adjusted revenues, which have been reconciled to the most directly comparable IFRS measure (revenues) earlier in the document:
Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
Organic revenue | $ | 662.4 | $ | 689.9 | $ | 1,351.7 | $ | 1,375.6 | |||||||||||||||
Revenues of acquired companies | — | 14.6 | — | 43.1 | |||||||||||||||||||
Impact of foreign exchange rate changes | 3.4 | 24.0 | 12.4 | 46.5 | |||||||||||||||||||
Total adjusted revenues | $ | 665.8 | $ | 728.5 | $ | 1,364.1 | $ | 1,465.2 | |||||||||||||||
Organic revenue growth | (9.1)% | (7.7)% | |||||||||||||||||||||
27
The following table reconciles non-cash working capital as a percentage of adjusted revenues to the most directly comparable IFRS measures:
As at | September 27, 2026 | March 31, 2026 | |||||||||
Accounts receivable | $ | 521.2 | $ | 523.7 | |||||||
Income tax receivable | 17.7 | 10.4 | |||||||||
Contract assets | 406.7 | 436.8 | |||||||||
Inventories | 301.6 | 295.2 | |||||||||
Deposits, prepaids and other assets | 95.4 | 94.9 | |||||||||
Accounts payable and accrued liabilities | (608.8) | (622.4) | |||||||||
Income tax payable | (39.8) | (34.1) | |||||||||
Contract liabilities | (290.8) | (307.3) | |||||||||
Provisions | (38.8) | (32.1) | |||||||||
Non-cash working capital | $ | 364.4 | $ | 365.1 | |||||||
Trailing six-month adjusted revenues annualized | $ | 2,728.2 | $ | 3,009.8 | |||||||
Working capital % | 13.4% | 12.1% | |||||||||
The following table reconciles net debt to the most directly comparable IFRS measures:
As at | September 27, 2026 | March 31, 2026 | |||||||||
Cash and cash equivalents | $ | 231.0 | $ | 285.0 | |||||||
Bank indebtedness | (2.4) | (6.7) | |||||||||
Current portion of lease liabilities | (36.7) | (35.2) | |||||||||
Current portion of long-term debt | (0.2) | (0.2) | |||||||||
Long-term lease liabilities | (109.9) | (119.5) | |||||||||
Long-term debt | (1,274.0) | (1,274.6) | |||||||||
Net Debt | $ | (1,192.2) | $ | (1,151.2) | |||||||
Pro Forma Adjusted EBITDA (TTM) | $ | 381.3 | $ | 413.0 | |||||||
Net Debt to Pro Forma Adjusted EBITDA | 3.1x | 2.8x | |||||||||
The following table reconciles free cash flow to the most directly comparable IFRS measures:
Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
Cash flows provided by operating activities | $ | 80.7 | $ | 28.5 | $ | 70.3 | $ | 184.3 | |||||||||||||||
Acquisition of property, plant and equipment | (8.2) | (8.1) | (16.2) | (15.2) | |||||||||||||||||||
Acquisition of intangible assets | (10.0) | (10.2) | (17.6) | (19.5) | |||||||||||||||||||
Free cash flow | $ | 62.5 | $ | 10.2 | $ | 36.5 | $ | 149.6 | |||||||||||||||
28
The following table calculates the adjusted effective tax rate based on net income before income taxes including adjusting items and adjusted income tax expense:
(in millions of dollars) | Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | |||||||||||||
Earnings from operations | $ | 23.2 | $ | 75.2 | $ | 47.4 | $ | 133.0 | |||||||||
| Amortization of acquisition-related intangible assets | 14.0 | 14.8 | 28.2 | 29.2 | |||||||||||||
| Acquisition-related transaction costs | 0.1 | 0.1 | 0.2 | 0.4 | |||||||||||||
| Restructuring charges | 21.3 | — | 27.0 | 2.5 | |||||||||||||
| Stock-based compensation forfeiture | — | (7.3) | — | (7.3) | |||||||||||||
Transportation reorganization | — | — | 7.6 | — | |||||||||||||
Services reorganization | — | — | 4.7 | — | |||||||||||||
CEO inducement | 1.4 | — | 2.8 | — | |||||||||||||
| Software-focused businesses reorganization | — | — | 7.1 | — | |||||||||||||
Other reorganization-related costs | 1.2 | — | 3.3 | — | |||||||||||||
| Mark to market portion of stock-based compensation | (3.8) | (3.7) | (2.8) | (0.1) | |||||||||||||
Adjusted earnings from operations | 57.4 | 79.1 | 125.5 | 157.7 | |||||||||||||
Net finance costs | 22.2 | 24.4 | 42.9 | 50.0 | |||||||||||||
Income before income taxes including adjusting items | 35.2 | 54.7 | 82.6 | 107.7 | |||||||||||||
Income tax expense | 6.0 | 17.2 | 9.8 | 25.1 | |||||||||||||
Estimated tax impact of adjusting items | 7.4 | 0.9 | 16.6 | 6.1 | |||||||||||||
Tax impact of unrecognized losses relating to reorganization activities | (4.2) | — | (4.2) | — | |||||||||||||
Additional tax provision related to the departure of the Company's former CEO in the fiscal year | — | (1.6) | — | (1.6) | |||||||||||||
Impact of tax rate change on deferred tax assets | — | (5.4) | — | (5.4) | |||||||||||||
Adjusted income tax expense | 9.2 | 11.1 | 22.2 | 24.2 | |||||||||||||
Adjusted effective income tax rate | 26.1 | % | 20.3 | % | 26.9 | % | 22.5 | % | |||||||||
Certain non-IFRS financial measures exclude the impact on stock-based compensation expense of the revaluation of RSUs and DSUs resulting specifically from the change in market price of the Company's common shares between periods. Management believes the adjustment provides further insight into the Company's performance.
The following table reconciles total stock-based compensation expense to its components:
Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | ||||||||||||||||||||||||||||||||||||||||
Total stock-based compensation expense (recovery) | $ | 0.4 | $ | 6.0 | $ | 2.5 | $ | 4.5 | $ | (6.7) | $ | 8.4 | $ | (2.3) | $ | 5.1 | |||||||||||||||||||||||||||||||
Less: stock-based compensation forfeiture1 | — | — | — | — | (7.3) | — | — | — | |||||||||||||||||||||||||||||||||||||||
Less: mark to market portion of stock-based compensation | (3.8) | 1.1 | 0.1 | 1.4 | (3.7) | 3.6 | (3.4) | 1.4 | |||||||||||||||||||||||||||||||||||||||
Base stock-based compensation expense | $ | 4.2 | $ | 4.9 | $ | 2.4 | $ | 3.1 | $ | 4.3 | $ | 4.8 | $ | 1.1 | $ | 3.7 | |||||||||||||||||||||||||||||||
1Reversal of previously recorded stock-based compensation expense due to departure of the Company's former CEO within the related fiscal year.
29
CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS
The preparation of the Company's interim condensed consolidated financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities at the end of the reporting period. Uncertainty about these estimates, judgments and assumptions could result in outcomes that require a material adjustment to the carrying amount of the asset or liability affected in future periods.
The Company based its assumptions on information available when the interim condensed consolidated financial statements were prepared. Existing circumstances and assumptions about future developments may change due to market changes or circumstances arising beyond the control of the Company. Such changes are reflected in the estimates as they occur.
There have been no material changes to the critical accounting estimates described in the Company's fiscal 2026 MD&A.
Macroeconomic environment
The Company continues to operate in an uncertain macroeconomic environment influenced by various factors, including cross-border tariffs, interest rate changes, inflation, supply chain dynamics and other impediments and uncertainties related to cross-border trade, geopolitical issues, regional conflicts, and the impacts of any pandemic or epidemic outbreak or resurgence. Any of these factors, alone or in combination, could affect the global and Canadian economies, which could adversely affect the Company's business, operations and customers. ATS monitors these dynamic macroeconomic conditions to assess any potential impacts on the business, financial results, and conditions of the Company. Management also monitors and assesses the impact of these factors on its judgments, estimates, accounting policies, and amounts recognized in the Company's interim condensed consolidated financial statements.
CONTROLS AND PROCEDURES
The Chief Executive Officer ("CEO") and the interim Chief Financial Officer ("interim CFO") of the Company are responsible for establishing and maintaining disclosure controls and procedures and internal controls over financial reporting for the Company. The control framework used in the design of disclosure controls and procedures and internal control over financial reporting is the "Internal Control – Integrated Framework (2013)" issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO").
Management is required to complete an evaluation of the design and operating effectiveness of the Company's disclosure controls and procedures which was conducted as of September 27, 2026 under the supervision of the CEO and interim CFO as required by CSA National Instrument 52-109 - Certification of Disclosure in Issuers' Annual and Interim Filings as well as Rule 13a-15(e) and Rules 15d-15(e) under the U.S. Securities Exchange Act of 1934, as amended (the "U.S. Exchange Act"). The evaluation included documentation, review, enquiries and other procedures considered appropriate in the circumstances. Based on that evaluation, the CEO and the interim CFO have concluded that the Company's disclosure controls and procedures were not effective as of September 27, 2026, due to the material weakness in the Company's internal controls over financial reporting as previously identified in the Controls and Procedures section of the fiscal 2026 MD&A.
30
Management, including the CEO and interim CFO, does not expect that the Company's disclosure controls or internal controls over financial reporting will prevent or detect all errors and all fraud or will be effective under all potential future conditions. A control system is subject to inherent limitations and, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system's objectives will be met.
Remediation plan for the material weakness
In response to the material weakness identified in the fiscal 2026 MD&A, management, with oversight of the Audit Committee of the Board of Directors of the Company, is continuing to implement effective internal controls to address the identified material weakness.
Management is implementing an upgrade of the existing enterprise resource planning ("ERP") system in one of its international divisions. The upgraded ERP system went live during the quarter and is currently undergoing post-implementation stabilization. The upgraded ERP system will support the implementation of an effective control design over the completeness and accuracy of data used in the performance of business controls and enhance internal controls through increased process automation. Management continues to evaluate and implement the related controls as part of its remediation activities.
Senior management has discussed the material weakness with the Audit Committee, which will continue to review progress on these remediation activities. While management believes these actions will contribute to the remediation of the material weakness, the corrective processes and related procedures have not yet been completed. Until the remediation steps set forth above are fully designed, implemented, and operate for a sufficient period of time such that they can be concluded to be operating effectively, the material weakness described above will not be considered remediated. No assurance can be provided at this time that the actions and remediation efforts will effectively remediate the remaining material weakness described above or prevent the occurrence of other material weaknesses in the Company's ICFR in the future. As the Company continues to evaluate and work to improve its internal control over financial reporting, management may take additional measures to address control deficiencies.
Changes in internal control over financial reporting
Except for the remediation activities described above, there have been no other significant changes in the Company's internal controls over financial reporting that have materially affected, or are reasonably likely to affect, internal control over financial reporting.
31
FORWARD-LOOKING STATEMENTS
This MD&A contains certain statements that may constitute forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws ("forward-looking statements"). All such statements are made pursuant to the "safe harbour" provisions of Canadian provincial and territorial securities laws and the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts regarding possible events, conditions or results of operations that ATS believes, expects or anticipates will or may occur in the future, including, but not limited to: the value creation strategy; the Company's strategy to expand through development of new markets and business platforms, expanding service offerings, investment in innovation and product development, and strategic and disciplined acquisitions, and the expected benefits to be derived therefrom; the ABM and possible margin improvements as a result from the execution of the ABM, including the timelines to achieve such improvements; the development of the Company's data-enabled automation capabilities; various core and end market opportunities for ATS; conversion of opportunities into Order Bookings; the announcement of new Order Bookings and the anticipated timeline for delivery; potential impacts on the time to convert opportunities into Order Bookings; expected Order Bookings activity over the balance of fiscal 2027; the expectation that the Company's Order Backlog will help mitigate some of the impact of variable Order Bookings on revenue in the short term; the conversion of Order Backlog into revenue, including the timing and pace of project execution and revenue recognition; the expected benefits where the Company engages with customers on enterprise-type solutions; the Company's plan to focus on increasing after-market sales and service revenue, including the benefits related thereto; the potential impact of the Company's approach to market and timing of customer decisions on Order Bookings, performance period, and timing of revenue recognition; the Company's expectations and beliefs regarding customer demand trends; the Company's expectations regarding lifecycle service opportunities with respect to its nuclear business; expected benefits with respect to the Company's efforts to grow its product portfolio and after-sale service revenues; the ability of after-sales revenues and reoccurring revenues to provide some balance to customers' capital expenditure cycles; the range of the expected reoccurring revenues on a trailing twelve-month basis; initiatives in furtherance of revenue growth and improvement of profitability; the expected improvement of the Company's adjusted earnings from operations margin in fiscal 2027 through operational initiatives and portfolio development, and a combination of lower costs achieved from existing and planned restructuring and reorganization activities, disciplined execution of the ABM across the portfolio, targeted commercial practices, and an improved after-market mix supported by the integration of services directly into the Company's operating units; the expected cost reductions as a result of the reorganization activities; the expected long-term adjusted earnings from operations margin target; management's expectations regarding adjusted earnings from operations margin for the remainder of fiscal 2027 and following the fourth quarter of fiscal 2027; the anticipated range of revenues for the following quarter; the expected revenue growth for fiscal 2027, and the Company's long term goal to grow revenues greater than market growth rates in its chosen markets; the expectation that the ongoing reorganization of the Company's transportation-related operations will remove dilutive revenues; the expectation that management will operate above its targeted leverage ratio for the remainder of fiscal 2027; the expected impacts of the Company's capital allocation plan; the Company's expected improvements in free cash flow and the multi-year free cash flow target; expectation of realization of cost and revenue synergies consistent with announced integration plans; the Company's long-term goal of non-cash working capital as a percentage of annualized revenues; the expectation to continue investing in non-cash working capital to support growth; planned reorganization activities in future quarters, including the Fixed Cost Transformation Program, the European Footprint Consolidation, the expected restructuring costs in future quarters, the expectation that the restructuring and other related costs to be funded by proceeds of the sale of buildings in the U.S. and in Germany in fiscal 2027, the reinvestment of a portion of savings from the reorganization
32
activities in higher-growth areas, the expectation of restructuring and reorganization activity to support the Company's margin expansion initiative throughout fiscal 2027 including the expected timing, scope, anticipated benefits of these initiatives to simplify the Company's operating structure and the expected annualized cost savings of such activities; the Company's expectations regarding the timing of recognition of gains as a result of the disposition of certain U.S. facilities; the Company's expectations regarding its ability to absorb fixed costs for the remainder of fiscal 2027; the Company's expectations regarding market conditions with respect to its various businesses, including laboratory equipment; the expected stock-based compensation expense per quarter in fiscal 2027; expectations in relation to meeting liquidity and funding requirements for investments; potential to use debt or equity financing to support strategic opportunities and growth strategy; underlying trends driving customer demand; potential impacts of variability in bookings caused by the timing and geographies of customer capital expenditure decisions on larger opportunities; the ability to achieve revenue growth organically and by identifying strategic acquisition opportunities; expected capital expenditures for fiscal 2027; the remediation plan for the material weakness in the Company's internal control over financial reporting, and the effectiveness of the upgraded ERP system; the uncertainty and potential impact on the Company's business and operations due to the current macroeconomic environment including the impacts of inflation, uncertainty caused by the supply chain dynamics, interest rate changes, tariffs imposed by the U.S. and the shifting trade dynamics, geo-political issues, and regional or global conflicts; steps taken by the Company to mitigate risks as a result of the tariffs imposed by the U.S., the expected future impact of such tariffs on the Company's business, including Section 338 tariffs and Section 301 tariffs, and the potential impact of changes to tariff policy; and the Company's belief with respect to the outcome or impact of any lawsuits, claims, counterclaims and contingencies.
Forward-looking statements are inherently subject to significant known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of ATS, or developments in ATS' business or in its industry, to differ materially from the anticipated results, performance, achievements, or developments expressed or implied by such forward-looking statements. Important risks, uncertainties, and factors that could cause actual results to differ materially from expectations expressed in the forward-looking statements include, but are not limited to: the impact of regional or global conflicts; general market performance including capital market conditions and availability and cost of credit; risks related to the shifting trade dynamics including tariffs, trade policy, and trade restrictions; risks related to a recession, slowdown, and/or sustained downturn in the economy; performance of the markets that ATS serves; industry challenges in securing the supply of labour, materials, and, in certain jurisdictions, energy sources such as natural gas; impact of inflation; interest rate changes; foreign currency and exchange risk; the relative weakness of the Canadian dollar; risks related to customer concentration; risks related to any customer disagreements; impact of factors such as increased pricing pressure, decreases in availability and a corresponding increase in cost of energy and supplies, and delays in relation thereto, further delays or revisions of customer awards, lower-than-expected Order Bookings, failure of expected Order Bookings to materialize over the balance of fiscal 2027, delays in converting Order Bookings or Order Backlog into revenue, and possible margin compression related thereto; the regulatory and tax environment; the emergence of new infectious diseases or any epidemic or pandemic outbreak or resurgence, and collateral consequences thereof, including the disruption of economic activity, volatility in capital and credit markets, and legislative and regulatory responses; the impacts of inflation, uncertainty caused by the supply chain dynamics, interest rate changes, shifting trade dynamics and tariffs, and regional or global conflicts that have in the past and may in the future lead to significant price and trading fluctuations in the market price for securities in the stock markets, including the TSX and the NYSE; the expected future impact of tariffs on the Company's business, including the Section 338 tariffs; the inability of the Company to shift production of tariff impacted volume to other facilities; energy shortages and global price increases; inability to successfully expand through development of new markets and business platforms, expanding service offerings, investment in innovation and product
33
development, and strategic and disciplined acquisition, due to an inability to grow expertise, personnel, and/or facilities at required rates or to identify, negotiate and conclude one or more acquisitions; or to raise, through debt or equity, or otherwise have available, required capital; that the ABM is not effective in accomplishing its goals; that ATS is unable to expand in emerging markets, or is delayed in relation thereto, due to any number of reasons, including inability to effectively execute organic or inorganic expansion plans, focus on other business priorities, or local government regulations or delays; that the timing of completion of new Order Bookings is other than as expected due to various reasons, including schedule changes or the customer exercising any right to withdraw the Order Booking or to terminate the program in whole or in part prior to its completion, thereby preventing ATS from realizing on the full benefit of the program; that some or all of the sales funnel is not converted to Order Bookings due to competitive factors or failure to meet customer needs; that the market opportunities ATS anticipates do not materialize, develop slower than expected or that ATS is unable to exploit such opportunities; failure to convert Order Backlog to revenue and/or variations in the amount of Order Backlog completed in any given quarter; timing of customer decisions related to large enterprise programs and potential for negative impact associated with any cancellations or non-performance in relation thereto; that the Company is not successful in growing its product portfolio and/or service offering or that expected benefits are not realized; that efforts to improve adjusted earnings from operations margin for the remainder of fiscal 2027 and following the fourth quarter of fiscal 2027 and over the long-term are unsuccessful, due to any number of reasons, including less than anticipated increase in after-sales service revenues or reduced margins attached to those revenues, inability to achieve lower costs through supply chain management, price and lead-time volatility, failure to develop, adopt internally, or have customers adopt, standardized platforms and technologies, inability to maintain current cost structure if revenues were to grow, and failure of ABM to impact margins; that after-sales or reoccurring revenues do not provide the expected balance to customers' expenditure cycles; that revenues are not in the expected range; that acquisitions made are not integrated as quickly or effectively as planned or expected and, as a result, anticipated benefits and synergies are not realized; non-cash working capital as a percentage of adjusted revenues operating at a level other than as expected due to reasons, including, the timing and nature of Order Bookings, the timing of payment milestones and payment terms in customer contracts, and delays in customer programs; that planned reorganization activities are not completed at the cost or within the timelines expected, or at all; underlying trends driving customer demand will not materialize or have the impact expected; that capital expenditure targets are increased in the future or the Company experiences cost increases in relation thereto; the remediation plan for the material weakness in the Company's internal control over financial reporting and the upgraded ERP system are not effective; risk that the ultimate outcome of lawsuits, claims, and contingencies give rise to material liabilities for which no provisions have been recorded; the consequence of activist initiatives on the business performance, results, or share price of the Company; the impact of analyst reports on price and trading volume of ATS' shares; impact of the leadership transition; and other risks and uncertainties detailed from time to time in ATS' filings with securities regulators, including, without limitation, the risk factors described in ATS' Annual Information Form, which are available on the SEDAR+ at www.sedarplus.ca and on the U.S. Securities Exchange Commission's EDGAR at www.sec.gov. ATS has attempted to identify important factors that could cause actual results to materially differ from current expectations; however, there may be other factors that cause actual results to differ materially from such expectations.
Forward-looking statements are necessarily based on a number of estimates, factors, and assumptions regarding, among others, management's current plans, estimates, projections, beliefs and opinions, the future performance and results of the Company's business and operations; the ability of ATS to execute on its business objectives; the effectiveness of ABM in accomplishing its goals; the ability to successfully implement margin expansion initiatives; management's assessment as to the project schedules across all customer contracts in Order Backlog, the strengthening of Order Bookings over the balance of fiscal 2027 and the conversion of those Order Bookings and Order Backlog into revenue
34
within expected timelines, faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity; management's assessment of the mix of projects in the funnel and Order Backlog that may or may not convert to revenue and the associated margins of such projects; the volume of outstanding projects the Company is contracted to perform, the size and duration of those projects, and the timing of project activities including design, assembly, testing, and installation will support revenue growth; initiatives in furtherance of the Company's goal of improving its adjusted earnings from operations margin in fiscal 2027 and over the long term will result in improvements to adjusted earnings from operations margin; the anticipated growth or capabilities in the life sciences, radiopharmaceuticals food & beverage, consumer products, energy, and nuclear markets; the ability to seek out, enter into and successfully integrate acquisitions; the Company's expectations of industry consolidation over the next two years; the Company's expectations regarding future market conditions; ongoing cost inflationary pressures and the Company's ability to respond to such inflationary pressures; the effects of foreign currency exchange rate fluctuations on its operations; the Company's competitive position in the industry, including global presence, size and critical mass, technical skills, capabilities and experience, product and technology portfolio, recognized brands, trusted customer relationships, and total-solutions capabilities; the underlying trends driving customer demand for ATS solutions remain favourable; the Company's ability to adapt and develop solutions that keep pace with continuing changes in technology and customer needs; the ability to maintain mutually beneficial relationships with the Company's customers; planned restructuring and reorganization activities will be implemented as expected and within anticipated cost ranges; and general economic and political conditions, and global events, including any regional and global conflicts, epidemic or pandemic outbreak or resurgence, and the international trade dynamics.
Forward-looking statements included in this MD&A are only provided to understand management's current expectations relating to future periods and, as such, are not appropriate for any other purpose. Although ATS believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and ATS cautions you not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. ATS does not undertake any obligation to update forward-looking statements contained herein other than as required by law.
Certain forward-looking information included herein may also constitute a "financial outlook" within the meaning of applicable securities laws. Such financial outlook may include, without limitation, statements regarding expected revenues, expected adjusted earnings from operations margin, adjusted earnings from operations margin targets, expected restructuring costs, expected capital expenditures and free cash flow targets. Financial outlook involves statements about ATS' prospective financial performance, financial position or cash flows that is based on and subject to the assumptions about future economic conditions and courses of action described above as well as management's assessment of project schedules across all customer contracts in Order Backlog, expectations for faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity, and lower costs achieved from the transportation reorganization. Such assumptions are based on management's assessment of the relevant information currently available and any financial outlook included herein is provided for the purpose of helping readers understand management's current expectations and plans for the future as of the date hereof. The actual results of ATS' operations may vary from the amounts set forth in any financial outlook and such variances may be material. Readers are cautioned that reliance on any financial outlook may not be appropriate for other purposes or in other circumstances and that the risk factors described above and other factors may cause actual results to differ materially from any financial outlook.
35
NON-IFRS AND OTHER FINANCIAL MEASURES
Throughout this document, management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company.
The terms "EBITDA", "organic revenue", "adjusted net income", "adjusted earnings from operations", "adjusted revenues", "adjusted EBITDA", "pro forma adjusted EBITDA", "adjusted basic earnings per share", "adjusted income tax provision", and "free cash flow", are non-IFRS financial measures, "EBITDA margin", "adjusted earnings from operations margin", "adjusted EBITDA margin", "organic revenue growth", "non-cash working capital as a percentage of adjusted revenues", "net debt to pro forma adjusted EBITDA", and "adjusted effective tax rate" are non-IFRS ratios, and "operating margin", "Order Bookings", "organic Order Bookings", "organic Order Bookings growth", "Order Backlog", and "book-to-bill ratio" are supplementary financial measures, all of which do not have any standardized meaning prescribed within IFRS and therefore may not be comparable to similar measures presented by other companies. Such measures should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. In addition, management uses "earnings from operations", which is an additional IFRS measure, to evaluate the performance of the Company. Earnings from operations is presented on the Company's consolidated statements of income as net income excluding income tax expense and net finance costs. Operating margin is an expression of the Company's earnings from operations as a percentage of adjusted revenues. EBITDA is defined as earnings from operations excluding depreciation and amortization. EBITDA margin is an expression of the Company's EBITDA as a percentage of adjusted revenues. Organic revenue is defined as adjusted revenues in the stated period excluding revenues from acquired companies for which the acquired company was not a part of the consolidated group in the comparable period. Organic revenue growth compares the stated period organic revenue with the reported adjusted revenue of the comparable prior period. Adjusted earnings from operations is defined as earnings from operations before items excluded from management's internal analysis of operating results, such as amortization expense of acquisition-related intangible assets, acquisition-related transaction and integration costs, restructuring charges, legal settlement and cancelled contract costs that arise outside of the ordinary course of business, the mark-to-market adjustment on stock-based compensation and certain other adjustments which would be non-recurring in nature ("adjustment items"). Adjusted earnings from operations margin is an expression of the Company's adjusted earnings from operations as a percentage of adjusted revenues. Adjusted revenues are defined as revenues before any adjustment items. Adjusted EBITDA is defined as adjusted earnings from operations excluding depreciation and amortization. Pro forma adjusted EBITDA is adjusted EBITDA on a pro forma basis to reflect full contribution from recent acquisitions. Adjusted EBITDA margin is an expression of the entity's adjusted EBITDA as a percentage of revenues. Adjusted basic earnings per share is defined as adjusted net income on a basic per share basis, where adjusted net income is defined as adjusted earnings from operations less net finance costs and income tax expense, plus tax effects of adjustment items and adjusted for other significant items of a non-recurring nature. Non-cash working capital as a percentage of adjusted revenues is defined as the sum of accounts receivable, contract assets, inventories, deposits, prepaids and other assets, less accounts payable, accrued liabilities, provisions and contract liabilities divided by the trailing two fiscal quarter adjusted revenues annualized. Adjusted income tax provision is defined as income tax provision including the tax impact of adjusting items and adjusting for the impact of additional one time tax transactions. Adjusted effective tax rate is adjusted income tax expressed as a percentage of pre tax income. Free cash flow is defined as cash provided by operating activities less property, plant and equipment and intangible asset expenditures. Net debt to pro forma adjusted EBITDA is the ratio of the net debt of the Company (cash and cash equivalents less bank indebtedness, long-term debt, and lease liabilities) to the trailing twelve month pro forma adjusted EBITDA. Order Bookings represent new orders for the supply of automation systems, services and products that
36
management believes are firm. Organic Order Bookings are defined as Order Bookings in the stated period excluding Order Bookings from acquired companies for which the acquired company was not a part of the consolidated group in the comparable period. Organic Order Bookings growth compares the stated period organic Order Bookings with the reported Order Bookings of the comparable prior period. Order Backlog is the estimated unearned portion of revenues on customer contracts that are in process and have not been completed at the specified date. Book to bill ratio is a measure of Order Bookings compared to adjusted revenue.
Following amendments to ATS' RSU Plan in 2022 to provide the Company with the option for settlement in shares purchased in the open market and the creation of the employee benefit trust to facilitate such settlement, ATS began to account for RSUs as equity-settled. However, prior RSU grants which will be cash-settled and DSU grants which will be cash-settled are accounted for as described in the Company's annual consolidated financial statements and have volatility period over period based on the fluctuating price of ATS' common shares. Certain non-IFRS financial measures (adjusted EBITDA, net debt to pro forma adjusted EBITDA, adjusted earnings from operations and adjusted basic earnings per share) exclude the impact on stock-based compensation expense of the revaluation of DSUs and RSUs resulting specifically from the change in market price of the Company's common shares between periods. Management believes that this adjustment provides insight into the Company's performance, as share price volatility drives variability in the Company's stock-based compensation expense.
Operating margin, adjusted earnings from operations, adjusted revenues, EBITDA, EBITDA margin, adjusted EBITDA, pro forma adjusted EBITDA and adjusted EBITDA margin are used by the Company to evaluate the performance of its operations. Management believes that earnings from operations is an important indicator in measuring the performance of the Company's operations on a pre-tax basis and without consideration as to how the Company finances its operations. Management believes that adjusted revenues, organic revenue and organic revenue growth, when considered with IFRS measures, allow the Company to better measure the Company's performance and evaluate long-term performance trends. Organic revenue growth also facilitates easier comparisons of the Company's performance with prior and future periods and relative comparisons to its peers. Management believes that EBITDA and adjusted EBITDA are important indicators of the Company's ability to generate operating cash flows to fund continued investment in its operations. Management believes that adjusted earnings from operations, adjusted earnings from operations margin, adjusted EBITDA, adjusted net income and adjusted basic earnings per share are important measures to increase comparability of performance between periods. The adjustment items used by management to arrive at these metrics are not considered to be indicative of the business' ongoing operating performance. Management uses the measure "non-cash working capital as a percentage of adjusted revenues" to assess overall liquidity. Management uses adjusted effective tax rate to better evaluate actual tax impact on the financial performance of the Company. Free cash flow is used by the Company to measure cash flow from operations after investment in property, plant and equipment and intangible assets. Management uses net debt to pro forma adjusted EBITDA as a measurement of leverage of the Company. Order Bookings provide an indication of the Company's ability to secure new orders for work during a specified period, while Order Backlog provides a measure of the value of Order Bookings that have not been completed at a specified point in time. Both Order Bookings and Order Backlog are indicators of future revenues that the Company expects to generate based on contracts that management believes to be firm. Organic Order Bookings and organic Order Bookings growth allow the Company to better measure the Company's performance and evaluate long-term performance trends. Organic Order Bookings growth also facilitates easier comparisons of the Company's performance with prior and future periods and relative comparisons to its peers. Book to bill ratio is used to measure the Company's ability and timeliness to convert Order Bookings into revenues. Management believes that ATS shareholders and potential investors in ATS use these additional IFRS measures and non-IFRS financial measures in making investment decisions and measuring operational results.
37
A reconciliation of (i) adjusted EBITDA and EBITDA to net income, (ii) adjusted earnings from operations to net income, (iii) adjusted net income to net income, (iv) adjusted basic earnings per share to basic earnings per share (v) free cash flow to its IFRS measure components (vi) adjusted revenues to revenue and (vii) organic revenue to revenue, in each case for the three and six months ended September 27, 2026 and September 28, 2025, is contained in this MD&A (see "Reconciliation of Non-IFRS Measures to IFRS Measures"). This MD&A also contains a reconciliation of (i) non-cash working capital as a percentage of adjusted revenues and (ii) net debt to their IFRS measure components, in each case at both September 27, 2026 and March 31, 2026 (see "Reconciliation of Non-IFRS Measures to IFRS Measures"). A reconciliation of adjusted earnings from operations to earnings from operations for the three and six months ended September 27, 2026 and September 28, 2025 is also contained in the MD&A (see "Earnings and Adjusted Earnings from Operations"). A reconciliation of Order Bookings and Order Backlog to total Company revenues for the three and six months ended September 27, 2026 and September 28, 2025 is also contained in this MD&A (see "Order Backlog Continuity"). A reconciliation of the adjusted effective tax rate for the three and six months ended September 27, 2026 is also contained in the MD&A (see "Reconciliation of Non-IFRS Measures to IFRS Measures").
38
Exhibit 99.2 | ||
ATS CORPORATION
Interim Condensed Consolidated Financial Statements
For the period ended September 27, 2026
(Unaudited)
ATS CORPORATION
Interim Condensed Consolidated Statements of Financial Position
(in thousands of Canadian dollars - unaudited)
| As at | Note | September 27 2026 | March 31 2026 | ||||||||||||||
| ASSETS | 12 | ||||||||||||||||
Current assets | |||||||||||||||||
| Cash and cash equivalents | $ | 230,968 | $ | 284,957 | |||||||||||||
| Accounts receivable | 18 | 521,208 | 523,738 | ||||||||||||||
| Income tax receivable | 17,686 | 10,356 | |||||||||||||||
| Contract assets | 18 | 406,746 | 436,847 | ||||||||||||||
| Inventories | 4 | 301,618 | 295,206 | ||||||||||||||
Deposits, prepaids and other assets | 5 | 95,412 | 94,873 | ||||||||||||||
| 1,573,638 | 1,645,977 | ||||||||||||||||
| Assets held for sale | 8 | 61,263 | 60,302 | ||||||||||||||
| 1,634,901 | 1,706,279 | ||||||||||||||||
| Non-current assets | |||||||||||||||||
Property, plant and equipment | 17 | 259,217 | 259,791 | ||||||||||||||
| Right-of-use assets | 6, 17 | 137,276 | 147,054 | ||||||||||||||
| Long-term deposits | 5 | 3,896 | 3,710 | ||||||||||||||
| Other assets | 7 | 9,737 | 4,464 | ||||||||||||||
| Goodwill | 1,411,763 | 1,399,253 | |||||||||||||||
| Intangible assets | 9, 17 | 680,300 | 704,210 | ||||||||||||||
| Deferred income tax assets | 14 | 130,220 | 115,269 | ||||||||||||||
| 2,632,409 | 2,633,751 | ||||||||||||||||
| Total assets | $ | 4,267,310 | $ | 4,340,030 | |||||||||||||
| LIABILITIES AND EQUITY | |||||||||||||||||
| Current liabilities | |||||||||||||||||
Bank indebtedness | 12 | $ | 2,407 | $ | 6,744 | ||||||||||||
| Accounts payable and accrued liabilities | 608,761 | 622,436 | |||||||||||||||
| Income tax payable | 39,839 | 34,123 | |||||||||||||||
| Contract liabilities | 18 | 290,844 | 307,306 | ||||||||||||||
| Provisions | 11 | 38,750 | 32,100 | ||||||||||||||
| Current portion of lease liabilities | 6 | 36,652 | 35,202 | ||||||||||||||
| Current portion of long-term debt | 12 | 177 | 173 | ||||||||||||||
| 1,017,430 | 1,038,084 | ||||||||||||||||
| Non-current liabilities | |||||||||||||||||
Employee benefits | 26,684 | 26,075 | |||||||||||||||
| Long-term provisions | 11 | 4,775 | 468 | ||||||||||||||
| Long-term lease liabilities | 6 | 109,895 | 119,486 | ||||||||||||||
| Long-term debt | 12 | 1,273,968 | 1,274,552 | ||||||||||||||
| Deferred income tax liabilities | 14 | 79,201 | 80,462 | ||||||||||||||
| Other long-term liabilities | 7 | 19,560 | 21,445 | ||||||||||||||
| 1,514,083 | 1,522,488 | ||||||||||||||||
| Total liabilities | $ | 2,531,513 | $ | 2,560,572 | |||||||||||||
Commitments and contingencies | 12, 16 | ||||||||||||||||
| EQUITY | |||||||||||||||||
Share capital | 13 | $ | 835,589 | $ | 852,805 | ||||||||||||
| Contributed surplus | 33,263 | 30,758 | |||||||||||||||
Accumulated other comprehensive income | 189,658 | 171,573 | |||||||||||||||
| Retained earnings | 675,583 | 722,621 | |||||||||||||||
| Equity attributable to shareholders | 1,734,093 | 1,777,757 | |||||||||||||||
| Non-controlling interests | 1,704 | 1,701 | |||||||||||||||
| Total equity | 1,735,797 | 1,779,458 | |||||||||||||||
| Total liabilities and equity | $ | 4,267,310 | $ | 4,340,030 | |||||||||||||
See accompanying notes to the interim condensed consolidated financial statements.
2
ATS CORPORATION
Interim Condensed Consolidated Statements of Income (Loss)
(in thousands of Canadian dollars, except per share amounts - unaudited)
Three months ended | Six months ended | ||||||||||||||||||||||||||||||||||
Note | September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | |||||||||||||||||||||||||||||||
Revenues | 17, 18 | $ | 665,766 | $ | 728,456 | $ | 1,359,487 | $ | 1,465,176 | ||||||||||||||||||||||||||
| Operating costs and expenses | |||||||||||||||||||||||||||||||||||
Cost of revenues | 476,282 | 510,581 | 980,052 | 1,027,451 | |||||||||||||||||||||||||||||||
| Selling, general and administrative | 144,607 | 149,372 | 298,629 | 300,507 | |||||||||||||||||||||||||||||||
| Restructuring costs | 11 | 21,293 | — | 26,951 | 2,493 | ||||||||||||||||||||||||||||||
| Stock-based compensation (recovery) | 15 | 389 | (6,740) | 6,446 | 1,699 | ||||||||||||||||||||||||||||||
Earnings from operations | 23,195 | 75,243 | 47,409 | 133,026 | |||||||||||||||||||||||||||||||
| Net finance costs | 19 | 22,201 | 24,413 | 42,920 | 50,054 | ||||||||||||||||||||||||||||||
Income before income taxes | 994 | 50,830 | 4,489 | 82,972 | |||||||||||||||||||||||||||||||
Income tax expense | 14 | 6,004 | 17,192 | 9,754 | 25,068 | ||||||||||||||||||||||||||||||
Net income (loss) | $ | (5,010) | $ | 33,638 | $ | (5,265) | $ | 57,904 | |||||||||||||||||||||||||||
| Attributable to | |||||||||||||||||||||||||||||||||||
Shareholders | $ | (4,954) | $ | 33,679 | $ | (5,263) | $ | 57,796 | |||||||||||||||||||||||||||
| Non-controlling interests | (56) | (41) | (2) | 108 | |||||||||||||||||||||||||||||||
| $ | (5,010) | $ | 33,638 | $ | (5,265) | $ | 57,904 | ||||||||||||||||||||||||||||
Earnings (loss) per share attributable to shareholders | |||||||||||||||||||||||||||||||||||
| Basic and diluted | 20 | $ | (0.05) | $ | 0.34 | $ | (0.05) | $ | 0.59 | ||||||||||||||||||||||||||
See accompanying notes to the interim condensed consolidated financial statements.
3
ATS CORPORATION
Interim Condensed Consolidated Statements of Comprehensive Income (Loss)
(in thousands of Canadian dollars - unaudited)
Three months ended | Six months ended | |||||||||||||||||||||||||||||||
September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | |||||||||||||||||||||||||||||
Net income (loss) | $ | (5,010) | $ | 33,638 | $ | (5,265) | $ | 57,904 | ||||||||||||||||||||||||
Other comprehensive income (loss): | ||||||||||||||||||||||||||||||||
Items to be reclassified subsequently to net income (loss): | ||||||||||||||||||||||||||||||||
Currency translation adjustment (net of income taxes of $nil) | (3,303) | 35,186 | 20,142 | 6,260 | ||||||||||||||||||||||||||||
Net unrealized gain (loss) on derivative financial instruments designated as cash flow hedges | 10 | (393) | (7,365) | (6,479) | 4,989 | |||||||||||||||||||||||||||
| Tax impact | 101 | 1,848 | 1,638 | (1,265) | ||||||||||||||||||||||||||||
Loss transferred to net income (loss) for derivatives designated as cash flow hedges | 10 | 2,373 | 1,273 | 3,626 | 4,556 | |||||||||||||||||||||||||||
| Tax impact | (598) | (307) | (905) | (1,126) | ||||||||||||||||||||||||||||
| Cross-currency interest rate swap adjustment | 10 | (389) | (113) | (1,874) | 1,932 | |||||||||||||||||||||||||||
| Tax impact | 97 | 28 | 468 | (483) | ||||||||||||||||||||||||||||
| Variable for fixed interest rate swap adjustment | 10 | 2,130 | 532 | 2,149 | 1,920 | |||||||||||||||||||||||||||
| Tax impact | (532) | (133) | (537) | (480) | ||||||||||||||||||||||||||||
Other comprehensive income (loss) | (514) | 30,949 | 18,228 | 16,303 | ||||||||||||||||||||||||||||
Comprehensive income (loss) | $ | (5,524) | $ | 64,587 | $ | 12,963 | $ | 74,207 | ||||||||||||||||||||||||
Attributable to | ||||||||||||||||||||||||||||||||
| Shareholders | $ | (5,464) | $ | 64,593 | $ | 12,960 | $ | 74,239 | ||||||||||||||||||||||||
| Non-controlling interests | (60) | (6) | 3 | (32) | ||||||||||||||||||||||||||||
| $ | (5,524) | $ | 64,587 | $ | 12,963 | $ | 74,207 | |||||||||||||||||||||||||
See accompanying notes to the interim condensed consolidated financial statements.
4
ATS CORPORATION
Interim Condensed Consolidated Statements of Changes in Equity
(in thousands of Canadian dollars - unaudited)
Six months ended September 27, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Share capital | Contributed surplus | Retained earnings | Currency translation adjustments | Cash flow hedge reserve | Total accumulated other comprehensive income | Non-controlling interests | Total equity | |||||||||||||||||||||||||||||||||||||||||||
Balance, as at March 31, 2026 | $ | 852,805 | $ | 30,758 | $ | 722,621 | $ | 162,354 | $ | 9,219 | $ | 171,573 | $ | 1,701 | $ | 1,779,458 | ||||||||||||||||||||||||||||||||||
Net loss | — | — | (5,263) | — | — | — | (2) | (5,265) | ||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | 20,137 | (1,914) | 18,223 | 5 | 18,228 | ||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income (loss) | — | — | (5,263) | 20,137 | (1,914) | 18,223 | 3 | 12,963 | ||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation | — | 7,990 | — | — | — | — | — | 7,990 | ||||||||||||||||||||||||||||||||||||||||||
| Exercise of stock options | 839 | (203) | — | — | — | — | — | 636 | ||||||||||||||||||||||||||||||||||||||||||
Settlement of RSUs (note 15) | 5,282 | (5,282) | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Common shares held in trust (note 15) | (2,589) | — | — | — | — | — | — | (2,589) | ||||||||||||||||||||||||||||||||||||||||||
Repurchase of common shares (note 13) | (20,748) | — | (41,775) | — | — | — | — | (62,523) | ||||||||||||||||||||||||||||||||||||||||||
| Hedging reserve reclassified to net income | — | — | — | — | (138) | (138) | — | (138) | ||||||||||||||||||||||||||||||||||||||||||
Balance, as at September 27, 2026 | $ | 835,589 | $ | 33,263 | $ | 675,583 | $ | 182,491 | $ | 7,167 | $ | 189,658 | $ | 1,704 | $ | 1,735,797 | ||||||||||||||||||||||||||||||||||
Six months ended September 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Share capital | Contributed surplus | Retained earnings | Currency translation adjustments | Cash flow hedge reserve | Total accumulated other comprehensive income | Non-controlling interests | Total equity | |||||||||||||||||||||||||||||||||||||||||||
Balance, as at March 31, 2025 | $ | 842,015 | $ | 36,539 | $ | 660,368 | $ | 170,927 | $ | (4,072) | $ | 166,855 | $ | 3,580 | $ | 1,709,357 | ||||||||||||||||||||||||||||||||||
Net income | — | — | 57,796 | — | — | — | 108 | 57,904 | ||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — | 6,400 | 10,043 | 16,443 | (140) | 16,303 | ||||||||||||||||||||||||||||||||||||||||||
| Total comprehensive income (loss) | — | — | 57,796 | 6,400 | 10,043 | 16,443 | (32) | 74,207 | ||||||||||||||||||||||||||||||||||||||||||
| Purchase of non-controlling interest | — | — | (2,564) | — | — | — | (1,806) | (4,370) | ||||||||||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | 823 | — | — | — | — | — | 823 | ||||||||||||||||||||||||||||||||||||||||||
| Exercise of stock options | 14,295 | (3,262) | — | — | — | — | — | 11,033 | ||||||||||||||||||||||||||||||||||||||||||
| Settlement of RSUs | 7,161 | (7,161) | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Common shares held in trust | (9,616) | — | — | — | — | — | — | (9,616) | ||||||||||||||||||||||||||||||||||||||||||
| Repurchase of common shares | (2,854) | — | (7,346) | — | — | — | — | (10,200) | ||||||||||||||||||||||||||||||||||||||||||
Hedging reserve reclassified to net income | — | — | — | — | (206) | (206) | — | (206) | ||||||||||||||||||||||||||||||||||||||||||
Balance, as at September 28, 2025 | $ | 851,001 | $ | 26,939 | $ | 708,254 | $ | 177,327 | $ | 5,765 | $ | 183,092 | $ | 1,742 | $ | 1,771,028 | ||||||||||||||||||||||||||||||||||
See accompanying notes to the interim condensed consolidated financial statements.
5
ATS CORPORATION
Interim Condensed Consolidated Statements of Cash Flows
(in thousands of Canadian dollars - unaudited)
| Three months ended | Six months ended | ||||||||||||||||||||||||||||||||||
| Note | September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | |||||||||||||||||||||||||||||||
| Operating activities | |||||||||||||||||||||||||||||||||||
Net income (loss) | $ | (5,010) | $ | 33,638 | $ | (5,265) | $ | 57,904 | |||||||||||||||||||||||||||
| Items not involving cash | |||||||||||||||||||||||||||||||||||
| Depreciation of property, plant and equipment | 7,586 | 8,616 | 17,259 | 17,020 | |||||||||||||||||||||||||||||||
| Amortization of right-of-use assets | 6 | 9,347 | 9,848 | 19,304 | 18,801 | ||||||||||||||||||||||||||||||
| Amortization of intangible assets | 20,330 | 20,967 | 40,931 | 40,924 | |||||||||||||||||||||||||||||||
| Impairment of assets | 9 | — | — | 7,088 | — | ||||||||||||||||||||||||||||||
| Deferred income taxes | 14 | (3,855) | (3,256) | (14,721) | (25,270) | ||||||||||||||||||||||||||||||
| Other items not involving cash | 2,012 | 3,178 | (3,305) | (265) | |||||||||||||||||||||||||||||||
| Stock-based compensation | 15 | 3,598 | (3,502) | 7,990 | 823 | ||||||||||||||||||||||||||||||
| Change in non-cash operating working capital | 21 | 46,673 | (40,998) | 1,052 | 74,336 | ||||||||||||||||||||||||||||||
Cash flows provided by operating activities | $ | 80,681 | $ | 28,491 | $ | 70,333 | $ | 184,273 | |||||||||||||||||||||||||||
| Investing activities | |||||||||||||||||||||||||||||||||||
| Acquisition of property, plant and equipment | $ | (8,161) | $ | (8,135) | $ | (16,185) | $ | (15,229) | |||||||||||||||||||||||||||
| Acquisition of intangible assets | (10,013) | (10,240) | (17,600) | (19,480) | |||||||||||||||||||||||||||||||
| Proceeds from disposal of property, plant and equipment | 176 | 34 | 1,225 | 125 | |||||||||||||||||||||||||||||||
Cash flows used in investing activities | $ | (17,998) | $ | (18,341) | $ | (32,560) | $ | (34,584) | |||||||||||||||||||||||||||
| Financing activities | |||||||||||||||||||||||||||||||||||
| Bank indebtedness | $ | 1,537 | $ | 5,098 | $ | (4,369) | $ | (19,967) | |||||||||||||||||||||||||||
| Repayment of long-term debt | (49) | (40,047) | (50,116) | (215,070) | |||||||||||||||||||||||||||||||
| Proceeds from long-term debt | 40,000 | 39,999 | 40,000 | 84,999 | |||||||||||||||||||||||||||||||
| Proceeds from exercise of stock options | 118 | 10,607 | 636 | 11,033 | |||||||||||||||||||||||||||||||
| Purchase of non-controlling interest | — | — | — | (4,370) | |||||||||||||||||||||||||||||||
| Repurchase of common shares | 13 | (61,297) | — | (61,297) | (10,000) | ||||||||||||||||||||||||||||||
| Acquisition of shares held in trust | 15 | (2,589) | (9,616) | (2,589) | (9,616) | ||||||||||||||||||||||||||||||
| Principal lease payments | (8,945) | (8,751) | (17,500) | (16,672) | |||||||||||||||||||||||||||||||
Cash flows used in financing activities | $ | (31,225) | $ | (2,710) | $ | (95,235) | $ | (179,663) | |||||||||||||||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | 577 | 1,263 | 2,315 | 1,339 | |||||||||||||||||||||||||||||||
Increase (decrease) in cash and cash equivalents | 32,035 | 8,703 | (55,147) | (28,635) | |||||||||||||||||||||||||||||||
Cash and cash equivalents, beginning of period | 198,933 | 188,609 | 284,957 | 225,947 | |||||||||||||||||||||||||||||||
| Initial adoption of amendments to IFRS 9 on April 1, 2026 | — | — | 1,158 | — | |||||||||||||||||||||||||||||||
Cash and cash equivalents, end of period | $ | 230,968 | $ | 197,312 | $ | 230,968 | $ | 197,312 | |||||||||||||||||||||||||||
| Supplemental information | |||||||||||||||||||||||||||||||||||
| Cash income taxes paid | $ | 866 | $ | 12,115 | $ | 25,799 | $ | 14,104 | |||||||||||||||||||||||||||
| Cash interest paid | $ | 27,371 | $ | 29,639 | $ | 43,299 | $ | 49,648 | |||||||||||||||||||||||||||
See accompanying notes to the interim condensed consolidated financial statements.
6
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
1. CORPORATE INFORMATION
ATS Corporation and its subsidiaries (collectively, "ATS" or the "Company") is an industry leader in planning, designing, building, commissioning and servicing automated manufacturing systems - including automation products and test solutions - for a broadly diversified base of customers.
The Company is listed on the Toronto Stock Exchange and the New York Stock Exchange under the ticker symbol "ATS" and is incorporated and domiciled in Ontario, Canada. The address of its registered office is 730 Fountain Street North, Cambridge, Ontario, Canada.
The interim condensed consolidated financial statements of the Company for the three and six months ended September 27, 2026 were authorized for issue by the Board of Directors (the "Board") on November 3, 2026.
2. BASIS OF PREPARATION
These interim condensed consolidated financial statements were prepared on a historical cost basis, except for certain financial instruments and other items that are measured as described in note 3 of the Company's annual consolidated financial statements for the year ended March 31, 2026. The interim condensed consolidated financial statements are presented in Canadian dollars, and all values are rounded to the nearest thousand, except where otherwise stated.
Statement of compliance
These interim condensed consolidated financial statements are prepared in accordance with International Accounting Standard ("IAS") 34 - Interim Financial Reporting. Accordingly, certain information and disclosures normally included in annual financial statements prepared in accordance with International Financial Reporting Standards ("IFRS"), as issued by the International Accounting Standards Board ("IASB"), have been omitted or condensed. These interim condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements of the Company for the year ended March 31, 2026.
Standards adopted in fiscal 2027
The accounting policies adopted in the preparation of these interim condensed consolidated financial statements are consistent with those followed in the presentation of the Company's annual consolidated financial statements for the year ended March 31, 2026, except as noted below:
(i) Adoption of amendments to IFRS 9 and IFRS 7
Effective April 1, 2026, the Company adopted the amendments to IFRS 9 and IFRS 7, issued by the IASB in May 2024. These amendments clarify the timing of derecognition for financial liabilities settled through electronic payment systems, provide additional guidance on assessing the contractual cash flow characteristics of financial assets with a contingent feature, and introduce new disclosure requirements for equity instruments designated at fair value through other comprehensive income and financial instruments with contingent features. The amendments were adopted in accordance with the applicable transition provisions, which do not require the restatement of comparative period information.
7
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
The table below shows the initial impact of adopting these amendments.
| March 31, 2026 as reported | Impact of amendments to IFRS 9 | April 1, 2026 upon adoption of amendments to IFRS 9 | |||||||||
Consolidated statements of financial position: | |||||||||||
Cash and cash equivalents | $ | 284,957 | $ | 1,158 | $ | 286,115 | |||||
Accounts receivable | 523,738 | 222 | 523,960 | ||||||||
Accounts payable and accrued liabilities | 622,436 | 1,380 | 623,816 | ||||||||
Standards issued but not yet effective
A number of new standards and amendments to standards have been issued but are not yet effective for the financial year ending March 31, 2027, and accordingly, have not been applied in preparing these interim condensed consolidated financial statements. The Company reasonably expects the following standards to be applicable at a future date:
(i) Issuance of IFRS 18 - Presentation and Disclosure in Financial Statements
On April 9, 2024, the IASB issued IFRS 18, which will replace IAS 1 for reporting periods beginning on or after January 1, 2027. The new standard aims to improve comparability and transparency of communication in financial statements. IFRS 18 introduces the following key changes:
•A revised structure for the statement of income, including new defined categories of income and expenses and required subtotals such as operating profit or loss and profit or loss before financing and income taxes;
•New presentation requirements for operating expenses, which must be presented directly on the face of the statement of income and classified based on their nature, function, or a combination of both;
•Enhanced disclosure requirements related to management-defined performance measures, including explanations of how such measures are calculated and how they reconcile to amounts presented in the financial statements; and
•Additional guidance on the aggregation and disaggregation of information in the financial statements and the notes to improve the organization and presentation of financial information.
The standard is required to be applied retrospectively in both annual and interim financial statements starting in the fiscal year ending March 31, 2028.
The Company is in the process of reviewing the new standard to determine the impact on its consolidated financial statements.
3. CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS
The preparation of the Company's interim condensed consolidated financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities at the end of the reporting period. However, uncertainty about these estimates, judgments and assumptions could result in outcomes that require a material adjustment to the carrying amount of the asset or liability affected in future periods.
8
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
The key assumptions concerning the future, and other key sources of estimation uncertainty at the reporting date, which have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next fiscal year are consistent with those disclosed in the Company's fiscal 2026 audited consolidated financial statements.
The Company based its estimates, judgments and assumptions on parameters available when the interim condensed consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market changes or circumstances arising beyond the control of the Company. Such changes are reflected in the estimates when they occur.
Tariffs: Management is monitoring the global tariff environment, including reciprocal measures from impacted jurisdictions. The tariff uncertainty under Section 338 has had a more material impact than previously anticipated, primarily affecting packaging equipment and customer decision making based on expected tariff impacts. In the first quarter of fiscal 2027, a refund process was initiated for tariffs imposed under the International Emergency Economic Powers Act ("IEEPA"). IEEPA tariff refunds received during the period have been recognized within cost of revenues, consistent with the presentation of the original tariff-related costs in the interim condensed consolidated financial statements. The impact of refunds recorded in the period do not have a material impact on the Company's interim condensed consolidated financial statements. Management will continue to monitor and assess the impact of the tariffs on its judgments, estimates, and amounts recognized in its interim condensed consolidated financial statements.
4. INVENTORIES
| As at | September 27 2026 | March 31 2026 | |||||||||
| Raw materials | $ | 141,055 | $ | 140,322 | |||||||
| Work in progress | 101,199 | 91,466 | |||||||||
| Finished goods | 59,364 | 63,418 | |||||||||
| $ | 301,618 | $ | 295,206 | ||||||||
The amount charged to net income (loss) and included in cost of revenues for the write-down of inventories for net realizable value adjustments during the three and six months ended September 27, 2026 was $2,184 and $3,682, respectively (three and six months ended September 28, 2025 - $1,963 and $4,262, respectively). The amount of inventories carried at net realizable value as at September 27, 2026 was $25,487 (March 31, 2026 - $20,992).
5. DEPOSITS, PREPAIDS AND OTHER ASSETS
| As at | September 27 2026 | March 31 2026 | |||||||||
| Prepaid assets | $ | 47,169 | $ | 40,571 | |||||||
Restricted cash (i) | 519 | 623 | |||||||||
Supplier deposits (ii) | 19,947 | 24,507 | |||||||||
| Investment tax credits receivable | 22,873 | 23,448 | |||||||||
| Forward foreign exchange contracts | 4,904 | 5,724 | |||||||||
| $ | 95,412 | $ | 94,873 | ||||||||
(i) Restricted cash primarily consists of a pledged account for post-employment benefit payments.
9
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
(ii) As at September 27, 2026, the long-term portion of deposits was $3,896 (March 31, 2026 - $3,710), which is recorded in long-term deposits in the interim condensed consolidated statements of financial position.
6. RIGHT-OF-USE ASSETS AND LEASE LIABILITIES
Changes in the net balance of right-of-use assets during the six months ended September 27, 2026 were as follows:
| Note | Buildings | Vehicles and equipment | Total | ||||||||||||||||||||
Balance, at March 31, 2026 | $ | 121,809 | $ | 25,245 | $ | 147,054 | |||||||||||||||||
| Additions | 11,139 | 4,187 | 15,326 | ||||||||||||||||||||
| Amortization | (13,217) | (6,087) | (19,304) | ||||||||||||||||||||
| Exchange and other adjustments | (5,920) | 120 | (5,800) | ||||||||||||||||||||
Balance, at September 27, 2026 | $ | 113,811 | $ | 23,465 | $ | 137,276 | |||||||||||||||||
Changes in the balance of lease liabilities during the six months ended September 27, 2026 were as follows:
| Note | |||||||||||
Balance, at March 31, 2026 | $ | 154,688 | |||||||||
| Additions | 15,326 | ||||||||||
| Interest | 3,863 | ||||||||||
| Payments | (21,363) | ||||||||||
| Exchange and other adjustments | (5,967) | ||||||||||
Balance, at September 27, 2026 | $ | 146,547 | |||||||||
| Less: current portion | 36,652 | ||||||||||
| $ | 109,895 | ||||||||||
The right-of-use assets and lease liabilities relate to leases of real estate properties, automobiles and other equipment. For the three and six months ended September 27, 2026, the Company recognized expense related to short-term and low-value leases of $826 and $1,907, respectively, in cost of revenues (September 28, 2025 - $1,013 and $2,129, respectively), and $654 and $1,224, respectively, in selling, general and administrative expenses (September 28, 2025 - $722 and $1,544, respectively) in the interim condensed consolidated statements of income (loss).
7. OTHER ASSETS AND LIABILITIES
Other assets consist of the following:
| As at | September 27 2026 | March 31 2026 | |||||||||
Cross-currency interest rate swap instruments (i) | $ | 175 | $ | — | |||||||
Variable for fixed interest rate swap instruments (ii), (iii) | 986 | — | |||||||||
Long-term investment tax credits (v) | 8,560 | 4,096 | |||||||||
Long-term forward foreign exchange contracts (iv) | — | 335 | |||||||||
Other | 16 | 33 | |||||||||
| $ | 9,737 | $ | 4,464 | ||||||||
10
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
Other long-term liabilities consist of the following:
| As at | September 27 2026 | March 31 2026 | |||||||||
Cross-currency interest rate swap instruments (i) | $ | 18,798 | $ | 20,406 | |||||||
Variable for fixed interest rate swap instruments (ii), (iii) | — | 200 | |||||||||
Long-term forward foreign exchange contracts (iv) | 29 | 108 | |||||||||
| Other | 733 | 731 | |||||||||
| $ | 19,560 | $ | 21,445 | ||||||||
(i) On December 5, 2024, the Company entered into a cross-currency interest rate swap instrument to swap U.S. $175,000 into Canadian dollars to hedge a portion of its foreign exchange risk related to its U.S. dollar-denominated Senior Notes ("U.S. Senior Notes"). The Company will receive interest of 4.125% U.S. per annum and pay interest of 3.128% Canadian. The terms of the hedging instrument will end on December 15, 2027.
The Company also entered into a cross-currency interest rate swap instrument on December 5, 2024 to swap 165,328 Euros into Canadian dollars to hedge the net investment in European operations. The Company will receive interest of 3.128% Canadian per annum and pay interest of 2.645% Euros. The terms of the hedging relationship will end on December 15, 2027.
(ii) On November 21, 2023, the Company entered into a variable for fixed interest rate swap instrument to swap the variable interest rate on the $300,000 outstanding on the secured credit facility at that date to a fixed 4.044% interest rate. The terms of the hedging relationship will end on November 4, 2026. The current portion of the variable for fixed interest rate swap instrument is recorded in deposits, prepaids and other assets for asset balances, and in accounts payable and accrued liabilities for liability balances, on the interim condensed consolidated statements of financial position.
On March 16, 2026, the Company discontinued hedge accounting on the $150,000 revolver portion of the credit facility due to a repayment of the hedged item. The $1,367 accumulated in other comprehensive income related to this portion of the hedge was transferred to the consolidated statements of income (loss) for the year ended March 31, 2026. The $150,000 term loan remains in the pre-existing hedging relationship.
(iii) On March 16, 2026, the Company entered into a forward-starting variable for fixed interest rate swap instrument to swap the variable interest rate on the $150,000 outstanding on the term loan to a fixed 3.264%. The terms of the hedging relationship will be effective November 4, 2026 and will end on November 4, 2028.
(iv) The current portion of the forward foreign exchange contracts is recorded in deposits, prepaids and other assets for asset balances, and in accounts payable and accrued liabilities for liability balances, on the interim condensed consolidated statements of financial position.
(v) The current portion of the investment tax credits is recorded in deposits, prepaids and other assets on the interim condensed consolidated statements of financial position.
11
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
8. ASSETS HELD FOR SALE
The Company has classified the land, building and leaseholds associated with certain facilities in the U.S. and a facility in Germany as held for sale as part of the reorganization of the Company's transportation-related business. The carrying value of assets classified as held for sale was $61,263 as at September 27, 2026 (March 31, 2026 – $60,302). Changes in the carrying value since March 31, 2026 were attributable to foreign exchange translation into the Company's presentation currency and not to changes in the underlying carrying value of the properties. The assessed fair value, less costs to sell, of the assets exceeds the current carrying value, and therefore no adjustments were recorded to the carrying value.
Subsequent to September 27, 2026, certain of the land, building and leaseholds associated with the U.S. facilities classified as held for sale were sold for consideration of $71,165, resulting in an estimated gain on disposal of approximately $12,175. The gain will be recognized in the third quarter of fiscal 2027. The Company entered into an agreement to lease back one of the buildings, which will be accounted for as a sale and leaseback transaction.
9. IMPAIRMENT OF INTANGIBLE ASSETS
The Company performed its annual intangible impairment tests in the fourth quarter of fiscal 2026. The impairment tests are based on value-in-use calculations. The key assumptions used to determine the recoverable amount for the different cash-generating units ("CGUs") were disclosed in the annual consolidated financial statements for the year ended March 31, 2026. On a quarterly basis, the Company reviews for indicators of impairment of its CGUs.
Software-focused business CGUs
In the first quarter of fiscal 2027, the Company performed an impairment assessment of certain intangible assets associated with its software-focused business CGUs due to a strategic repositioning in its product offerings in those businesses, resulting in an indicator of impairment. The recoverable amount of the CGU was determined using a value-in-use methodology, which incorporates management's estimates of future cash flows, and an appropriate discount rate reflecting the risks specific to the CGU. The projected cash flows were updated to reflect the expected impact of the strategic repositioning and changes in the anticipated demand profile of the affected products and services.
As a result of this analysis, the Company recognized an impairment charge of $7,088 against certain intangible assets. The impairment expense has been recorded within cost of revenues in the interim condensed consolidated statements of income (loss).
Sensitivity to changes in assumptions
For the impairment tests performed for the period ended June 28, 2026, the estimated recoverable amount is equal to its carrying value. Consequently, any adverse change in key assumptions could result in a further impairment loss. The key assumptions for the recoverable amount are disclosed below:
Growth rate - The rates used in the determination of the recoverable amount are based on market growth rates for the specific industry, updated for expected impact of the repositioning. Minor changes in the growth rate do not materially impact the impairment calculation.
12
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
Discount rate - The discount rate used was 12.5%, which was estimated based on the weighted average cost of capital for the CGUs. Minor changes in the discount rate do not materially impact the impairment calculation.
10. FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
During the three and six months ended September 27, 2026 and the three and six months ended September 28, 2025, there were no changes in the classification of financial assets as a result of a change in the purpose or use of those assets. The Company uses derivative instruments, including cross-currency interest rate swaps, interest rate swaps, and forward foreign exchange contracts, to manage exposure to foreign exchange rate and interest rate fluctuations. These derivative instruments are categorized as Level 2 in the fair value hierarchy with fair value determined using a discounted cash flow technique, incorporating inputs that are observable in the market or can be derived from observable market data. The Company does not have any Level 1 or Level 3 instruments.
During the three and six months ended September 27, 2026 and the three and six months ended September 28, 2025, there were no transfers of financial instruments between Level 1 and Level 2 fair value measurements, and no transfers into or out of Level 3 fair value measurements.
Instruments not subject to hedge accounting
As part of the Company's risk management strategy, forward contract derivative financial instruments are used to manage foreign currency exposure related to the translation of foreign currency net assets to the subsidiary's functional currency. As these instruments have not been designated as hedges, the change in fair value is recorded in selling, general and administrative expenses in the interim condensed consolidated statements of income (loss).
For the three and six months ended September 27, 2026, the Company recorded risk management losses of $7,044 and $6,804, respectively (three and six months ended September 28, 2025 - losses of $6,858 and $5,978, respectively), on foreign currency risk management forward contracts in the interim condensed consolidated statements of income (loss). Included in these amounts, during the three and six months ended September 27, 2026, were unrealized losses of $3,051 and $1,916, respectively (three and six months ended September 28, 2025 - unrealized losses of $1,908 and $7,792, respectively), representing the change in fair value. In addition, during the three and six months ended September 27, 2026, the Company realized foreign exchange losses of $3,993 and $4,888, respectively (three and six months ended September 28, 2025 - realized losses of $4,950 and gains of $1,814, respectively), related to forward derivative contracts which were settled.
11. PROVISIONS
| Warranty | Restructuring | Other | Total | ||||||||||||||||||||
Balance, at March 31, 2026 | $ | 10,075 | $ | 19,750 | $ | 2,743 | $ | 32,568 | |||||||||||||||
| Provisions made | 1,397 | 26,951 | 8,720 | 37,068 | |||||||||||||||||||
| Provisions used | (2,766) | (15,343) | (8,233) | (26,342) | |||||||||||||||||||
| Exchange adjustments | 100 | 115 | 16 | 231 | |||||||||||||||||||
Balance, at September 27, 2026 | $ | 8,806 | $ | 31,473 | $ | 3,246 | $ | 43,525 | |||||||||||||||
Warranty provisions
Warranty provisions are related to sales of products and are based on experience reflecting statistical trends of warranty costs.
13
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
Restructuring
Restructuring charges are recognized in the period incurred and when the criteria for provisions are fulfilled. Termination benefits are recognized as a liability and an expense when the Company is demonstrably committed through a formal restructuring plan.
The Company periodically undertakes reviews of its operations to ensure alignment with strategic market opportunities including the realignment of the cost structure and capital needs of its businesses. In addition, in the first quarter of fiscal 2027, the Company announced its Fixed Cost Transformation Program (the "Program"), a multi-phase initiative to simplify the Company's operating structure, optimize its global footprint, and reduce fixed costs. During the three and six months ended September 27, 2026, restructuring expenses of $21,293 and $26,951, respectively, were recorded in connection with the Program and with other restructuring activities (September 28, 2025 - $nil and $2,493, respectively).
Included in the restructuring provisions are $4,775 of costs classified as long-term due to country-specific requirements for termination benefits (March 31, 2026 - $468).
Other provisions
Other provisions are related to medical insurance expenses that have been incurred during the period but are not yet paid, and other miscellaneous provisions.
12. BANK INDEBTEDNESS AND LONG-TERM DEBT
On December 4, 2025, the Company amended its Credit Facility, extending the maturity date to December 4, 2029. The Credit Facility consists of (i) a $900,000 secured committed revolving line of credit; and (ii) a fully drawn $150,000 secured term credit facility. The Company incurred transaction costs of $2,640, which were deferred and are being amortized over the term of the Credit Facility. The Credit Facility is secured by the Company's assets, including a pledge of shares of certain of the Company's subsidiaries. Certain of the Company's subsidiaries also provide guarantees under the Credit Facility. At September 27, 2026, the Company had utilized $190,000 under the Credit Facility, of which $190,000 was classified as long-term debt (March 31, 2026 - $200,000) and $nil by way of letters of credit (March 31, 2026 - $nil).
The Credit Facility is available in Canadian dollars by way of prime rate advances, Term CORRA advances and/or Daily Compounded CORRA advances, in U.S. dollars by way of base rate advances and/or Term SOFR advances, in Euros by way of EURIBOR advances, in British pounds sterling by way of Daily Simple SONIA advances, and by way of letters of credit for certain purposes. The interest rates applicable to the Credit Facility are determined based on a net debt-to-EBITDA ratio as defined in the Credit Facility. For prime rate advances and base rate advances, the interest rate is equal to the agent's prime rate or the agent's U.S. dollar base rate in Canada, respectively, plus a margin ranging from 0.45% to 2.00%. For Term CORRA advances, Daily Compounded CORRA advances, Term SOFR advances, EURIBOR advances and Daily Simple SONIA advances, the interest rate is equal to the Term CORRA rate, the Daily Compounded CORRA rate, the Term SOFR rate, the EURIBOR rate or the Daily Simple SONIA rate, respectively, plus a margin that varies from 1.45% to 3.00%. The Company pays a fee for usage of financial letters of credit that ranges from 1.45% to 3.00%, and a fee for usage of non-financial letters of credit that ranges from 0.97% to 2.00%. The Company pays a standby fee on the unadvanced portions of the amounts available for advance or drawdown under the Credit Facility at rates ranging from 0.29% to 0.60%. The Company's Credit Facility is subject to changes in market interest rates. Changes in economic conditions outside of the Company's control could result in higher interest rates, thereby increasing its interest expense. The Company uses a variable for fixed interest rate swap to hedge a portion of its Credit Facility (see note 7). The Credit Facility is subject to financial covenants
14
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
including a net debt-to-EBITDA test and an interest coverage test. Under the terms of the Credit Facility, the Company is restricted from encumbering any assets with certain permitted exceptions. At September 27, 2026, all of the covenants were met.
The Company has additional credit facilities available of $111,592 (40,001 EUR, $24,000 U.S., 110,000 THB, 2,500 GBP, 5,000 CNY, $1,000 AUD and $1,776 CAD). The total amount outstanding on these facilities as at September 27, 2026 was $4,184, of which $2,407 was classified as bank indebtedness (March 31, 2026 - $6,744), $1,777 was classified as long-term debt (March 31, 2026 - $1,920) and $nil by way of letters of credit (March 31, 2026 - $nil). The interest rates applicable to the credit facilities range from 3.05% to 7.00% per annum, in local currency. A portion of the long-term debt is secured by certain assets of the Company.
The Company's U.S. $350,000 aggregate principal amount of U.S. Senior Notes were issued at par, bear interest at a rate of 4.125% per annum and mature on December 15, 2028. After December 15, 2023, the Company may redeem the U.S. Senior Notes, in whole at any time or in part from time to time, at specified redemption prices and subject to certain conditions required by the U.S. Senior Notes. If the Company experiences a change of control, the Company may be required to repurchase the U.S. Senior Notes, in whole or in part, at a purchase price equal to 101% of the aggregate principal amount of the U.S. Senior Notes, plus accrued and unpaid interest, if any, to, but not including, the redemption date. The U.S. Senior Notes contain customary covenants that restrict, subject to certain exceptions and thresholds, some of the activities of the Company and its subsidiaries, including the Company's ability to dispose of assets, incur additional debt, pay dividends, create liens, make investments, and engage in specified transactions with affiliates. At September 27, 2026, all of the covenants were met. Subject to certain exceptions, the U.S. Senior Notes are guaranteed by each of the subsidiaries of the Company that is a borrower or has guaranteed obligations under the Credit Facility. Transaction fees of $8,100 were deferred and are being amortized over the term of the U.S. Senior Notes. The Company uses a cross-currency interest rate swap instrument to hedge a portion of its U.S. Senior Notes (see note 7).
On August 21, 2024, the Company completed a private placement of $400,000 aggregate principal amount of CAD senior unsecured notes ("CAD Senior Notes"). The CAD Senior Notes were issued at par, bear interest at a rate of 6.50% per annum and mature on August 21, 2032. On December 19, 2024, the Company completed a private placement of an additional $200,000 of CAD Senior Notes, bringing the total amount of CAD Senior Notes issued to $600,000. The additional CAD Senior Notes were issued at a premium of $1,250, which is classified as long-term debt. The Company may redeem the CAD Senior Notes, at any time after August 21, 2027, in whole or in part, at specified redemption prices and subject to certain conditions required by the CAD Senior Notes. If the Company experiences a change of control, the Company may be required to repurchase the CAD Senior Notes, in whole or in part, at a purchase price equal to 101% of the aggregate principal amount of the CAD Senior Notes, plus accrued and unpaid interest, if any, to, but not including, the redemption date. The CAD Senior Notes contain customary covenants that restrict, subject to certain exceptions and thresholds, some of the activities of the Company and its subsidiaries, including the Company's ability to dispose of assets, incur additional debt, pay dividends, create liens, make investments, and engage in specified transactions with affiliates. Transaction fees of $9,604 were deferred and are being amortized over the term of the CAD Senior Notes. At September 27, 2026, all of the covenants were met. Subject to certain exceptions, the CAD Senior Notes are guaranteed by each of the subsidiaries of the Company that is a borrower or has guaranteed obligations under the Credit Facility.
15
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
(i) Bank indebtedness
| As at | September 27 2026 | March 31 2026 | |||||||||
| Other facilities | $ | 2,407 | $ | 6,744 | |||||||
(ii) Long-term debt
| As at | September 27 2026 | March 31 2026 | |||||||||
| Credit Facility | $ | 190,000 | $ | 200,000 | |||||||
| Senior Notes | 1,096,012 | 1,087,954 | |||||||||
| Other facilities | 1,777 | 1,920 | |||||||||
| Issuance costs | (13,644) | (15,149) | |||||||||
| 1,274,145 | 1,274,725 | ||||||||||
| Less: current portion | 177 | 173 | |||||||||
| $ | 1,273,968 | $ | 1,274,552 | ||||||||
Scheduled principal repayments and interest payments on long-term debt as at September 27, 2026 are as follows (variable interest repayments on the Credit Facility are not reflected in the table below as they fluctuate based on the amounts drawn):
Principal | Interest | ||||||||||
| Less than one year | $ | 177 | $ | 59,380 | |||||||
| One - two years | 475 | 59,362 | |||||||||
| Two - three years | 495,398 | 49,132 | |||||||||
| Three - four years | 190,376 | 38,900 | |||||||||
| Four - five years | 399 | 38,877 | |||||||||
| Thereafter | 600,964 | 37,826 | |||||||||
| $ | 1,287,789 | $ | 283,477 | ||||||||
13. SHARE CAPITAL
Authorized share capital of the Company consists of an unlimited number of common shares, without par value, for unlimited consideration.
On December 18, 2025, the Company announced that the Toronto Stock Exchange ("TSX") had accepted a notice filed by the Company of its intention to make a normal course issuer bid ("NCIB"). Under the NCIB, ATS may purchase for cancellation up to a maximum of 8,225,621 common shares during the 12-month period ending December 21, 2026.
During the six months ended September 27, 2026, the Company purchased 2,244,461 common shares under the current NCIB program for $61,297. At September 27, 2026, a total of 5,981,160 common shares remained available for repurchase under the current NCIB. All purchases are made in accordance with the bid at prevalent market prices plus brokerage fees, or such other prices that may be permitted by the TSX, with consideration allocated to share capital up to the average carrying amount of the shares, and any excess allocated to retained earnings. Included in share capital is $1,226 (March 31, 2026 - $200) of transaction costs related to taxes on the share repurchase (note 14).
16
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
The changes in the common shares issued and outstanding during the period presented were as follows:
| Note | Number of common shares | Share capital | ||||||||||||
Balance, at March 31, 2026 | 96,997,452 | $ | 852,805 | |||||||||||
| Exercise of stock options | 22,921 | 839 | ||||||||||||
| Common shares purchased and held in trust | 15 | (66,339) | (2,589) | |||||||||||
| Settlement of RSUs | 15 | 98,693 | 5,282 | |||||||||||
| Repurchase of common shares | (2,244,461) | (20,748) | ||||||||||||
Balance, at September 27, 2026 | 94,808,266 | $ | 835,589 | |||||||||||
14. TAXATION
(i) Reconciliation of income taxes: Income tax expense differs from the amounts that would be obtained by applying the combined Canadian basic federal and provincial income tax rate to income before income taxes. These differences result from the following items:
| Three months ended | Six months ended | ||||||||||||||||||||||||||||||||||
| Note | September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | |||||||||||||||||||||||||||||||
Income before income taxes and non-controlling interest | $ | 994 | $ | 50,830 | $ | 4,489 | $ | 82,972 | |||||||||||||||||||||||||||
| Combined Canadian basic federal and provincial income tax rate | 26.50% | 26.50% | 26.50% | 26.50% | |||||||||||||||||||||||||||||||
Income tax expense based on combined Canadian basic federal and provincial income tax rate | $ | 264 | $ | 13,470 | $ | 1,190 | $ | 21,988 | |||||||||||||||||||||||||||
Increase (decrease) in income taxes resulting from: | |||||||||||||||||||||||||||||||||||
| Adjustments in respect of current income tax of previous periods | 841 | 1,018 | 833 | 564 | |||||||||||||||||||||||||||||||
Non-taxable items net of non-deductible items | 392 | (2,020) | (974) | (4,234) | |||||||||||||||||||||||||||||||
| Change in unrecognized assets | 4,091 | 538 | 7,226 | 1,988 | |||||||||||||||||||||||||||||||
| Income taxed at different rates and statutory rate changes | 571 | 4,239 | 2,043 | 5,315 | |||||||||||||||||||||||||||||||
| Manufacturing and processing allowance and all other items | (155) | (53) | (564) | (553) | |||||||||||||||||||||||||||||||
At the effective income tax rate of 217% (September 28, 2025 – 30%) | $ | 6,004 | $ | 17,192 | $ | 9,754 | $ | 25,068 | |||||||||||||||||||||||||||
Income tax expense (recovery) reported in the interim condensed consolidated statements of income (loss): | |||||||||||||||||||||||||||||||||||
Current tax expense | $ | 9,859 | $ | 20,448 | $ | 24,475 | $ | 50,338 | |||||||||||||||||||||||||||
Deferred tax recovery | (3,855) | (3,256) | (14,721) | (25,270) | |||||||||||||||||||||||||||||||
| $ | 6,004 | $ | 17,192 | $ | 9,754 | $ | 25,068 | ||||||||||||||||||||||||||||
| Deferred tax related to items charged or credited directly to equity and goodwill: | |||||||||||||||||||||||||||||||||||
Gain (loss) on revaluation of cash flow hedges | $ | (932) | $ | 1,436 | $ | 664 | $ | (3,354) | |||||||||||||||||||||||||||
| Other items recognized through equity | (181) | 1,162 | 1,498 | 290 | |||||||||||||||||||||||||||||||
| Income tax charged directly to equity and goodwill | $ | (1,113) | $ | 2,598 | $ | 2,162 | $ | (3,064) | |||||||||||||||||||||||||||
On May 2, 2024, the Canadian federal government tabled Bill C-69 for the first reading in Parliament. Bill C-69 includes revised provisions to implement the Global Minimum Tax Act ("GMTA") and other
17
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
measures from the federal budget tabled on April 16, 2024. The GMTA introduces a 15% global minimum tax in Canada, aligning with the OECD Pillar Two regime. On June 20, 2024, Bill C-69 received Royal Assent, enacting the GMTA. Consequently, the impact of the GMTA is reflected in the interim condensed consolidated financial statements. During the three and six months ended September 27, 2026, the Company recognized income tax expense related to Pillar Two income taxes of $136 and $303, respectively ($599 and $1,172 in the three and six months ended September 28, 2025, respectively), in the interim condensed consolidated statement of income (loss).
On June 20, 2024, Bill C-59 received Royal Assent, enacting a 2% tax on certain share buybacks. The impact of this tax is reflected in the interim condensed consolidated financial statements (note 13).
15. STOCK-BASED COMPENSATION
In the calculation of the stock-based compensation expense in the interim condensed consolidated statements of income (loss), the fair value of the Company's stock option grants were estimated using the Black-Scholes option pricing model for time-vesting stock options. During the three and six months ended September 27, 2026, the Company granted nil and 168,088 time-vesting stock options, respectively (3,441 and 354,106 in the three and six months ended September 28, 2025, respectively). The stock options granted vest over four years and expire on the seventh anniversary from the date of issue.
September 27 2026 | September 28 2025 | |||||||||||||||||||
| Number of stock options | Weighted average exercise price | Number of stock options | Weighted average exercise price | |||||||||||||||||
| Stock options outstanding, beginning of period | 1,067,391 | $ | 40.49 | 994,599 | $ | 35.87 | ||||||||||||||
| Granted | 168,088 | 41.30 | 354,106 | 40.32 | ||||||||||||||||
Exercised (i) | (22,921) | 27.75 | (421,427) | 26.18 | ||||||||||||||||
| Forfeited | (50,337) | 42.61 | (387,939) | 43.86 | ||||||||||||||||
| Stock options outstanding, end of period | 1,162,221 | $ | 40.77 | 539,339 | $ | 40.62 | ||||||||||||||
| Stock options exercisable, end of period, time-vested options | 169,622 | $ | 38.09 | 206,048 | $ | 34.17 | ||||||||||||||
(i) For the six months ended September 27, 2026, the weighted average share price at the date of exercise was $39.11 (September 28, 2025 - $37.76).
The fair values of the Company's stock options issued during the periods presented were estimated at the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions. Expected stock price volatility was determined at the time of the grant by considering historical share price volatility. Expected stock option grant life was determined at the time of the grant by considering the average of the grant vesting period and the grant exercise period.
18
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
For the six months ended | September 27 2026 | September 28 2025 | |||||||||
Weighted average risk-free interest rate | 3.09 | % | 2.90 | % | |||||||
Dividend yield | 0 | % | 0 | % | |||||||
Weighted average expected volatility | 38 | % | 37 | % | |||||||
Weighted average expected life | 4.75 years | 4.75 years | |||||||||
Number of stock options granted: Time-vested | 168,088 | 354,106 | |||||||||
Weighted average exercise price per option | $ 41.30 | $ 40.32 | |||||||||
Weighted average value per option: Time-vested | $ 15.24 | $ 14.52 | |||||||||
Restricted Share Unit Plan:
During the three and six months ended September 27, 2026, the Company granted 20,294 and 195,613 time-vesting restricted share units ("RSUs") (298,274 in the three and six months ended September 28, 2025), and nil and 124,049 performance-based RSUs (255,205 in the three and six months ended September 28, 2025). The Company measures these RSUs based on the fair value at the date of grant, and compensation expense is recognized over the vesting period in the interim condensed consolidated statements of income (loss) with a corresponding increase in contributed surplus. The performance-based RSUs vest upon successful achievement of certain operational and share price targets.
On May 18, 2022, the RSU plan was amended so that RSUs granted may be settled in ATS Common Shares, where deemed advisable by the Company, as an alternative to cash payments. It is the Company's intention to settle these RSUs with ATS Common Shares, and therefore the Company measures these RSUs as equity awards based on fair value. During the three and six months ended September 27, 2026, 66,339 common shares were purchased for $2,589, and placed in trust (238,621 shares for $9,616 in the three and six months ended September 28, 2025).
During the three and six months ended September 27, 2026, the Company settled 92,464 time-vesting RSUs and 6,229 performance-based RSUs (131,057 time-vesting RSUs and 55,839 performance-based RSUs in the three and six months ended September 28, 2025) in ATS Common Shares from the common shares held in trust (note 13). At September 27, 2026, 1,076,826 shares are held in a trust and may be used to settle some or all of the RSU grants when they are fully vested (March 31, 2026 - 1,109,180 shares held in trust). The trust is consolidated in the Company's interim condensed consolidated financial statements with the value of the acquired common shares presented as a reduction of share capital.
Deferred Stock Unit Plan:
During the three and six months ended September 27, 2026, the Company granted nil and 58,354 Deferred Stock Units ("DSUs"), respectively (three and six months ended September 28, 2025 - 9,018 and 58,019, respectively). During the three and six months ended September 27, 2026, nil and 222,898 units were redeemed for $nil and $9,647 (September 28, 2025 - no units). As at September 27, 2026, the value of the outstanding liability related to the DSUs was $7,971 (March 31, 2026 - $19,168). The DSU liability is revalued at each reporting date based on the change in the Company's stock price. The DSU liability is included in accounts payable and accrued liabilities on the interim condensed consolidated statements of financial position. The change in value of the DSU liability is included in the interim condensed consolidated statements of income (loss) in the period of change.
The following table shows the compensation expense (recovery) related to the Company's share-based payment plans:
19
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
For the three months ended | September 27 2026 | September 28 2025 | |||||||||
| Stock options | $ | 1,059 | $ | (707) | |||||||
| RSUs | 2,539 | (2,797) | |||||||||
| DSUs | (3,209) | (3,236) | |||||||||
| $ | 389 | $ | (6,740) | ||||||||
For the six months ended | September 27 2026 | September 28 2025 | |||||||||
| Stock options | $ | 2,134 | $ | (16) | |||||||
| RSUs | 5,856 | 839 | |||||||||
| DSUs | (1,544) | 876 | |||||||||
| $ | 6,446 | $ | 1,699 | ||||||||
16. COMMITMENTS AND CONTINGENCIES
| Minimum purchase obligations as at | September 27 2026 | ||||
| Less than one year | $ | 264,857 | |||
| One - two years | 16,083 | ||||
| Two - three years | 2,390 | ||||
| Three - four years | 245 | ||||
| Four - five years | 60 | ||||
| More than five years | 48 | ||||
| $ | 283,683 | ||||
The Company's off-balance sheet arrangements consist of purchase obligations, primarily commitments for material purchases, which have been entered into in the normal course of business.
In accordance with industry practice, the Company is liable to customers for obligations relating to contract completion and timely delivery. In the normal conduct of its operations, the Company may provide letters of credit as security for advances received from customers pending delivery and contract performance. In addition, the Company provides letters of credit for post-retirement obligations and may provide letters of credit as security on equipment under lease and on order. As at September 27, 2026, the total value of outstanding letters of credit was approximately $274,447 (March 31, 2026 - $283,871).
In the normal course of operations, the Company is party to a number of lawsuits, claims and contingencies. Although it is possible that liabilities may be incurred in instances for which no accruals have been made, the Company does not believe that the ultimate outcome of these matters will have a material impact on its interim condensed consolidated statements of financial position.
17. SEGMENTED DISCLOSURE
The Company's operations are reported as one operating segment, Automation Systems, which plans, allocates resources, builds capabilities and implements best practices on a global basis.
Geographic segmentation of revenues is determined based on revenues by customer location. Non-current assets represent property, plant and equipment, right-of-use assets and intangible assets that are attributable to individual geographic segments, based on location of the respective operations.
20
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
| As at | September 27, 2026 | ||||||||||||||||
| Right-of-use assets | Property, plant and equipment | Intangible assets | |||||||||||||||
| Canada | $ | 42,474 | $ | 67,307 | $ | 79,119 | |||||||||||
| United States | 17,867 | 76,905 | 397,103 | ||||||||||||||
| Germany | 22,697 | 51,116 | 44,318 | ||||||||||||||
| Italy | 34,940 | 51,987 | 130,346 | ||||||||||||||
| Other Europe | 16,937 | 8,720 | 25,712 | ||||||||||||||
| Other | 2,361 | 3,182 | 3,702 | ||||||||||||||
| Total Company | $ | 137,276 | $ | 259,217 | $ | 680,300 | |||||||||||
| As at | March 31, 2026 | ||||||||||||||||
| Right-of-use assets | Property, plant and equipment | Intangible assets | |||||||||||||||
| Canada | $ | 41,073 | $ | 66,059 | $ | 81,747 | |||||||||||
| United States | 23,027 | 79,427 | 403,402 | ||||||||||||||
| Germany | 25,264 | 52,814 | 46,079 | ||||||||||||||
| Italy | 35,927 | 49,204 | 132,706 | ||||||||||||||
| Other Europe | 18,539 | 9,403 | 35,095 | ||||||||||||||
| Other | 3,224 | 2,884 | 5,181 | ||||||||||||||
| Total Company | $ | 147,054 | $ | 259,791 | $ | 704,210 | |||||||||||
| Revenues from external customers | Three months ended | Six months ended | ||||||||||||||||||||||||||||||
September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | |||||||||||||||||||||||||||||
| Canada | $ | 61,414 | $ | 41,222 | $ | 123,465 | $ | 71,869 | ||||||||||||||||||||||||
| United States | 265,935 | 313,900 | 570,009 | 631,747 | ||||||||||||||||||||||||||||
| Germany | 55,314 | 69,417 | 109,783 | 148,117 | ||||||||||||||||||||||||||||
| Italy | 22,775 | 23,109 | 51,878 | 50,823 | ||||||||||||||||||||||||||||
| Other Europe | 165,078 | 163,339 | 312,767 | 315,933 | ||||||||||||||||||||||||||||
| Other | 95,250 | 117,469 | 191,585 | 246,687 | ||||||||||||||||||||||||||||
Total Company | $ | 665,766 | $ | 728,456 | $ | 1,359,487 | $ | 1,465,176 | ||||||||||||||||||||||||
For the six months ended September 27, 2026, the Company had revenues from a single customer that amounted to 10.2% of total consolidated revenues (six months ended September 28, 2025 - no revenues from a single customer amounted to 10% or more).
18. REVENUE FROM CONTRACTS WITH CUSTOMERS
(a) Revenue by type:
Three months ended | Six months ended | |||||||||||||||||||||||||||||||
September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | |||||||||||||||||||||||||||||
| Revenues from construction contracts | $ | 324,342 | $ | 401,596 | $ | 683,549 | $ | 823,104 | ||||||||||||||||||||||||
| Services rendered | 179,135 | 168,733 | 361,961 | 332,838 | ||||||||||||||||||||||||||||
| Sale of goods | 162,289 | 158,127 | 313,977 | 309,234 | ||||||||||||||||||||||||||||
Total Company | $ | 665,766 | $ | 728,456 | $ | 1,359,487 | $ | 1,465,176 | ||||||||||||||||||||||||
21
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
(b) Disaggregation of revenue from contracts with customers:
Three months ended | Six months ended | |||||||||||||||||||||||||||||||
| Revenues by market | September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | ||||||||||||||||||||||||||||
| Life Sciences | $ | 355,839 | $ | 374,458 | $ | 701,773 | $ | 753,212 | ||||||||||||||||||||||||
| Industrial & Consumer | 136,381 | 178,219 | 311,946 | 362,294 | ||||||||||||||||||||||||||||
| Food & Beverage | 99,580 | 124,773 | 216,546 | 263,228 | ||||||||||||||||||||||||||||
| Energy | 73,966 | 51,006 | 129,222 | 86,442 | ||||||||||||||||||||||||||||
| Total Company | $ | 665,766 | $ | 728,456 | $ | 1,359,487 | $ | 1,465,176 | ||||||||||||||||||||||||
Three months ended | Six months ended | |||||||||||||||||||||||||||||||
| Timing of revenue recognition based on transfer of control | September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | ||||||||||||||||||||||||||||
| Goods and services transferred at a point in time | $ | 162,289 | $ | 158,127 | $ | 313,977 | $ | 309,234 | ||||||||||||||||||||||||
| Goods and services transferred over time | 503,477 | 570,329 | 1,045,510 | 1,155,942 | ||||||||||||||||||||||||||||
| Total Company | $ | 665,766 | $ | 728,456 | $ | 1,359,487 | $ | 1,465,176 | ||||||||||||||||||||||||
(c) Contract balances:
| As at | September 27 2026 | March 31 2026 | |||||||||
| Trade receivables | $ | 508,531 | $ | 504,577 | |||||||
| Contract assets | 406,746 | 436,847 | |||||||||
| Contract liabilities | (290,844) | (307,306) | |||||||||
Unearned revenue (i) | (82,459) | (93,713) | |||||||||
| Net contract balances | $ | 541,974 | $ | 540,405 | |||||||
(i) The unearned revenue liability is included in accounts payable and accrued liabilities on the interim condensed consolidated statements of financial position.
Included in the March 31, 2026 net contract asset balance is an impairment charge relating to the reorganization of the Company's Transportation business, along with other costs from the reorganization, which resulted in an increase to cost of revenues of $28,600.
19. NET FINANCE COSTS
Three months ended | Six months ended | |||||||||||||||||||||||||||||||
For the six months ended | Note | September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | |||||||||||||||||||||||||||
| Interest expense | $ | 20,295 | $ | 22,885 | $ | 39,671 | $ | 47,112 | ||||||||||||||||||||||||
| Interest on lease liabilities | 6 | 2,023 | 1,676 | 3,863 | 3,226 | |||||||||||||||||||||||||||
| Interest income | (117) | (148) | (614) | (284) | ||||||||||||||||||||||||||||
| $ | 22,201 | $ | 24,413 | $ | 42,920 | $ | 50,054 | |||||||||||||||||||||||||
20. EARNINGS (LOSS) PER SHARE
Basic earnings (loss) per share
Earnings (loss) per common share is calculated by dividing earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding.
22
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
Diluted earnings (loss) per share
The treasury stock method is used to determine the dilutive impact of stock options and RSUs. This method assumes any proceeds from the exercise of stock options and vesting of RSUs would be used to purchase common shares at the average market price during the period.
Three months ended | Six months ended | ||||||||||||||||||||||||||||
September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | ||||||||||||||||||||||||||
| Weighted average number of common shares outstanding | 97,454,985 | 97,772,195 | 97,782,307 | 97,723,256 | |||||||||||||||||||||||||
| Dilutive effect of RSUs | — | 127,884 | — | 180,744 | |||||||||||||||||||||||||
| Dilutive effect of stock option conversion | — | 138,049 | — | 153,581 | |||||||||||||||||||||||||
Diluted weighted average number of common shares outstanding (i) | 97,454,985 | 98,038,128 | 97,782,307 | 98,057,581 | |||||||||||||||||||||||||
(i) As of September 27, 2026, the weighted average number of common shares outstanding equalled the diluted weighted average number of common shares outstanding as all stock-based compensation was antidilutive.
The Company presents basic and diluted earnings (loss) per share data. Basic earnings (loss) per share is calculated by dividing the net income (loss) attributable to shareholders of the Company by the weighted average number of common shares outstanding during the period, adjusted for common shares held in trust under the RSU plan. Diluted earnings (loss) per share is determined by further adjusting the weighted average number of common shares outstanding for the effects of all potential dilutive shares, which comprise stock options, RSUs and performance-based RSUs granted to executive officers and designated employees.
For the three and six months ended September 27, 2026, stock options to purchase 402,054 common shares, 369,019 RSUs, and nil performance-based RSUs are excluded from the weighted average number of common shares in the calculation of diluted earnings (loss) per share as they are antidilutive (371,756 common shares, 5,352 RSUs and nil performance-based RSUs were excluded for the three and six months ended September 28, 2025).
23
ATS CORPORATION
Notes to Interim Condensed Consolidated Financial Statements
(in thousands of Canadian dollars, except per share amounts - unaudited)
21. SUPPLEMENTAL CASH FLOW INFORMATION
The following table sets forth the supplemental cash flow information on net change in non-cash working capital:
Three months ended | Six months ended | |||||||||||||||||||||||||||||||
September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | |||||||||||||||||||||||||||||
| Accounts receivable | $ | (10,246) | $ | (61,514) | $ | 2,752 | $ | 135,366 | ||||||||||||||||||||||||
| Income tax receivable | (2,764) | 5,476 | (7,330) | 21,448 | ||||||||||||||||||||||||||||
| Contract assets | 40,391 | 9,242 | 30,101 | (47,527) | ||||||||||||||||||||||||||||
| Inventories | 3,241 | (10,109) | (6,412) | (396) | ||||||||||||||||||||||||||||
| Deposits, prepaids and other assets | 1,312 | 940 | (1,300) | (21,086) | ||||||||||||||||||||||||||||
Accounts payable and accrued liabilities | 193 | 44,321 | (16,281) | 11,454 | ||||||||||||||||||||||||||||
| Income tax payable | 11,348 | (1,067) | 5,716 | 6,525 | ||||||||||||||||||||||||||||
| Contract liabilities | (8,271) | (16,916) | (16,462) | (24,401) | ||||||||||||||||||||||||||||
| Provisions | 13,368 | (4,815) | 10,957 | (7,814) | ||||||||||||||||||||||||||||
| Foreign exchange and other | (1,899) | (6,556) | (689) | 767 | ||||||||||||||||||||||||||||
| Total change in non-cash working capital | $ | 46,673 | $ | (40,998) | $ | 1,052 | $ | 74,336 | ||||||||||||||||||||||||
24
| Appendix 99.3 | ||
FORM 52-109F2
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE
I, Doug Wright, Chief Executive Officer of ATS Corporation, certify the following:
1. Review: I have reviewed the interim financial report and interim MD&A (together, the "interim filings") of ATS Corporation ("the issuer"), for the interim period ended September 27, 2026.
2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the period covered by the interim filings.
3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.
4. Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.
5. Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings
a.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
i.material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and
ii.information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
b.designed ICFR, or caused it to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with the issuer’s GAAP.
5.1 Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO").
5.2 ICFR - material weakness relating to design: The issuer has disclosed in its interim MD&A for each material weakness relating to design existing at the end of the interim period
a.a description of the material weakness;
b.the impact of the material weakness on the issuer's financial reporting and its ICFR; and
c.the issuer's current plans, if any, or any actions already undertaken, for remediating the material weakness.
5.3 N/A
6. Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on June 29, 2026 and ended on September 27, 2026 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.
Date: November 4, 2026
/s/ “Doug Wright”
Doug Wright
Chief Executive Officer
Appendix 99.4 | ||
FORM 52-109F2
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE
CERTIFICATION OF INTERIM FILINGS
FULL CERTIFICATE
I, Anne Cybulski, Interim Chief Financial Officer of ATS Corporation, certify the following:
1. Review: I have reviewed the interim financial report and interim MD&A, (together, the "interim filings") of ATS Corporation ("the issuer"), for the interim period ended September 27, 2026.
2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the period covered by the interim filings.
3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings.
4. Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.
5. Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the end of the period covered by the interim filings
a.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
i.material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and
ii.information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and
b.designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.
5.1 Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).
5.2 ICFR - material weakness relating to design: The issuer has disclosed in its interim MD&A for each material weakness relating to design existing at the end of the interim period
a.a description of the material weakness;
b.the impact of the material weakness on the issuer's financial reporting and its ICFR; and
c.the issuer's current plans, if any, or any actions already undertaken, for remediating the material weakness.
5.3 N/A
6. Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on June 29, 2026 and ended on September 27, 2026 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.
Date: November 4, 2026
/s/ “Anne Cybulski”
Anne Cybulski
Interim Chief Financial Officer
| Appendix 99.5 | ||
ATS Reports Second Quarter Fiscal 2027 Results
11/04/2026
Cambridge, ON / BUSINESS WIRE / ATS Corporation (TSX and NYSE: ATS) ("ATS" or the "Company") today reported its financial results for the three and six months ended September 27, 2026. All references to "$" or "dollars" in this news release are to Canadian dollars unless otherwise indicated.
Today ATS reported second quarter results for fiscal 2027. Order Bookings were $827 million, up 12.7% year over year and 26.1% from the first quarter, led by life sciences. Life sciences Order Backlog ended the quarter at the highest level in the Company's history. The Company also continued to make improvements on aftermarket services and the ATS Business Model ("ABM"), with a clear view on the portfolio, strategy and execution across its businesses, while driving progress on its previously announced Fixed Cost Transformation Program.
Second quarter highlights:
•Revenues were $665.8 million compared to $728.5 million a year ago.
•Net loss was $5.0 million compared to net income of $33.6 million a year ago.
•Basic loss per share was 5 cents, compared to earnings per share of 34 cents a year ago.
•Adjusted EBITDA1 was $80.7 million compared to $103.7 million a year ago.
•Adjusted basic earnings per share1 were 27 cents compared to 45 cents a year ago.
•Order Bookings2 were $827 million, compared to $734 million a year ago.
•Order Backlog2 was $2,009 million, compared to $2,070 million a year ago.
"We continue to see healthy customer demand across all served markets, and our growing aftermarket business further strengthens the quality and resilience of our portfolio," said Doug Wright, Chief Executive Officer. "While a delay in non-life sciences Order Bookings, including from tariff uncertainty, has added near-term pressure as some customers delay capital decisions, I am encouraged by both the year-over-year and sequential increase in Order Bookings in the quarter and believe we have the pieces in place to return to strong growth at improved returns on capital."
Year-to-date highlights:
•Revenues were $1,359.5 million (adjusted revenues1 $1,364.1 million) compared to $1,465.2 million (adjusted revenues1 $1,465.2 million) a year ago.
•Net loss was $5.3 million compared to net income of $57.9 million a year ago.
•Basic loss per share was 5 cents, compared to earnings per share of 59 cents a year ago.
•Adjusted EBITDA1 was $173.4 million compared to $205.3 million a year ago.
•Adjusted basic earnings per share1 were $0.62 compared to $0.85 a year ago.
•Order Bookings2 were $1,482 million, compared to $1,427 million a year ago.
Mr. Wright added: "We remain confident in the long-term growth opportunities across our markets, supported by strong momentum in radiopharma and nuclear, as well as a healthy trailing twelve-month book-to-bill ratio. We are taking deliberate actions to strengthen execution, including enhancing our leadership team and advancing our Fixed Cost Transformation Program. With our return-driven
1 Non-IFRS measure: see "Non-IFRS and Other Financial Measures".
2 Supplementary financial measure: see "Non-IFRS and Other Financial Measures".
2 Supplementary financial measure: see "Non-IFRS and Other Financial Measures".
operating models and disciplined capital deployment, we believe we are well positioned to capitalize on the opportunities ahead as a leading global automation player."
Second quarter performance highlights
Second quarter revenues were $665.8 million and decreased by 8.6% year-over-year, due to a more normalized level of GLP-1-related activities compared to the prior year, and lower activity in other non-life sciences businesses, partially offset by growth in energy and revenues from services.
Adjusted earnings from operations for the quarter were $57.4 million (8.6% adjusted earnings from operations margin), compared to $79.1 million (10.9% adjusted earnings from operations margin) a year ago, primarily due to lower volumes and mix.
During the second quarter, the Company purchased 2,244,461 common shares for an aggregate purchase cost of approximately $61.3 million under its normal course issuer bid ("NCIB"), at an average price of $27.32 per share. The NCIB remains one component of the Company’s overall capital allocation strategy and is complementary to its acquisition growth plans.
Updated fiscal 2027 performance expectations
Management continues to see healthy activity in the Company's pipelines across its chosen end markets, supported by its differentiated technologies, deep domain expertise, and strong customer relationships. In the second quarter of fiscal 2027, Order Bookings were $827 million, including the highest life sciences quarterly total since the second quarter of fiscal 2025, and the Company's second-highest quarter of life sciences Order Bookings on record. Strength in radiopharmaceuticals and medical devices markets drove Order Bookings, resulting in ATS' book-to-bill ratio being approximately 1.05:1 on a trailing-twelve-month basis. Management also continues to see increasing revenue contribution from services and remains well positioned to participate in the long-term growth of the nuclear and radiopharmaceutical markets, although customer awards in these markets can vary in timing and size.
During the second quarter of fiscal 2027, the Company experienced temporary delays in Order Bookings within its non-life sciences businesses, primarily related to packaging automation equipment. These delays reflected a timing shift in customer orders, which was further exacerbated by tariffs imposed under Section 338 of the Tariff Act of 1930 ("Section 338 tariffs") that came into effect in late August 2026 following the breakdown of trade talks between Canada and the U.S. and affected packaging equipment manufactured in Canada and sold into the U.S. As a result of these delays and the execution time for the Company's Order Backlog to convert to revenues, Management does not expect to achieve its previous goals for modest revenue growth and for margin expansion of 50 to 75 basis points in fiscal 2027. Third quarter fiscal 2027 revenues are expected to be $640 million to $680 million. Management's revenue estimates are calculated each quarter based on the assessment of project schedules across all customer contracts in Order Backlog, expectations for faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity.
At the end of October the U.S. announced modifications to Section 338 tariffs, which eliminate the impact on a majority of the covered products. This modification is expected to be beneficial to ATS and its affected customers as they digest the various changes over time and advance their capital
expenditure plans. The near-term impact has been driven primarily by customer deferral of capital decisions, including as a result of tariff uncertainty, rather than by the Company's ability to serve those customers, or the strength of the Company's pipelines. The Company's global manufacturing footprint provides the flexibility to shift production of tariff-impacted volume to U.S. facilities if needed and the Company has been evaluating such adjustments in consultation with affected customers.
Fixed Cost Transformation Program and margin expansion update
In the second quarter of fiscal 2027, the Company advanced the implementation of its previously announced Fixed Cost Transformation Program, a multi-phase initiative to simplify its operating structure, optimize its global footprint and reduce fixed costs. When completed, the program is designed to deliver $65 million to $75 million of annualized cost savings, equivalent to approximately 250 basis points of adjusted earnings from operations margin. This represents approximately half of the 500 basis points of adjusted earnings from operations margin expansion required to move from ATS' fiscal 2026 base of approximately 10% to the Company's long-term target of 15%. The Company has made initial progress in line with its expectations; however, lower revenues and mix are temporarily offsetting the benefits of the program in the near term. To date, the Fixed Cost Transformation Program has resulted in several announced facility closures, including in Europe, which will result in the reduction of approximately 10% in the Company's overall square footage. As a result of the announced actions from Fixed Cost Transformation and other restructuring activities, the Company expects to reduce its workforce, including subcontractors, by approximately 300 to 400, with additional adjustments expected as further steps in the program are taken.
Of the $21.3 million of restructuring costs recorded in the second quarter of fiscal 2027, approximately half was related to the Fixed Cost Transformation Program. Management continues to expect that payback on restructuring will be less than one year, with some variability depending on jurisdiction.
Given the nature of the facility and reorganization activities involved, implementation is expected to continue over the next 15 months, with benefits accruing progressively as program actions are completed within the original 18-month timeframe.
Management continues to believe that executing on the Company's long-term growth opportunities and operational-improvement initiatives, together with portfolio optimization and cost-reduction activities, including the Fixed Cost Transformation Program, support the Company's achievement of its long-term adjusted earnings from operations margin target of 15%.
Financial results
(In millions of dollars, except per share and margin data)
Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Variance | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | Variance | |||||||||||||||||||||||||||
| Revenues | $ | 665.8 | $ | 728.5 | (8.6)% | $ | 1,359.5 | $ | 1,465.2 | (7.2)% | ||||||||||||||||||||||
Adjusted revenues1 | $ | 665.8 | $ | 728.5 | (8.6)% | $ | 1,364.1 | $ | 1,465.2 | (6.9)% | ||||||||||||||||||||||
Net income (loss) | $ | (5.0) | $ | 33.6 | (114.9)% | $ | (5.3) | $ | 57.9 | (109.2)% | ||||||||||||||||||||||
Adjusted earnings from operations1 | $ | 57.4 | $ | 79.1 | (27.4)% | $ | 125.5 | $ | 157.7 | (20.4)% | ||||||||||||||||||||||
Adjusted earnings from operations margin2 | 8.6% | 10.9% | (224)bps | 9.2% | 10.8% | (156)bps | ||||||||||||||||||||||||||
Adjusted EBITDA1 | $ | 80.7 | $ | 103.7 | (22.2)% | $ | 173.4 | $ | 205.3 | (15.5)% | ||||||||||||||||||||||
Adjusted EBITDA margin2 | 12.1% | 14.2% | (211)bps | 12.7% | 14.0% | (130)bps | ||||||||||||||||||||||||||
Basic earnings (loss) per share | $ | (0.05) | $ | 0.34 | (114.7)% | $ | (0.05) | $ | 0.59 | (108.5)% | ||||||||||||||||||||||
Adjusted basic earnings per share1 | $ | 0.27 | $ | 0.45 | (40.0)% | $ | 0.62 | $ | 0.85 | (27.1)% | ||||||||||||||||||||||
Order Bookings3 | $ | 827 | $ | 734 | 12.7% | $ | 1,482 | $ | 1,427 | 3.9% | ||||||||||||||||||||||
| As At | September 27 2026 | September 28 2025 | Variance | ||||||||||||||
Order Backlog3 | $ | 2,009 | $ | 2,070 | (2.9)% | ||||||||||||
1Non-IFRS financial measure — See "Non-IFRS and Other Financial Measures".
2Non-IFRS ratio — See "Non-IFRS and Other Financial Measures".
3Supplementary financial measure — See "Non-IFRS and Other Financial Measures".
Second quarter summary
Second quarter fiscal 2027 revenues were 8.6% or $62.7 million lower than in the corresponding period a year ago, primarily reflecting a year-over-year decrease in organic revenue (excluding contributions from acquired companies and foreign exchange translation) of $66.1 million or 9.1%, partially offset by the positive impact of foreign exchange translation. Revenues generated from construction contracts decreased 19.2% or $77.2 million from the prior period primarily due to lower Order Backlog entering the period. Revenues from services increased 6.1% or $10.3 million, primarily due to organic revenue growth on higher Order Backlog entering the period and the positive impact of foreign exchange translation. Revenues from the sale of goods increased 2.7% or $4.2 million, which included a positive impact from foreign exchange translation. Organic revenue is a non-IFRS financial measure - see "Non-IFRS and Other Financial Measures."
By market, revenues generated in life sciences decreased $18.7 million or 5.0% year-over-year. This was primarily due to timing of both customer capital allocation as well as project execution. Revenues in industrial & consumer decreased $41.8 million or 23.5% compared to the prior year as a result of lower activity in certain legacy industrial applications, as the Company continues to reposition its capabilities
towards other strategic areas. Revenues generated in food & beverage decreased $25.2 million or 20.2% from the corresponding period last year due to lower Order Backlog entering the period, in addition to timing of project execution. Revenues in energy increased $23.0 million or 45.1% year-over-year primarily related to execution of nuclear projects.
Net loss for the second quarter of fiscal 2027 was $5.0 million ((5) cents per share basic), compared to net income of $33.6 million (34 cents per share basic and diluted) for the second quarter of fiscal 2026. The decrease primarily reflected lower revenues. Adjusted basic earnings per share were 27 cents compared to 45 cents in the second quarter of fiscal 2026.
Depreciation and amortization expense was $37.3 million in the second quarter of fiscal 2027, compared to $39.4 million a year ago.
Restructuring costs for the three and six months ended September 27, 2026 were $21.3 million and $27.0 million, respectively, compared to nil and $2.5 million in the corresponding periods a year ago.
EBITDA was $60.5 million (9.1% EBITDA margin) in the second quarter of fiscal 2027 compared to $114.6 million (15.7% EBITDA margin) in the second quarter of fiscal 2026. EBITDA for the second quarter of fiscal 2027 included $21.3 million of restructuring charges, $0.1 million of incremental costs related to acquisition activity, $1.4 million related to CEO inducement costs, $1.2 million of other reorganization-related costs, and a $3.8 million recovery of stock-based compensation revaluation expense. EBITDA for the corresponding period in the prior year included $0.1 million of incremental costs related to acquisition activity, $7.3 million of stock-based compensation recovery due to forfeiture of unvested awards, and $3.7 million recovery of stock-based compensation revaluation expenses. Excluding these amounts, adjusted EBITDA was $80.7 million (12.1% adjusted EBITDA margin), compared to $103.7 million (14.2% adjusted EBITDA margin) for the corresponding period in the prior year. Lower adjusted EBITDA primarily reflected lower revenues. EBITDA and adjusted EBITDA are non-IFRS financial measures, and EBITDA margin and adjusted EBITDA margin are non-IFRS ratios — see "Non-IFRS and Other Financial Measures."
Order Backlog Continuity
(In millions of dollars)
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
Opening Order Backlog | $ | 1,889 | $ | 2,068 | $ | 1,958 | $ | 2,139 | |||||||||||||||
Adjusted Revenues | (666) | (728) | (1,364) | (1,465) | |||||||||||||||||||
Order Bookings | 827 | 734 | 1,482 | 1,427 | |||||||||||||||||||
Order Backlog Adjustments1 | (41) | (4) | (67) | (31) | |||||||||||||||||||
Total | $ | 2,009 | $ | 2,070 | $ | 2,009 | $ | 2,070 | |||||||||||||||
1.Order Backlog adjustments include foreign exchange adjustments, and normal course scope changes and cancellations.
Order Bookings
Second quarter of fiscal 2027 Order Bookings were $827 million, a 12.7% year-over-year increase, primarily reflecting a 12.4% increase in organic Order Bookings. By market, Order Bookings in life sciences increased compared to the prior-year period, reflecting continued customer capital investment across a broad range of applications, including large enterprise orders. Order Bookings within life
sciences remain well diversified, including orders for radiopharmaceutical applications and for a range of pharmaceutical and medical device automation solutions. Order Bookings decreased in industrial & consumer compared to the prior period a year ago, primarily due to the timing of customer projects and the Company's ongoing portfolio repositioning towards opportunities that support improved profitability and capital efficiency. Order Bookings in food & beverage increased compared to the prior-year period due to the timing of customer orders. Order Bookings in energy decreased compared to the prior-year period primarily due to the timing of customer projects, specifically for nuclear refurbishment projects, and due to strong nuclear refurbishment-related activity in the prior-year period that benefited from several large project awards. Given the nature of the nuclear market, Order Bookings can fluctuate based on the timing of customer investment decisions and project awards. Organic Order Bookings and Organic Order Bookings growth are supplementary financial measures — see "Non-IFRS and Other Financial Measures."
Backlog
At September 27, 2026, Order Backlog was $2,009 million, 2.9% lower than at September 28, 2025.
Outlook
The life sciences funnel remains strong and diversified, with opportunities across strategic submarkets such as pharmaceuticals, radiopharmaceuticals and medical devices, partially offsetting lower levels of GLP‑1-related activity compared to recent periods. Management continues to identify opportunities with both new and existing customers across diagnostic and therapeutic radiopharmaceuticals, isotope production, wearable devices, automated pharmacy solutions, contact lenses and pre-filled syringes, as well as integrated life sciences solutions that leverage capabilities from across the Company. Management continues to see strong customer interest in specialized radiopharmaceutical production, containment and automation solutions, supported primarily by increasing adoption of therapeutic applications and ongoing investment in isotope production. As programs advance from clinical development towards commercialization, management continues to observe broader market activity aimed at securing capacity, enhancing supply-chain resilience and supporting reliable, compliant operations in highly regulated environments. ATS' differentiated capabilities in radiopharmaceutical containment systems, integrated automation and lifecycle support position the Company to participate in multiple phases of customer investment across the radiopharmaceutical value chain. ATS continues to strengthen its coordinated go-to-market approach, with initiatives focused on broader market coverage, improved customer engagement and development of a pipeline of opportunities.
Funnel activity in industrial & consumer is stable. While discretionary consumer spending may influence the timing of certain customer investments, the Company continues to broaden its opportunity pipeline across specialized industrial applications. These opportunities allow ATS to deploy its differentiated automation, testing and high-speed assembly capabilities into higher-value areas such as data center infrastructure, warehouse packaging automation and other mission-critical production environments.
Funnel activity in food & beverage remains strong despite lower order activity in certain markets, particularly global tomato processing, following elevated investment levels in recent years. ATS continues to see opportunities across its core and adjacent end markets and is expanding its opportunity set beyond tomato processing into fresh fruit processing, secondary processing and packaging applications. Customer demand is increasingly focused on solutions that improve productivity and reduce operating costs, rather than investments primarily intended to add capacity. In addition, customers' equipment replacement requirements may support investment activity even during
periods of softer underlying demand. Through its market position and capabilities, management believes it is well positioned to participate as customer investment activity improves over time.
Funnel activity in energy remains strong, supported by industry investment in energy security, infrastructure modernization and new power generation capacity to support data center needs. Within nuclear, demand related to CANDU reactor refurbishment and life-extension programs continues to support capital project opportunities in the near term and lifecycle service opportunities over the longer term. ATS is also engaged in front-end engineering, design and prototype-equipment development for small modular reactors and conventional new builds. As customer programs advance, ATS can support automation for modular fabrication and assembly, fuel fabrication and related manufacturing processes, as well as fuel handling and other specialized testing systems designed for reliable and repeatable operation in high-risk environments. Opportunities in fuel fabrication are also emerging as customers seek to strengthen domestic supply chains and invest in the facilities and equipment required to support future reactor deployment. Based on management's assessment of where ATS' capabilities can be deployed, the Company's addressable opportunity on a reactor program may represent a low-single-digit percentage of total customer capital expenditure, depending on the application.
After-sales revenues and reoccurring revenues, which ATS defines as revenues from ancillary products and services associated with equipment sales, and revenues from customers who purchase non-customized ATS products at regular intervals, are expected to provide some balance to customers' capital expenditure cycles. Management expects reoccurring revenues to be in the range of 25%-35% on a trailing-twelve-month basis and remains focused on expanding this proportion of the business over time. After-sales service revenues are accretive to the Company's overall margin, and growth in this proportion is expected to support the Company's margin expansion targets.
Across its end markets, ATS' competitive position is reinforced by a broad base of differentiated technologies, products and engineering know-how developed across the portfolio. These capabilities include precision and high-speed assembly systems for medical-device applications, modular sterile-filling platforms that integrate containment, inspection and magnetic conveyance, and adaptable automation platforms that can be deployed across emerging industrial applications. The Company is also advancing practical artificial intelligence and data-enabled automation applications combining machine vision, data, analytics and machine learning with automated equipment and lifecycle service offerings. Current applications include advanced inspection and sorting, digital tools for regulated workflows, and solutions intended to improve equipment performance, maintenance and operator effectiveness. These capabilities are at varying stages of development and are expected to support higher-value automation solutions and lifecycle service opportunities across complex and regulated applications.
Customers seeking to de-risk or enhance supply chain resiliency, address skilled worker shortages or combat higher labour costs present ongoing and future opportunities for ATS. Management believes that the underlying trends driving customer demand for ATS solutions, including growing labour constraints, production onshoring or reshoring and the need for scalable, high-quality, energy-efficient production, remain favourable. In addition, funnel growth in markets where sustainability requirements are a focus for customers — including nuclear and grid battery storage, as well as consumer goods packaging — provides ATS with opportunities to use its capabilities to respond to customer needs, such as global and regional requirements to reduce carbon emissions.
Order Backlog of $2,009 million is expected to help mitigate some of the impact of quarterly variability in Order Bookings on revenues in the short term. The Company's Order Backlog includes several large enterprise programs that have longer periods of performance and therefore longer revenue recognition cycles, particularly in life sciences.
Management's approach to long-term value creation is centered on disciplined execution of the Company's Growth Algorithm, which is designed to drive sustainable growth in per-share cash generation. The Growth Algorithm combines organic growth, disciplined acquisitions, margin expansion and improved working-capital efficiency, while supporting continued investment in differentiated technologies, lifecycle services and strategic acquisitions. Together, these priorities are intended to enhance the quality, resilience and growth of the Company's earnings and cash flow profile. Management also considers return on invested capital and cash return on investment as part of its capital allocation framework. This framework is intended to balance growth, profitability and capital efficiency across organic investments, acquisitions and operational improvement initiatives, with the objective of maximizing long-term shareholder value.
As management increases its focus on cash returns, improving non-cash working capital velocity and asset utilization more broadly are clear priorities within the Company's operating models. These priorities are intended to support stronger cash generation and improved returns on invested capital. The Company's long-term goal is to maintain its investment in non-cash working capital as a percentage of annualized revenues below 15%, although fluctuations are expected on a quarter-over-quarter basis. The Company expects that continued cash flows from operations, together with cash and cash equivalents on hand and credit available under operating and long-term credit facilities, will be sufficient to fund its requirements for investments in non-cash working capital and capital assets, and to fund strategic investment plans including some potential acquisitions. Acquisitions could result in additional debt or equity financing requirements for the Company. Non-cash working capital as a percentage of adjusted revenues is a non-IFRS ratio — see"Non-IFRS and Other Financial Measures."
For further details on the Company's outlook, please see "Outlook" in its Management's Discussion and Analysis for the second quarter ending September 27, 2026 ("Q2 MD&A").
Reorganization and Transformation Activity
Total restructuring expenses
Total restructuring expenses in the second quarter of fiscal 2027 were $21.3 million, with approximately half related to the Fixed Cost Transformation Program.
Fixed Cost Transformation Program
In the second quarter of fiscal 2027, the Company recorded restructuring expenses primarily related to its European Footprint Consolidation and the activities described above.
Transportation reorganization and other restructuring activities
The Company completed the restructuring activities announced in the fourth quarter of fiscal 2026 in the second quarter of fiscal 2027.
At quarter end, two U.S. facilities and one German facility were held for sale, with one U.S. facility expected to be structured as a sale and leaseback following quarter end. Subsequent to quarter end,
the Company completed the sale of the two U.S. facilities for consideration of $71.2 million, resulting in an estimated gain on disposal of approximately $12.2 million. The Company entered into an agreement to lease back one of the facilities to support the growth of the nuclear business in the U.S. The transaction will be recognized in the third quarter of fiscal 2027. Proceeds from the sale of these facilities are expected to fund restructuring activities and other costs of exiting businesses.
Tariffs
The majority of the Company's shipments from Canada into the U.S. fall within the current terms of the U.S.-Mexico-Canada trade agreement ("USMCA"). In 2026, the U.S. declined to agree to extend the USMCA in its current form, triggering annual joint reviews that will continue until the parties either agree to an extension or the agreement expires on July 1, 2036. Although the USMCA remains in full force and effect, the annual review process, and the ability of any party to withdraw from the agreement on six months' written notice, creates potential long-term uncertainty regarding North American free trade compounded by additional tariffs imposed by the U.S. on certain goods from various jurisdictions globally, including Canada and Europe; and further tariffs and trade agreements continue to be discussed. The uncertainty of Section 338 tariffs has had a more material impact during the quarter than previously anticipated, primarily affecting packaging equipment and customer decision making based on expected tariff impacts. Subsequent changes to tariff policy may reduce the impact of these tariffs on the Company going forward, although the effect of such changes may not translate immediately into Order Bookings and revenues. The Company does not currently expect tariffs imposed under Section 301 of the Trade Act of 1974 ("Section 301 tariffs") to have a material impact and continues to assess the application of these tariffs. Management continues to actively monitor the situation as it evolves and is taking steps to mitigate risks where possible while continuing to offer support to customers based on their needs, which may include onshoring or reshoring production. Supply chain impacts resulting from shifting trade dynamics have been largely mitigated through alternative sourcing, along with pricing strategies. While the Company could see impacts over time arising from unmitigated costs related to the tariffs themselves, potential supplier price increases, and the timing and geographic shifts in customers' capital deployment, ATS' global footprint and decentralized operating model, supported by the ABM, provide some flexibility to address potential disruptions over the long term. On a trailing-twelve-month basis, the Company's equipment and product adjusted revenues from its Canadian and European operations being sold into the U.S. remained consistent with the range previously disclosed of just over 20% of the Company's adjusted revenues.
Quarterly Conference Call
ATS will host a conference call and webcast at 8:30 a.m. eastern time on Wednesday, November 4, 2026 to discuss its quarterly results. The listen-only webcast can be accessed at https://events.q4inc.com/attendee/753614756 and the conference call can be accessed by dialing (833) 461-5787 five minutes prior and quoting reference number 753614756. A replay of the conference will be available on the ATS website following the call. Alternatively, a telephone recording of the call will be available for one week (until midnight November 11, 2026) by dialing (833) 309-1852 and using the access code 753614756.
About ATS
ATS Corporation is an industry-leading automation solutions provider to many of the world's most successful companies. ATS uses its extensive knowledge base and global capabilities in custom automation, repeat automation, automation products and value-added solutions including pre-automation and after-sales services, to address the sophisticated manufacturing automation systems and service needs of multinational customers in markets such as life sciences, food & beverage, industrial and consumer, and energy. Founded in 1978, ATS employs over 7,000 people at more than 65 manufacturing facilities and over 85 offices in North America, Europe, Asia and Oceania. The Company's common shares are traded on the Toronto Stock Exchange ("TSX") and the New York Stock Exchange ("NYSE") under the symbol ATS. Visit the Company's website at www.atsautomation.com.
| For more information, contact: | For general media inquiries, contact: | ||||
| David Ocampo | Matthew Robinson | ||||
| Head of Investor Relations | Director, Corporate Affairs & Communications | ||||
| ATS Corporation | ATS Corporation | ||||
| 730 Fountain Street North | 730 Fountain Street North | ||||
| Cambridge, ON, N3H 4R7 | Cambridge, ON, N3H 4R7 | ||||
| (519) 653-6500 | (519) 653-6500 | ||||
| docampo@atsautomation.com | mrobinson@atsautomation.com | ||||
SOURCE: ATS Corporation
Consolidated Adjusted Revenues
(In millions of dollars)
| Adjusted revenues by type | Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | |||||||||||||||||||
Revenues from construction contracts | $ | 324.4 | $ | 401.6 | $ | 688.2 | $ | 823.1 | |||||||||||||||
Services rendered | 179.1 | 168.8 | 361.9 | 332.9 | |||||||||||||||||||
| Sale of goods | 162.3 | 158.1 | 314.0 | 309.2 | |||||||||||||||||||
| Total adjusted revenues | $ | 665.8 | $ | 728.5 | $ | 1,364.1 | $ | 1,465.2 | |||||||||||||||
| Adjusted revenues by market | Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | |||||||||||||||||||
| Life Sciences | $ | 355.8 | $ | 374.5 | $ | 701.6 | $ | 753.2 | |||||||||||||||
| Industrial & Consumer | 136.4 | 178.2 | 312.0 | 362.4 | |||||||||||||||||||
| Food & Beverage | 99.6 | 124.8 | 216.6 | 263.2 | |||||||||||||||||||
| Energy | 74.0 | 51.0 | 133.9 | 86.4 | |||||||||||||||||||
| Total adjusted revenues | $ | 665.8 | $ | 728.5 | $ | 1,364.1 | $ | 1,465.2 | |||||||||||||||
Consolidated Operating Results
(In millions of dollars)
(In millions of dollars)
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
| Earnings from operations | $ | 23.2 | $ | 75.2 | $ | 47.4 | $ | 133.0 | |||||||||||||||
| Amortization of acquisition-related intangible assets | 14.0 | 14.8 | 28.2 | 29.2 | |||||||||||||||||||
| Acquisition-related transaction costs | 0.1 | 0.1 | 0.2 | 0.4 | |||||||||||||||||||
Restructuring charges2 | 21.3 | — | 27.0 | 2.5 | |||||||||||||||||||
Stock-based compensation forfeiture3 | — | (7.3) | — | (7.3) | |||||||||||||||||||
Transportation reorganization4 | — | — | 7.6 | — | |||||||||||||||||||
Services reorganization5 | — | — | 4.7 | — | |||||||||||||||||||
| CEO inducement | 1.4 | — | 2.8 | — | |||||||||||||||||||
Software-focused businesses reorganization | — | — | 7.1 | — | |||||||||||||||||||
Other reorganization-related costs5 | 1.2 | — | 3.3 | — | |||||||||||||||||||
| Mark to market portion of stock-based compensation | (3.8) | (3.7) | (2.8) | (0.1) | |||||||||||||||||||
Adjusted earnings from operations1 | $ | 57.4 | $ | 79.1 | $ | 125.5 | $ | 157.7 | |||||||||||||||
1Non-IFRS financial measure — see "Non-IFRS and Other Financial Measures."
2Approximately half of the restructuring costs recognized in the second quarter of fiscal 2027 related to the Fixed Cost Transformation Program.
3Reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
4Included in the year-to-date transportation reorganization costs was a decrease of $4.6 million of revenue, a $2.3 million increase in cost of revenues and a $0.7 million increase in SG&A expense.
5Included in the year-to-date services reorganization is a $3.5 million increase to cost of revenues, $0.7 million of amortization charges recorded to cost of revenues, and $0.5 million increase to SG&A expense.
6Included in the year to date other reorganization-related costs is a $2.4 million increase to cost of revenues, a $0.3 million increase to SG&A expense, and $0.6 million of amortization recorded to SG&A expense.
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
| Earnings from operations | $ | 23.2 | $ | 75.2 | $ | 47.4 | $ | 133.0 | |||||||||||||||
| Depreciation and amortization | 37.3 | 39.4 | 77.5 | 76.8 | |||||||||||||||||||
EBITDA1 | $ | 60.5 | $ | 114.6 | $ | 124.9 | $ | 209.8 | |||||||||||||||
Restructuring charges2 | 21.3 | — | 27.0 | 2.5 | |||||||||||||||||||
| Acquisition-related transaction costs | 0.1 | 0.1 | 0.2 | 0.4 | |||||||||||||||||||
Stock-based compensation forfeiture | — | (7.3) | — | (7.3) | |||||||||||||||||||
| Transportation reorganization | — | — | 7.6 | — | |||||||||||||||||||
Services reorganization4 | — | — | 4.0 | — | |||||||||||||||||||
| CEO inducement | 1.4 | — | 2.8 | — | |||||||||||||||||||
| Software-focused businesses reorganization | — | — | 7.1 | — | |||||||||||||||||||
Other reorganization-related costs5 | 1.2 | — | 2.6 | — | |||||||||||||||||||
| Mark to market portion of stock-based compensation | (3.8) | (3.7) | (2.8) | (0.1) | |||||||||||||||||||
Adjusted EBITDA1 | $ | 80.7 | $ | 103.7 | $ | 173.4 | $ | 205.3 | |||||||||||||||
1Non-IFRS financial measure — See "Non-IFRS and Other Financial Measures".
2Approximately half of the restructuring costs recognized in the second quarter of fiscal 2027 related to the Fixed Cost Transformation Program.
3Reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
4Year-to-date services reorganization costs incurred in the quarter include $0.7 million of amortization costs arising from a change in useful lives of certain assets. These amounts are excluded from the reconciling adjustment as they are already excluded in the calculation of EBITDA.
5Year-to-date other reorganization-related costs incurred in the quarter include $0.6 million of amortization costs arising from a change in useful lives of certain assets. These amounts are excluded from the reconciling adjustment as they are already excluded in the calculation of EBITDA.
Order Backlog by Market
(In millions of dollars)
| As at | September 27 2026 | September 28 2025 | |||||||||
| Life Sciences | $ | 1,238 | $ | 1,144 | |||||||
Industrial & Consumer | 312 | 431 | |||||||||
| Food & Beverage | 223 | 218 | |||||||||
| Energy | 236 | 277 | |||||||||
Total | $ | 2,009 | $ | 2,070 | |||||||
Reconciliation of Non-IFRS Measures to IFRS Measures
(In millions of dollars, except per share data)
The following table reconciles adjusted EBITDA and EBITDA to the most directly comparable IFRS measure (net income (loss)):
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
| Adjusted EBITDA | $ | 80.7 | $ | 103.7 | $ | 173.4 | $ | 205.3 | |||||||||||||||
Less: Restructuring charges1 | 21.3 | — | 27.0 | 2.5 | |||||||||||||||||||
| Less: Acquisition-related transaction costs | 0.1 | 0.1 | 0.2 | 0.4 | |||||||||||||||||||
Less: Stock-based compensation forfeiture2 | — | (7.3) | — | (7.3) | |||||||||||||||||||
Less: Transportation reorganization | — | — | 7.6 | — | |||||||||||||||||||
Less: Services reorganization3 | — | — | 4.0 | — | |||||||||||||||||||
| Less: CEO inducement | 1.4 | — | 2.8 | — | |||||||||||||||||||
| Less: Software-focused businesses reorganization | — | — | 7.1 | — | |||||||||||||||||||
Less: Other reorganization-related costs4 | 1.2 | — | 2.6 | — | |||||||||||||||||||
| Less: Mark to market portion of stock-based compensation | (3.8) | (3.7) | (2.8) | (0.1) | |||||||||||||||||||
| EBITDA | $ | 60.5 | $ | 114.6 | $ | 124.9 | $ | 209.8 | |||||||||||||||
| Less: Depreciation and amortization expense | 37.3 | 39.4 | 77.5 | 76.8 | |||||||||||||||||||
| Earnings from operations | $ | 23.2 | $ | 75.2 | $ | 47.4 | $ | 133.0 | |||||||||||||||
| Less: Net finance costs | 22.2 | 24.4 | 42.9 | 50.0 | |||||||||||||||||||
| Less: Income tax expense | 6.0 | 17.2 | 9.8 | 25.1 | |||||||||||||||||||
| Net income (loss) | $ | (5.0) | $ | 33.6 | $ | (5.3) | $ | 57.9 | |||||||||||||||
1Approximately half of the restructuring costs recognized in the second quarter of fiscal 2027 related to the Fixed Cost Transformation Program.
2Reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
3Year-to-date services reorganization costs incurred in the quarter include $0.7 million of amortization costs arising from a change in useful lives of certain assets. These amounts are excluded from the reconciling adjustment as they are already excluded in the calculation of EBITDA.
4Other reorganization-related costs incurred in the quarter include $0.6 million of amortization costs arising from a change in useful lives of certain assets. These amounts are excluded from the reconciling adjustment as they are already excluded in the calculation of EBITDA.
The following table reconciles adjusted earnings from operations, adjusted net income, and adjusted basic earnings per share to the most directly comparable IFRS measures (net income (loss) and basic earnings (loss) per share):
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings from operations | Finance costs | Income tax recovery | Net income (loss) | Basic EPS | Earnings from operations | Finance costs | Income tax expense (recovery) | Net Income | Basic EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported (IFRS) | $ | 23.2 | $ | (22.2) | $ | (6.0) | $ | (5.0) | $ | (0.05) | $ | 75.2 | $ | (24.4) | $ | (17.2) | $ | 33.6 | $ | 0.34 | |||||||||||||||||||||||||||||||||||||||
| Amortization of acquisition- related intangibles | 14.0 | — | — | 14.0 | 0.14 | 14.8 | — | — | 14.8 | 0.15 | |||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring charges1 | 21.3 | — | — | 21.3 | 0.22 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Acquisition-related transaction costs | 0.1 | — | — | 0.1 | — | 0.1 | — | — | 0.1 | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation forfeiture2 | — | — | — | — | — | (7.3) | — | — | (7.3) | (0.07) | |||||||||||||||||||||||||||||||||||||||||||||||||
| CEO inducement | 1.4 | — | — | 1.4 | 0.02 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Other reorganization-related costs | 1.2 | — | — | 1.2 | 0.01 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Mark to market portion of stock-based compensation | (3.8) | — | — | (3.8) | (0.04) | (3.7) | — | — | (3.7) | (0.04) | |||||||||||||||||||||||||||||||||||||||||||||||||
Adjustment to income tax expense3 | — | — | (3.2) | (3.2) | (0.03) | — | — | 6.1 | 6.1 | 0.07 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted (non-IFRS) | $ | 57.4 | $ | 26.0 | $ | 0.27 | $ | 79.1 | $ | 43.6 | $ | 0.45 | |||||||||||||||||||||||||||||||||||||||||||||||
1Approximately half of the restructuring costs recognized in the second quarter of fiscal 2027 related to the Fixed Cost Transformation Program.
2Reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
3For a breakdown of items included in adjustments to income tax expense (recovery) see reconciliation of adjusted effective income tax rate table.
Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings from operations | Finance costs | Income tax recovery | Net income (loss) | Basic EPS | Earnings from operations | Finance costs | Income tax expense (recovery) | Net income | Basic EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported (IFRS) | $ | 47.4 | $ | (42.9) | $ | (9.8) | $ | (5.3) | $ | (0.05) | $ | 133.0 | $ | (50.0) | $ | (25.1) | $ | 57.9 | $ | 0.59 | |||||||||||||||||||||||||||||||||||||||
| Amortization of acquisition- related intangibles | 28.2 | — | — | 28.2 | 0.29 | 29.2 | — | — | 29.2 | 0.30 | |||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring charges1 | 27.0 | — | — | 27.0 | 0.28 | 2.5 | — | — | 2.5 | 0.03 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Acquisition-related transaction costs | 0.2 | — | — | 0.2 | — | 0.4 | — | — | 0.4 | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation forfeiture2 | — | — | — | — | — | (7.3) | — | — | (7.3) | (0.08) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Transportation reorganization | 7.6 | — | — | 7.6 | 0.08 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Services reorganization | 4.7 | — | — | 4.7 | 0.05 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| CEO inducement | 2.8 | — | — | 2.8 | 0.03 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Software-focused businesses reorganization | 7.1 | — | — | 7.1 | 0.07 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Other reorganization-related costs | 3.3 | — | — | 3.3 | 0.03 | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
| Mark to market portion of stock-based compensation | (2.8) | — | — | (2.8) | (0.03) | (0.1) | — | — | (0.1) | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Adjustment to income tax expense (recovery)3 | — | (12.4) | (12.4) | (0.13) | — | — | 0.9 | 0.9 | 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Adjusted (non-IFRS) | $ | 125.5 | $ | 60.4 | $ | 0.62 | $ | 157.7 | $ | 83.5 | $ | 0.85 | |||||||||||||||||||||||||||||||||||||||||||||||
1Approximately half of the restructuring costs recognized in the second quarter of fiscal 2027 related to the Fixed Cost Transformation Program.
2Reversal of previously recorded stock-based compensation expense due to the departure of the Company's former CEO.
3For a breakdown of items included in adjustments to income tax expense (recovery) see reconciliation of adjusted effective income tax rate table.
The following table reconciles organic revenue to adjusted revenues, which have been reconciled to the most directly comparable IFRS measure (revenues) earlier in this press release:
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
| Organic revenue | $ | 662.4 | $ | 689.9 | $ | 1,351.7 | $ | 1,375.6 | |||||||||||||||
| Revenues of acquired companies | — | 14.6 | — | 43.1 | |||||||||||||||||||
| Impact of foreign exchange rate changes | 3.4 | 24.0 | 12.4 | 46.5 | |||||||||||||||||||
| Total adjusted revenues | $ | 665.8 | $ | 728.5 | $ | 1,364.1 | $ | 1,465.2 | |||||||||||||||
| Organic revenue growth | (9.1)% | (7.7)% | |||||||||||||||||||||
The following table reconciles non-cash working capital as a percentage of adjusted revenues to the most directly comparable IFRS measures:
| As at | September 27, 2026 | March 31, 2026 | |||||||||
| Accounts receivable | $ | 521.2 | $ | 523.7 | |||||||
| Income tax receivable | 17.7 | 10.4 | |||||||||
| Contract assets | 406.7 | 436.8 | |||||||||
| Inventories | 301.6 | 295.2 | |||||||||
| Deposits, prepaids and other assets | 95.4 | 94.9 | |||||||||
| Accounts payable and accrued liabilities | (608.8) | (622.4) | |||||||||
| Income tax payable | (39.8) | (34.1) | |||||||||
| Contract liabilities | (290.8) | (307.3) | |||||||||
| Provisions | (38.8) | (32.1) | |||||||||
| Non-cash working capital | $ | 364.4 | $ | 365.1 | |||||||
| Trailing six-month adjusted revenues annualized | $ | 2,728.2 | $ | 3,009.8 | |||||||
| Working capital % | 13.4% | 12.1% | |||||||||
The following table reconciles net debt to the most directly comparable IFRS measures:
| As at | September 27, 2026 | March 31, 2026 | |||||||||
| Cash and cash equivalents | $ | 231.0 | $ | 285.0 | |||||||
| Bank indebtedness | (2.4) | (6.7) | |||||||||
| Current portion of lease liabilities | (36.7) | (35.2) | |||||||||
| Current portion of long-term debt | (0.2) | (0.2) | |||||||||
| Long-term lease liabilities | (109.9) | (119.5) | |||||||||
| Long-term debt | (1,274.0) | (1,274.6) | |||||||||
| Net Debt | $ | (1,192.2) | $ | (1,151.2) | |||||||
| Pro Forma Adjusted EBITDA (TTM) | $ | 381.3 | $ | 413.0 | |||||||
| Net Debt to Pro Forma Adjusted EBITDA | 3.1x | 2.8x | |||||||||
The following table reconciles free cash flow to the most directly comparable IFRS measures:
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
| Cash flows provided by operating activities | $ | 80.7 | $ | 28.5 | $ | 70.3 | $ | 184.3 | |||||||||||||||
| Acquisition of property, plant and equipment | (8.2) | (8.1) | (16.2) | (15.2) | |||||||||||||||||||
| Acquisition of intangible assets | (10.0) | (10.2) | (17.6) | (19.5) | |||||||||||||||||||
| Free cash flow | $ | 62.5 | $ | 10.2 | $ | 36.5 | $ | 149.6 | |||||||||||||||
The following table calculates the adjusted effective tax rate based on net income before income taxes including adjusting items and adjusted income tax expense:
| (in millions of dollars) | Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | |||||||||||||
| Earnings from operations | $ | 23.2 | $ | 75.2 | $ | 47.4 | $ | 133.0 | |||||||||
| Amortization of acquisition-related intangible assets | 14.0 | 14.8 | 28.2 | 29.2 | |||||||||||||
| Acquisition-related transaction costs | 0.1 | 0.1 | 0.2 | 0.4 | |||||||||||||
| Restructuring charges | 21.3 | — | 27.0 | 2.5 | |||||||||||||
| Stock-based compensation forfeiture | — | (7.3) | — | (7.3) | |||||||||||||
| Transportation reorganization | — | — | 7.6 | — | |||||||||||||
| Services reorganization | — | — | 4.7 | — | |||||||||||||
| CEO inducement | 1.4 | — | 2.8 | — | |||||||||||||
| Software-focused businesses reorganization | — | — | 7.1 | — | |||||||||||||
Other reorganization-related costs | 1.2 | — | 3.3 | — | |||||||||||||
| Mark to market portion of stock-based compensation | (3.8) | (3.7) | (2.8) | (0.1) | |||||||||||||
| Adjusted earnings from operations | 57.4 | 79.1 | 125.5 | 157.7 | |||||||||||||
| Net finance costs | 22.2 | 24.4 | 42.9 | 50.0 | |||||||||||||
| Income before income taxes including adjusting items | 35.2 | 54.7 | 82.6 | 107.7 | |||||||||||||
| Income tax expense | 6.0 | 17.2 | 9.8 | 25.1 | |||||||||||||
| Estimated tax impact of adjusting items | 7.4 | 0.9 | 16.6 | 6.1 | |||||||||||||
| Tax impact of unrecognized losses relating to reorganization activities | (4.2) | — | (4.2) | — | |||||||||||||
| Additional tax provision related to the departure of the Company's former CEO in the fiscal year | — | (1.6) | — | (1.6) | |||||||||||||
| Impact of tax rate change on deferred tax assets | — | (5.4) | — | (5.4) | |||||||||||||
| Adjusted income tax expense | 9.2 | 11.1 | 22.2 | 24.2 | |||||||||||||
| Adjusted effective income tax rate | 26.1 | % | 20.3 | % | 26.9 | % | 22.5 | % | |||||||||
Certain non-IFRS financial measures exclude the impact on stock-based compensation expense of the revaluation of restricted share units ("RSUs") and deferred share units ("DSUs") resulting specifically from the change in market price of the Company's common shares between periods. Management believes the adjustment provides further insight into the Company's performance.
The following table reconciles total stock-based compensation expense to its components:
| (in millions of dollars) | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | |||||||||||||||||||||||||||||||||||||||
| Total stock-based compensation expense (recovery) | $ | 0.4 | $ | 6.0 | $ | 2.5 | $ | 4.5 | $ | (6.7) | $ | 8.4 | $ | (2.3) | $ | 5.1 | |||||||||||||||||||||||||||||||
Less: stock-based compensation forfeiture1 | — | — | — | — | (7.3) | — | — | — | |||||||||||||||||||||||||||||||||||||||
| Less: Mark to market portion of stock-based compensation | (3.8) | 1.1 | 0.1 | 1.4 | (3.7) | 3.6 | (3.4) | 1.4 | |||||||||||||||||||||||||||||||||||||||
| Base stock-based compensation expense | $ | 4.2 | $ | 4.9 | $ | 2.4 | $ | 3.1 | $ | 4.3 | $ | 4.8 | $ | 1.1 | $ | 3.7 | |||||||||||||||||||||||||||||||
1Reversal of previously recorded stock-based compensation expense due to departure of the Company's former CEO within the related fiscal year.
INVESTMENTS, LIQUIDITY, CASH FLOW AND FINANCIAL RESOURCES
(In millions of dollars, except ratios)
(In millions of dollars, except ratios)
| As at | September 27, 2026 | March 31, 2026 | |||||||||
| Cash and cash equivalents | $ | 231.0 | $ | 285.0 | |||||||
Debt-to-equity ratio1 | 0.92:1 | 0.89:1 | |||||||||
1Debt is calculated as bank indebtedness, long-term debt and lease liabilities. Equity is calculated as total equity less accumulated other comprehensive income.
| Three Months Ended September 27, 2026 | Three Months Ended September 28, 2025 | Six Months Ended September 27, 2026 | Six Months Ended September 28, 2025 | ||||||||||||||||||||
| Cash, beginning of period | $ | 198.9 | $ | 188.6 | $ | 285.0 | $ | 225.9 | |||||||||||||||
| Total cash provided by (used in): | |||||||||||||||||||||||
| Operating activities | 80.7 | 28.5 | 70.3 | 184.3 | |||||||||||||||||||
| Investing activities | (18.0) | (18.4) | (32.6) | (34.6) | |||||||||||||||||||
| Financing activities | (31.2) | (2.7) | (95.2) | (179.6) | |||||||||||||||||||
| Net foreign exchange difference | 0.6 | 1.3 | 2.3 | 1.3 | |||||||||||||||||||
| Initial adoption of amendments to IFRS 9 | — | — | 1.2 | — | |||||||||||||||||||
| Cash, end of period | $ | 231.0 | $ | 197.3 | $ | 231.0 | $ | 197.3 | |||||||||||||||
ATS CORPORATION
Interim Condensed Consolidated Statements of Financial Position
(in thousands of Canadian dollars - unaudited)
| As at | September 27 2026 | March 31 2026 | ||||||||||||
| ASSETS | ||||||||||||||
Current assets | ||||||||||||||
| Cash and cash equivalents | $ | 230,968 | $ | 284,957 | ||||||||||
| Accounts receivable | 521,208 | 523,738 | ||||||||||||
| Income tax receivable | 17,686 | 10,356 | ||||||||||||
| Contract assets | 406,746 | 436,847 | ||||||||||||
| Inventories | 301,618 | 295,206 | ||||||||||||
Deposits, prepaids and other assets | 95,412 | 94,873 | ||||||||||||
| 1,573,638 | 1,645,977 | |||||||||||||
| Assets held for sale | 61,263 | 60,302 | ||||||||||||
| 1,634,901 | 1,706,279 | |||||||||||||
| Non-current assets | ||||||||||||||
Property, plant and equipment | 259,217 | 259,791 | ||||||||||||
| Right-of-use assets | 137,276 | 147,054 | ||||||||||||
| Long-term deposits | 3,896 | 3,710 | ||||||||||||
| Other assets | 9,737 | 4,464 | ||||||||||||
| Goodwill | 1,411,763 | 1,399,253 | ||||||||||||
| Intangible assets | 680,300 | 704,210 | ||||||||||||
| Deferred income tax assets | 130,220 | 115,269 | ||||||||||||
| 2,632,409 | 2,633,751 | |||||||||||||
| Total assets | $ | 4,267,310 | $ | 4,340,030 | ||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||
| Current liabilities | ||||||||||||||
Bank indebtedness | $ | 2,407 | $ | 6,744 | ||||||||||
| Accounts payable and accrued liabilities | 608,761 | 622,436 | ||||||||||||
| Income tax payable | 39,839 | 34,123 | ||||||||||||
| Contract liabilities | 290,844 | 307,306 | ||||||||||||
| Provisions | 38,750 | 32,100 | ||||||||||||
| Current portion of lease liabilities | 36,652 | 35,202 | ||||||||||||
| Current portion of long-term debt | 177 | 173 | ||||||||||||
| 1,017,430 | 1,038,084 | |||||||||||||
| Non-current liabilities | ||||||||||||||
Employee benefits | 26,684 | 26,075 | ||||||||||||
| Long-term provisions | 4,775 | 468 | ||||||||||||
| Long-term lease liabilities | 109,895 | 119,486 | ||||||||||||
| Long-term debt | 1,273,968 | 1,274,552 | ||||||||||||
| Deferred income tax liabilities | 79,201 | 80,462 | ||||||||||||
| Other long-term liabilities | 19,560 | 21,445 | ||||||||||||
| 1,514,083 | 1,522,488 | |||||||||||||
| Total liabilities | $ | 2,531,513 | $ | 2,560,572 | ||||||||||
| EQUITY | ||||||||||||||
Share capital | $ | 835,589 | $ | 852,805 | ||||||||||
| Contributed surplus | 33,263 | 30,758 | ||||||||||||
| Accumulated other comprehensive income | 189,658 | 171,573 | ||||||||||||
| Retained earnings | 675,583 | 722,621 | ||||||||||||
| Equity attributable to shareholders | 1,734,093 | 1,777,757 | ||||||||||||
| Non-controlling interests | 1,704 | 1,701 | ||||||||||||
| Total equity | 1,735,797 | 1,779,458 | ||||||||||||
| Total liabilities and equity | $ | 4,267,310 | $ | 4,340,030 | ||||||||||
Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company's profile on SEDAR+ at www.sedarplus.ca, the Company's profile on the U.S. Securities and Exchange Commission's website at www.sec.gov, and on the Company's website at www.atsautomation.com.
ATS CORPORATION
Interim Condensed Consolidated Statements of Income (Loss)
(in thousands of Canadian dollars, except per share amounts - unaudited)
| Three months ended | Six months ended | |||||||||||||||||||||||||||||||
September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | |||||||||||||||||||||||||||||
Revenues | $ | 665,766 | $ | 728,456 | $ | 1,359,487 | $ | 1,465,176 | ||||||||||||||||||||||||
| Operating costs and expenses | ||||||||||||||||||||||||||||||||
Cost of revenues | 476,282 | 510,581 | 980,052 | 1,027,451 | ||||||||||||||||||||||||||||
| Selling, general and administrative | 144,607 | 149,372 | 298,629 | 300,507 | ||||||||||||||||||||||||||||
| Restructuring costs | 21,293 | — | 26,951 | 2,493 | ||||||||||||||||||||||||||||
| Stock-based compensation (recovery) | 389 | (6,740) | 6,446 | 1,699 | ||||||||||||||||||||||||||||
| Earnings from operations | 23,195 | 75,243 | 47,409 | 133,026 | ||||||||||||||||||||||||||||
| Net finance costs | 22,201 | 24,413 | 42,920 | 50,054 | ||||||||||||||||||||||||||||
| Income before income taxes | 994 | 50,830 | 4,489 | 82,972 | ||||||||||||||||||||||||||||
| Income tax expense | 6,004 | 17,192 | 9,754 | 25,068 | ||||||||||||||||||||||||||||
| Net income (loss) | $ | (5,010) | $ | 33,638 | $ | (5,265) | $ | 57,904 | ||||||||||||||||||||||||
| Attributable to | ||||||||||||||||||||||||||||||||
Shareholders | $ | (4,954) | $ | 33,679 | $ | (5,263) | $ | 57,796 | ||||||||||||||||||||||||
| Non-controlling interests | (56) | (41) | (2) | 108 | ||||||||||||||||||||||||||||
| $ | (5,010) | $ | 33,638 | $ | (5,265) | $ | 57,904 | |||||||||||||||||||||||||
| Earnings (loss) per share attributable to shareholders | ||||||||||||||||||||||||||||||||
| Basic and diluted | $ | (0.05) | $ | 0.34 | $ | (0.05) | $ | 0.59 | ||||||||||||||||||||||||
Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company's profile on SEDAR+ at www.sedarplus.ca, the Company's profile on the U.S. Securities and Exchange Commission's website at www.sec.gov, and on the Company's website at www.atsautomation.com.
ATS CORPORATION
Interim Condensed Consolidated Statements of Cash Flows
(in thousands of Canadian dollars - unaudited)
| Three months ended | Six months ended | |||||||||||||||||||||||||||||||
September 27 2026 | September 28 2025 | September 27 2026 | September 28 2025 | |||||||||||||||||||||||||||||
| Operating activities | ||||||||||||||||||||||||||||||||
| Net income (loss) | $ | (5,010) | $ | 33,638 | $ | (5,265) | $ | 57,904 | ||||||||||||||||||||||||
| Items not involving cash | ||||||||||||||||||||||||||||||||
| Depreciation of property, plant and equipment | 7,586 | 8,616 | 17,259 | 17,020 | ||||||||||||||||||||||||||||
| Amortization of right-of-use assets | 9,347 | 9,848 | 19,304 | 18,801 | ||||||||||||||||||||||||||||
| Amortization of intangible assets | 20,330 | 20,967 | 40,931 | 40,924 | ||||||||||||||||||||||||||||
| Impairment of assets | — | — | 7,088 | — | ||||||||||||||||||||||||||||
| Deferred income taxes | (3,855) | (3,256) | (14,721) | (25,270) | ||||||||||||||||||||||||||||
| Other items not involving cash | 2,012 | 3,178 | (3,305) | (265) | ||||||||||||||||||||||||||||
| Stock-based compensation | 3,598 | (3,502) | 7,990 | 823 | ||||||||||||||||||||||||||||
| Change in non-cash operating working capital | 46,673 | (40,998) | 1,052 | 74,336 | ||||||||||||||||||||||||||||
Cash flows provided by operating activities | $ | 80,681 | $ | 28,491 | $ | 70,333 | $ | 184,273 | ||||||||||||||||||||||||
| Investing activities | ||||||||||||||||||||||||||||||||
| Acquisition of property, plant and equipment | $ | (8,161) | $ | (8,135) | $ | (16,185) | $ | (15,229) | ||||||||||||||||||||||||
| Acquisition of intangible assets | (10,013) | (10,240) | (17,600) | (19,480) | ||||||||||||||||||||||||||||
| Proceeds from disposal of property, plant and equipment | 176 | 34 | 1,225 | 125 | ||||||||||||||||||||||||||||
Cash flows used in investing activities | $ | (17,998) | $ | (18,341) | $ | (32,560) | $ | (34,584) | ||||||||||||||||||||||||
| Financing activities | ||||||||||||||||||||||||||||||||
| Bank indebtedness | $ | 1,537 | $ | 5,098 | $ | (4,369) | $ | (19,967) | ||||||||||||||||||||||||
| Repayment of long-term debt | (49) | (40,047) | (50,116) | (215,070) | ||||||||||||||||||||||||||||
| Proceeds from long-term debt | 40,000 | 39,999 | 40,000 | 84,999 | ||||||||||||||||||||||||||||
| Proceeds from exercise of stock options | 118 | 10,607 | 636 | 11,033 | ||||||||||||||||||||||||||||
| Purchase of non-controlling interest | — | — | — | (4,370) | ||||||||||||||||||||||||||||
| Repurchase of common shares | (61,297) | — | (61,297) | (10,000) | ||||||||||||||||||||||||||||
| Acquisition of shares held in trust | (2,589) | (9,616) | (2,589) | (9,616) | ||||||||||||||||||||||||||||
| Principal lease payments | (8,945) | (8,751) | (17,500) | (16,672) | ||||||||||||||||||||||||||||
Cash flows used in financing activities | $ | (31,225) | $ | (2,710) | $ | (95,235) | $ | (179,663) | ||||||||||||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | 577 | 1,263 | 2,315 | 1,339 | ||||||||||||||||||||||||||||
Increase (decrease) in cash and cash equivalents | 32,035 | 8,703 | (55,147) | (28,635) | ||||||||||||||||||||||||||||
Cash and cash equivalents, beginning of period | 198,933 | 188,609 | 284,957 | 225,947 | ||||||||||||||||||||||||||||
| Initial adoption of amendments to IFRS 9 on April 1, 2026 | — | — | 1,158 | — | ||||||||||||||||||||||||||||
Cash and cash equivalents, end of period | $ | 230,968 | $ | 197,312 | $ | 230,968 | $ | 197,312 | ||||||||||||||||||||||||
| Supplemental information | ||||||||||||||||||||||||||||||||
| Cash income taxes paid | $ | 866 | $ | 12,115 | $ | 25,799 | $ | 14,104 | ||||||||||||||||||||||||
| Cash interest paid | $ | 27,371 | $ | 29,639 | $ | 43,299 | $ | 49,648 | ||||||||||||||||||||||||
Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company's profile on SEDAR+ at www.sedarplus.ca, the Company's profile on the U.S. Securities and Exchange Commission's website at www.sec.gov, and on the Company's website at www.atsautomation.com.
Non-IFRS and Other Financial Measures
Throughout this document, management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company.
The terms "EBITDA", "organic revenue", "adjusted net income", "adjusted earnings from operations", "adjusted revenues", "adjusted EBITDA", "pro forma adjusted EBITDA", "adjusted basic earnings per share", "adjusted income tax provision", and "free cash flow", are non-IFRS financial measures, "EBITDA margin", "adjusted earnings from operations margin", "adjusted EBITDA margin", "organic revenue growth", "non-cash working capital as a percentage of adjusted revenues", "net debt to pro forma adjusted EBITDA", and "adjusted effective tax rate" are non-IFRS ratios, and "operating margin", "Order Bookings", "organic Order Bookings", "organic Order Bookings growth", "Order Backlog", and "book-to-bill ratio" are supplementary financial measures, all of which do not have any standardized meaning prescribed within IFRS and therefore may not be comparable to similar measures presented by other companies. Such measures should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. In addition, management uses "earnings from operations", which is an additional IFRS measure, to evaluate the performance of the Company. Earnings from operations is presented on the Company's consolidated statements of income as net income excluding income tax expense and net finance costs. Operating margin is an expression of the Company's earnings from operations as a percentage of adjusted revenues. EBITDA is defined as earnings from operations excluding depreciation and amortization. EBITDA margin is an expression of the Company's EBITDA as a percentage of adjusted revenues. Organic revenue is defined as adjusted revenues in the stated period excluding revenues from acquired companies for which the acquired company was not a part of the consolidated group in the comparable period. Organic revenue growth compares the stated period organic revenue with the reported adjusted revenue of the comparable prior period. Adjusted earnings from operations is defined as earnings from operations before items excluded from management's internal analysis of operating results, such as amortization expense of acquisition-related intangible assets, acquisition-related transaction and integration costs, restructuring charges, legal settlement and cancelled contract costs that arise outside of the ordinary course of business, the mark-to-market adjustment on stock-based compensation and certain other adjustments which would be non-recurring in nature ("adjustment items"). Adjusted earnings from operations margin is an expression of the Company's adjusted earnings from operations as a percentage of adjusted revenues. Adjusted revenues are defined as revenues before any adjustment items. Adjusted EBITDA is defined as adjusted earnings from operations excluding depreciation and amortization. Pro forma adjusted EBITDA is adjusted EBITDA on a pro forma basis to reflect full contribution from recent acquisitions. Adjusted EBITDA margin is an expression of the entity's adjusted EBITDA as a percentage of revenues. Adjusted basic earnings per share is defined as adjusted net income on a basic per share basis, where adjusted net income is defined as adjusted earnings from operations less net finance costs and income tax expense, plus tax effects of adjustment items and adjusted for other significant items of a non-recurring nature. Non-cash working capital as a percentage of adjusted revenues is defined as the sum of accounts receivable, contract assets, inventories, deposits, prepaids and other assets, less accounts payable, accrued liabilities, provisions and contract liabilities divided by the trailing two fiscal quarter adjusted revenues annualized. Adjusted income tax provision is defined as income tax provision including the tax impact of adjusting items and adjusting for the impact of additional one time tax transactions. Adjusted effective tax rate is adjusted income tax expressed as a percentage of pre tax income. Free cash flow is defined as cash provided by operating activities less property, plant and equipment and intangible asset expenditures. Net debt to pro forma adjusted EBITDA is the ratio of the net debt of the Company (cash and cash equivalents less bank indebtedness,
long-term debt, and lease liabilities) to the trailing twelve month pro forma adjusted EBITDA. Order Bookings represent new orders for the supply of automation systems, services and products that management believes are firm. Organic Order Bookings are defined as Order Bookings in the stated period excluding Order Bookings from acquired companies for which the acquired company was not a part of the consolidated group in the comparable period. Organic Order Bookings growth compares the stated period organic Order Bookings with the reported Order Bookings of the comparable prior period. Order Backlog is the estimated unearned portion of revenues on customer contracts that are in process and have not been completed at the specified date. Book to bill ratio is a measure of Order Bookings compared to adjusted revenue.
Following amendments to ATS' RSU Plan in 2022 to provide the Company with the option for settlement in shares purchased in the open market and the creation of the employee benefit trust to facilitate such settlement, ATS began to account for RSUs as equity-settled. However, prior RSU grants which will be cash-settled and DSU grants which will be cash-settled are accounted for as described in the Company's annual consolidated financial statements and have volatility period over period based on the fluctuating price of ATS' common shares. Certain non-IFRS financial measures (adjusted EBITDA, net debt to pro forma adjusted EBITDA, adjusted earnings from operations and adjusted basic earnings per share) exclude the impact on stock-based compensation expense of the revaluation of DSUs and RSUs resulting specifically from the change in market price of the Company's common shares between periods. Management believes that this adjustment provides insight into the Company's performance, as share price volatility drives variability in the Company's stock-based compensation expense.
Operating margin, adjusted earnings from operations, adjusted revenues, EBITDA, EBITDA margin, adjusted EBITDA, pro forma adjusted EBITDA and adjusted EBITDA margin are used by the Company to evaluate the performance of its operations. Management believes that earnings from operations is an important indicator in measuring the performance of the Company's operations on a pre-tax basis and without consideration as to how the Company finances its operations. Management believes that adjusted revenues, organic revenue and organic revenue growth, when considered with IFRS measures, allow the Company to better measure the Company's performance and evaluate long-term performance trends. Organic revenue growth also facilitates easier comparisons of the Company's performance with prior and future periods and relative comparisons to its peers. Management believes that EBITDA and adjusted EBITDA are important indicators of the Company's ability to generate operating cash flows to fund continued investment in its operations. Management believes that adjusted earnings from operations, adjusted earnings from operations margin, adjusted EBITDA, adjusted net income and adjusted basic earnings per share are important measures to increase comparability of performance between periods. The adjustment items used by management to arrive at these metrics are not considered to be indicative of the business' ongoing operating performance. Management uses the measure "non-cash working capital as a percentage of adjusted revenues" to assess overall liquidity. Management uses adjusted effective tax rate to better evaluate actual tax impact on the financial performance of the Company. Free cash flow is used by the Company to measure cash flow from operations after investment in property, plant and equipment and intangible assets. Management uses net debt to pro forma adjusted EBITDA as a measurement of leverage of the Company. Order Bookings provide an indication of the Company's ability to secure new orders for work during a specified period, while Order Backlog provides a measure of the value of Order Bookings that have not been completed at a specified point in time. Both Order Bookings and Order Backlog are indicators of future revenues that the Company expects to generate based on contracts that management believes to be firm. Organic Order Bookings and organic Order Bookings growth allow the Company to better measure the
Company's performance and evaluate long-term performance trends. Organic Order Bookings growth also facilitates easier comparisons of the Company's performance with prior and future periods and relative comparisons to its peers. Book to bill ratio is used to measure the Company's ability and timeliness to convert Order Bookings into revenues. Management believes that ATS shareholders and potential investors in ATS use these additional IFRS measures and non-IFRS financial measures in making investment decisions and measuring operational results.
A reconciliation of (i) adjusted EBITDA and EBITDA to net income, (ii) adjusted earnings from operations to net income, (iii) adjusted net income to net income, (iv) adjusted basic earnings per share to basic earnings per share (v) free cash flow to its IFRS measure components (vi) adjusted revenues to revenue and (vii) organic revenue to revenue, in each case for the three- and six-months ended September 27, 2026 and September 28, 2025 is contained in this document (see "Reconciliation of Non-IFRS Measures to IFRS Measures"). This document also contains a reconciliation of (i) non-cash working capital as a percentage of adjusted revenues and (ii) net debt to their IFRS measure components, in each case at both September 27, 2026 and March 31, 2026 (see "Reconciliation of Non-IFRS Measures to IFRS Measures"). A reconciliation of Order Bookings and Order Backlog to total Company revenues for the three- and six-months ended September 27, 2026 and September 28, 2025 is also contained in this news release (see "Order Backlog Continuity").
Forward-Looking Statements
This news release contains certain statements that may constitute forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws ("forward-looking statements"). All such statements are made pursuant to the "safe harbour" provisions of Canadian provincial and territorial securities laws and the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts regarding possible events, conditions or results of operations that ATS believes, expects or anticipates will or may occur in the future, including, but not limited to: the value creation strategy; the Company's strategy to expand through development of new markets and business platforms, expanding service offerings, investment in innovation and product development, and strategic and disciplined acquisitions, and the expected benefits to be derived therefrom; the ABM and possible margin improvements as a result from the execution of the ABM, including the timelines to achieve such improvements; the development of the Company's data-enabled automation capabilities; various core and end market opportunities for ATS; conversion of opportunities into Order Bookings; the announcement of new Order Bookings and the anticipated timeline for delivery; potential impacts on the time to convert opportunities into Order Bookings; expected Order Bookings activity over the balance of fiscal 2027; the expectation that the Company's Order Backlog will help mitigate some of the impact of variable Order Bookings on revenue in the short term; the conversion of Order Backlog into revenue, including the timing and pace of project execution and revenue recognition; the expected benefits where the Company engages with customers on enterprise-type solutions; the Company's plan to focus on increasing after-market sales and service revenue, including the benefits related thereto; the potential impact of the Company's approach to market and timing of customer decisions on Order Bookings, performance period, and timing of revenue recognition; the Company's expectations and beliefs regarding customer demand trends; the Company's expectations regarding lifecycle service opportunities with respect to its nuclear business; expected benefits with respect to the Company's efforts to grow its product portfolio and after-sale service revenues; the ability of after-sales revenues and reoccurring revenues to provide some balance to customers' capital expenditure cycles; the range of the expected reoccurring revenues on a trailing twelve-month basis; initiatives in furtherance of
revenue growth and improvement of profitability; the expected improvement of the Company's adjusted earnings from operations margin in fiscal 2027 through operational initiatives and portfolio development, and a combination of lower costs achieved from existing and planned restructuring and reorganization activities, disciplined execution of the ABM across the portfolio, targeted commercial practices, and an improved after-market mix supported by the integration of services directly into the Company's operating units; the expected cost reductions as a result of the reorganization activities; the expected long-term adjusted earnings from operations margin target; management's expectations regarding adjusted earnings from operations margin for the remainder of fiscal 2027 and following the fourth quarter of fiscal 2027; the anticipated range of revenues for the following quarter; the expected revenue growth for fiscal 2027, and the Company's long term goal to grow revenues greater than market growth rates in its chosen markets; the expectation that the ongoing reorganization of the Company's transportation-related operations will remove dilutive revenues; the expectation that management will operate above its targeted leverage ratio for the remainder of fiscal 2027; the expected impacts of the Company's capital allocation plan; the Company's expected improvements in free cash flow and the multi-year free cash flow target; expectation of realization of cost and revenue synergies consistent with announced integration plans; the Company's long-term goal of non-cash working capital as a percentage of annualized revenues; the expectation to continue investing in non-cash working capital to support growth; planned reorganization activities in future quarters, including the Fixed Cost Transformation Program, the European Footprint Consolidation, the expected restructuring costs in future quarters, the expectation that the restructuring and other related costs to be funded by proceeds of the sale of buildings in the U.S. and in Germany in fiscal 2027, the reinvestment of a portion of savings from the reorganization activities in higher-growth areas, the expectation of restructuring and reorganization activity to support the Company's margin expansion initiative throughout fiscal 2027 including the expected timing, scope, anticipated benefits of these initiatives to simplify the Company's operating structure and the expected annualized cost savings of such activities; the Company's expectations regarding the timing of recognition of gains as a result of the disposition of certain U.S. facilities; the Company's expectations regarding its ability to absorb fixed costs for the remainder of fiscal 2027; the Company's expectations regarding market conditions with respect to its various businesses, including laboratory equipment; the expected stock-based compensation expense per quarter in fiscal 2027; expectations in relation to meeting liquidity and funding requirements for investments; potential to use debt or equity financing to support strategic opportunities and growth strategy; underlying trends driving customer demand; potential impacts of variability in bookings caused by the timing and geographies of customer capital expenditure decisions on larger opportunities; the ability to achieve revenue growth organically and by identifying strategic acquisition opportunities; expected capital expenditures for fiscal 2027; the remediation plan for the material weakness in the Company's internal control over financial reporting, and the effectiveness of the upgraded ERP system; the uncertainty and potential impact on the Company's business and operations due to the current macroeconomic environment including the impacts of inflation, uncertainty caused by the supply chain dynamics, interest rate changes, tariffs imposed by the U.S. and the shifting trade dynamics, geo-political issues, and regional or global conflicts; steps taken by the Company to mitigate risks as a result of the tariffs imposed by the U.S., the expected future impact of such tariffs on the Company's business, including Section 338 tariffs and Section 301 tariffs, and the potential impact of changes to tariff policy; and the Company's belief with respect to the outcome or impact of any lawsuits, claims, counterclaims and contingencies.
Forward-looking statements are inherently subject to significant known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of
ATS, or developments in ATS' business or in its industry, to differ materially from the anticipated results, performance, achievements, or developments expressed or implied by such forward-looking statements. Important risks, uncertainties, and factors that could cause actual results to differ materially from expectations expressed in the forward-looking statements include, but are not limited to: the impact of regional or global conflicts; general market performance including capital market conditions and availability and cost of credit; risks related to the shifting trade dynamics including tariffs, trade policy, and trade restrictions; risks related to a recession, slowdown, and/or sustained downturn in the economy; performance of the markets that ATS serves; industry challenges in securing the supply of labour, materials, and, in certain jurisdictions, energy sources such as natural gas; impact of inflation; interest rate changes; foreign currency and exchange risk; the relative weakness of the Canadian dollar; risks related to customer concentration; risks related to any customer disagreements; impact of factors such as increased pricing pressure, decreases in availability and a corresponding increase in cost of energy and supplies, and delays in relation thereto, further delays or revisions of customer awards, lower-than-expected Order Bookings, failure of expected Order Bookings to materialize over the balance of fiscal 2027, delays in converting Order Bookings or Order Backlog into revenue, and possible margin compression related thereto; the regulatory and tax environment; the emergence of new infectious diseases or any epidemic or pandemic outbreak or resurgence, and collateral consequences thereof, including the disruption of economic activity, volatility in capital and credit markets, and legislative and regulatory responses; the impacts of inflation, uncertainty caused by the supply chain dynamics, interest rate changes, shifting trade dynamics and tariffs, and regional or global conflicts that have in the past and may in the future lead to significant price and trading fluctuations in the market price for securities in the stock markets, including the TSX and the NYSE; the expected future impact of tariffs on the Company's business, including the Section 338 tariffs; the inability of the Company to shift production of tariff impacted volume to other facilities; energy shortages and global price increases; inability to successfully expand through development of new markets and business platforms, expanding service offerings, investment in innovation and product development, and strategic and disciplined acquisition, due to an inability to grow expertise, personnel, and/or facilities at required rates or to identify, negotiate and conclude one or more acquisitions; or to raise, through debt or equity, or otherwise have available, required capital; that the ABM is not effective in accomplishing its goals; that ATS is unable to expand in emerging markets, or is delayed in relation thereto, due to any number of reasons, including inability to effectively execute organic or inorganic expansion plans, focus on other business priorities, or local government regulations or delays; that the timing of completion of new Order Bookings is other than as expected due to various reasons, including schedule changes or the customer exercising any right to withdraw the Order Booking or to terminate the program in whole or in part prior to its completion, thereby preventing ATS from realizing on the full benefit of the program; that some or all of the sales funnel is not converted to Order Bookings due to competitive factors or failure to meet customer needs; that the market opportunities ATS anticipates do not materialize, develop slower than expected or that ATS is unable to exploit such opportunities; failure to convert Order Backlog to revenue and/or variations in the amount of Order Backlog completed in any given quarter; timing of customer decisions related to large enterprise programs and potential for negative impact associated with any cancellations or non-performance in relation thereto; that the Company is not successful in growing its product portfolio and/or service offering or that expected benefits are not realized; that efforts to improve adjusted earnings from operations margin for the remainder of fiscal 2027 and following the fourth quarter of fiscal 2027 and over the long-term are unsuccessful, due to any number of reasons, including less than anticipated increase in after-sales service revenues or reduced margins attached to those revenues, inability to achieve lower costs through supply chain management, price and lead-time volatility, failure to develop, adopt internally, or
have customers adopt, standardized platforms and technologies, inability to maintain current cost structure if revenues were to grow, and failure of ABM to impact margins; that after-sales or reoccurring revenues do not provide the expected balance to customers' expenditure cycles; that revenues are not in the expected range; that acquisitions made are not integrated as quickly or effectively as planned or expected and, as a result, anticipated benefits and synergies are not realized; non-cash working capital as a percentage of adjusted revenues operating at a level other than as expected due to reasons, including, the timing and nature of Order Bookings, the timing of payment milestones and payment terms in customer contracts, and delays in customer programs; that planned reorganization activities are not completed at the cost or within the timelines expected, or at all; underlying trends driving customer demand will not materialize or have the impact expected; that capital expenditure targets are increased in the future or the Company experiences cost increases in relation thereto; the remediation plan for the material weakness in the Company's internal control over financial reporting and the upgraded ERP system are not effective; risk that the ultimate outcome of lawsuits, claims, and contingencies give rise to material liabilities for which no provisions have been recorded; the consequence of activist initiatives on the business performance, results, or share price of the Company; the impact of analyst reports on price and trading volume of ATS' shares; impact of the leadership transition; and other risks and uncertainties detailed from time to time in ATS' filings with securities regulators, including, without limitation, the risk factors described in ATS' Annual Information Form, which are available on the SEDAR+ at www.sedarplus.ca and on the U.S. Securities Exchange Commission's EDGAR at www.sec.gov. ATS has attempted to identify important factors that could cause actual results to materially differ from current expectations; however, there may be other factors that cause actual results to differ materially from such expectations.
Forward-looking statements are necessarily based on a number of estimates, factors, and assumptions regarding, among others, management's current plans, estimates, projections, beliefs and opinions, the future performance and results of the Company's business and operations; the ability of ATS to execute on its business objectives; the effectiveness of ABM in accomplishing its goals; the ability to successfully implement margin expansion initiatives; management's assessment as to the project schedules across all customer contracts in Order Backlog, the strengthening of Order Bookings over the balance of fiscal 2027 and the conversion of those Order Bookings and Order Backlog into revenue within expected timelines, faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity; management's assessment of the mix of projects in the funnel and Order Backlog that may or may not convert to revenue and the associated margins of such projects; the volume of outstanding projects the Company is contracted to perform, the size and duration of those projects, and the timing of project activities including design, assembly, testing, and installation will support revenue growth; initiatives in furtherance of the Company's goal of improving its adjusted earnings from operations margin in fiscal 2027 and over the long term will result in improvements to adjusted earnings from operations margin; the anticipated growth or capabilities in the life sciences, radiopharmaceuticals food & beverage, consumer products, energy, and nuclear markets; the ability to seek out, enter into and successfully integrate acquisitions; the Company's expectations of industry consolidation over the next two years; the Company's expectations regarding future market conditions; ongoing cost inflationary pressures and the Company's ability to respond to such inflationary pressures; the effects of foreign currency exchange rate fluctuations on its operations; the Company's competitive position in the industry, including global presence, size and critical mass, technical skills, capabilities and experience, product and technology portfolio, recognized brands, trusted customer relationships, and total-solutions capabilities; the underlying trends driving customer demand for ATS solutions remain favourable; the Company's ability to adapt and develop solutions that
keep pace with continuing changes in technology and customer needs; the ability to maintain mutually beneficial relationships with the Company's customers; planned restructuring and reorganization activities will be implemented as expected and within anticipated cost ranges; and general economic and political conditions, and global events, including any regional and global conflicts, epidemic or pandemic outbreak or resurgence, and the international trade dynamics.
Forward-looking statements included in this news release are only provided to understand management's current expectations relating to future periods and, as such, are not appropriate for any other purpose. Although ATS believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and ATS cautions you not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. ATS does not undertake any obligation to update forward-looking statements contained herein other than as required by law.
Certain forward-looking information included in this news release may also constitute a "financial outlook" within the meaning of applicable securities laws. Such financial outlook may include, without limitation, statements regarding expected revenues, expected adjusted earnings from operations margin, adjusted earnings from operations margin targets, expected restructuring costs, expected capital expenditures and free cash flow targets. Financial outlook involves statements about ATS' prospective financial performance, financial position or cash flows that is based on and subject to the assumptions about future economic conditions and courses of action described above as well as management's assessment of project schedules across all customer contracts in Order Backlog, expectations for faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity, and lower costs achieved from the transportation reorganization. Such assumptions are based on management's assessment of the relevant information currently available and any financial outlook included herein is provided for the purpose of helping readers understand management's current expectations and plans for the future as of the date hereof. The actual results of ATS' operations may vary from the amounts set forth in any financial outlook and such variances may be material. Readers are cautioned that reliance on any financial outlook may not be appropriate for other purposes or in other circumstances and that the risk factors described above and other factors may cause actual results to differ materially from any financial outlook.